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A B S T R A C T  
 
Estrogens, particularly its biologically active form 17β-estradiol (estradiol), have 
repeatedly been illustrated to have long-lasting influences over cognitive function 
and behaviour, which is believed to be, in part, driven by estrogenic regulation of 
synaptic plasticity. Specifically, estrogens have been shown to rapidly, within 
minutes, regulate dendritic spine dynamics, and shape synapse structure and 
function. Critically, the rapid effects of estrogens on synapses are mediated by 
specific signalling pathways, which have been shown to be required for 
estrogenic-facilitation of learning and memory. More recently, emerging evidence 
indicates that estrogens regulate learning and memory through the modulation of 
local protein synthesis; the ability to produce nascent proteins without the need 
for gene transcription. However, the molecular and cellular mechanisms that 
underlie estrogen’s ability to regulate local protein synthesis and furthermore, 
whether such a mechanism can ultimately impact synaptic function in both male 
and female brains is currently unknown. The role of acute estrogen signalling in 
regulating local protein synthesis within the hippocampus of males and females 
was investigated in this thesis.  
 
Employing a combination of Surface Sensing of Translation (SUnSET) and 
fluorescent non-canonical amino acid tagging (FUNCAT) assays, estradiol was 
found to increase protein synthesis within 2 hour estradiol treatment in male and 
ovariectomised (OVX) hippocampal slices. This was mediated by two different 
signalling pathways in both sexes. Interestingly, in concert with this increased 
local translation, there was an increase in a subset of synaptic proteins and 
dendritic spines observed within the same time-frame in both sexes. These 
proteins are targeted to dendritic spines in the primary neuronal model. This study 
proposes a novel mode of estrogen signaling that could result in long-lasting 
changes in neuronal circuitry and cognitive function. Further research is 
warranted to test the beneficial effects of estradiol in the context of a local protein 
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C H A P T E R  1  
 




O V E R V I E W  
 
There is compelling evidence that the regulation of structure and function of 
neuronal circuits is an essential component of normal cognitive function and 
behaviour. The general consensus is that neuronal circuits, post initial 
formation, still remain plastic to a certain extent during adulthood. This allows 
different morphological modifications to occur in response to environmental and 
extracellular stimuli during adulthood. For instance, agents such as steroid 
hormones are able to trigger alterations in distinctive elements of the neuronal 
circuity through the initiation of different signalling cascades and neuronal 
processes. There is mounting evidence illustrating that alterations in the 
neuronal circuity seems to correlate with alterations in distinct processes such 
as learning and memory, and behaviour.  
 
Steroid hormones such as estrogens have been reported to influence nervous 
system development and function (Losel et al., 2003). They have been 
implicated in numerous physiological functions such as reproductive, 
development, cardiovascular and neuronal function (Brinton, 2009; McEwen 
and Alves, 1999). One of the most studied effects of estrogens in the brain is its 
ability to influence cognition. The enhancing effects of estrogens has been 
reported in rodent and non-human primate models and to a lesser extent 
humans (Sellers et al. 2015a). Estrogens have also been suggested to have 
beneficial effects in disease both in protection against pathology and potentially 
as a restorative agent (Sellers et al., 2015a; Srivastava et al., 2013). However, 
a large clinical trial, the Women’s Health Initiative, found no benefits on 
cognition from hormone therapy and, instead reported a decline in cognitive 
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function and increased risk of dementia and stroke (Espeland et al., 2004; 
Shumaker et al., 2003, 2004). This study was widely criticised due to: the use of 
65 years or older, women who were at least 15 years post-menopause; the 
variability in their health; and the use of conjugated equine estrogens and 
synthetic progesterone within the trial (Brinton, 2005). In support, studies have 
proposed a ‘window of opportunity’ for when the brain is still responsive to 
estrogens following menopause or surgical removal of ovaries  (Singh et al., 
2013). In support of this, other studies have reported positive effects of 
estrogens on memory in female humans (Sherwin and McGill, 2003). Recently, 
work from our group has begun to investigate whether estrogens can induce 
cellular effects associated with enhancement of cognition, in human neurons 
generated from induced pluripotent stem cells (hiPSCs) (Shum et al., 2015). 
Consistent with the prediction that estrogens can positively modulate cognition 
in humans, estrogens have shown to regulate cellular parameters such as 
structural plasticity in hiPSC-neurons (Shum & Srivastava, personal 
communication). Therefore, together with the beneficial effects of estradiol 
reported on rodent and non-human primate models, and recently in hiPSC-
models from our lab, there is increased interest for further research on 
understanding the role of estrogens on cognitive functioning and behaviour. 
 
Classically, estrogens, and in particular the biologically active form 17β-estradiol 
(estradiol; E2), have been demonstrated to exert their effects on the brain 
through gene transcription over several hours to days (Srivastava et al., 2013). 
However, it is now greatly appreciated that they can also facilitate rapid effects 
that manifest within minutes to hours (Frick and Kim, 2018; Luine, 2015; Sellers 
et al., 2015a; Srivastava et al., 2013). Much recent research has delved in 
understanding the underlying molecular mechanisms of these rapid effects on 
the functioning of the hippocampus and much of the work from our lab has 
focussed on the cortex. These rapid estrogenic actions have been shown to 
mediate different neuronal functions such as synaptic plasticity, cognition and 
neuroprotection (Srivastava et al., 2013). Countless rodent studies have 
exemplified the significance of rapid estrogen-induced modulatory effects on 
cognitive augmentation, including memory processing and social behaviours 
(Choleris et al., 2012; Frick and Kim, 2018; Luine et al., 2018). The long-lasting 
influences over cognitive function and behaviour is believed to be in part driven 
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by estrogenic regulation of synaptic plasticity (Srivastava and Penzes, 2011). 
The underlying molecular and cellular mechanisms mediating this plasticity 
have yet to be fully elucidated. Multiple lines of evidence have demonstrated 
that estradiol can rapidly influence protein translation machinery and signalling 
pathways involved in protein synthesis in neurons. However, the mechanisms 
linking rapid estrogenic signaling with protein synthesis, and the outcome of 
engaging this mechanism is currently unknown. The following sections will 
review the influence of estradiol on synaptic plasticity in the brain. Following 
this, evidence for local protein synthesis along dendrites of neuronal cells will be 
discussed. Finally, evidence for a role for local protein synthesis in estrogenic 
signaling will be presented. 
 
E S T R O G E N  S I G N A L L I N G  I N  T H E  B R A I N  
 
Classical vs. rapid signalling 
 
A series of landmark papers first identified that estradiol could influence the 
neuronal architecture. The rat estrous cycle was found to mediate fluctuations in 
dendritic spines (Woolley et al., 1990) and synapse density (Woolley and 
McEwen, 1992) in the CA1 region of the hippocampus. Dendritic spines are 
small actin-rich protrusions that decorate the dendrites of neuronal cells and 
house post-synaptic densities (PSDs) (Chubykin et al., 2007; Harris and 
Stevens, 1989). PSDs consist of a large number of key proteins that 
synchronise to form functional excitatory synapses - the point of communication 
between two neurons (McAllister, 2007). Ovariectomy1 (OVX)-induced loss of 
dendritic spines was found to be rescued by chronic estradiol treatment in the 
CA1 hippocampus (Gould et al., 1990). Studies that followed showed that: 
dendritic spine numbers were highest during the proestrous phase where 
estradiol levels are higher and lowest during estrous phase where estradiol 
levels are lower (Woolley et al., 1990); synapse density followed the same 
pattern (Woolley and McEwen, 1992); estradiol treatment increased synapse 
density (Woolley and McEwen, 1992); and estradiol-mediated increase in 
dendritic spines was dependent on N-methyl-D-aspartate receptor (NMDAR) 
                                            
1 The surgical removal of one or both ovaries. 
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activation (Woolley and McEwen, 1994). These observations were then thought 
to be dependent on gonadally-driven estradiol acting on the brain. Current 
research has juxtaposed the classical views of estrogens influencing plasticity 
over several hours to days. It is now greatly appreciated that estrogens can 
rapidly facilitate plasticity, within minutes to hours through a ‘non-genomic’ 
mechanism (Srivastava et al., 2013), which is reviewed later. This rapid 
estradiol-mediated modulation is supported by compelling research challenging 
the classical dogma that the brain is targeted by gonadally-driven estrogens. 
There is accumulating evidence illustrating the presence of estrogen receptors 
(ERs) at extra-nuclear sites such as synapses and along dendritic shafts, in 
addition to the nucleus.  Moreover, estradiol can also be synthesised de novo in 
the brain (Frick, 2015; Sellers et al., 2015a; Srivastava et al., 2013). It is thus, 
thought that estradiol synthesised de novo in the brain may locally control 
synaptic changes within a rapid time-frame in the brain. 
 
Estradiol synthesis in the hippocampus 
 
The rapid effects of estradiol in the brain have been suggested to be mediated 
by locally synthesised estradiol (Cornil et al., 2012; Srivastava and Penzes, 
2011). The biosynthesis of estrogens both peripherally and within the brain 
depend on the precursor cholesterol (Woolley, 2007). Estrogens can be directly 
converted from cholesterol in the brain or from circulating androgens produced 
in the steriogenic organs outside the brain (Cornil et al., 2006; Srivastava et al., 
2013). It is aromatase cytochrome P450 (aromatase) however, that is the final 
enzyme (Simpson et al., 1994) and the rate-limiting step (Srivastava et al., 
2013) of the biosynthesis of estradiol producing three estrogen compounds: 
estrone, estriol and estradiol, of which estradiol is the most potent. Estradiol 
levels are higher in the hippocampus, picomolar to nanomolars, compared to 
circulating levels, lower picomolars in both male and female rats (Hojo et al., 
2009). Hippocampal estradiol levels are also higher in OVX female rats 
compared to the circulating estradiol levels during all stages of the estrous cycle 
(Kato et al., 2013). This is thought to be a direct consequence of de novo 
synthesised estrogens. Critically, only high concentrations of estrogens elicit 
rapid effects (Srivastava et al., 2013). Therefore, circulating levels may not be 
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high enough to induce any rapid effects within the brain, and thus, it is likely that 
locally produced estradiol exert these effects (Cornil et al., 2006; Hojo et al., 
2009). Additionally, estradiol is synthesised de novo in both male (Hojo et al., 
2004) and female (Prange-Kiel et al., 2003) hippocampus suggesting that this is 
not unique to females. It is also important to consider how circulating estrogens 
show no specificity within the brain, as changes in estradiol levels would impact 
all areas of the brain expressing ERs equally. Conversely, locally produced 
estrogens could regulate cellular functions in a spatially restricted manner 
(Cornil et al., 2006; Srivastava et al., 2013). For estradiol to regulate rapid 
effects in the brain, it would need to be synthesised locally and thus, aromatase 
would have to be locally available. The following sections describe the 
localisation of aromatase within the brain and discuss its effects on synaptic 
plasticity.  
 
LOCALISATION OF AROMATASE 
 
Aromatase has been localised to a number of brain regions in rodents including 
the amygdala, cortex, hippocampus and the hypothalamus (MacLusky et al., 
1994). In humans, aromatase expression has also been demonstrated in the 
male and female cortex (Yague et al., 2006). Although found in glial cells, this 
enzyme is highly expressed in pyramidal cells (Yague et al., 2006). Aromatase 
is also present at synapses (Hojo et al., 2004; MacLusky et al., 1994; 
Srivastava et al., 2010; Yague et al., 2008). Specifically, aromatase localises 
pre-synaptically (Cornil et al., 2012; Naftolin et al., 1996; Remage-Healey et al., 
2011; Srivastava et al., 2010); co-localisation with pre-synaptic marker bassoon, 
and axonal marker tau5 was previously observed in the cortex in vitro 
(Srivastava et al., 2010). This study also reported co-localisation with post-
synaptic density protein 95 (PSD-95), an abundant protein found at PSDs. 
Other studies have also described a post-synaptic localisation (Naftolin et al., 
1996; Prange-Kiel et al., 2006). Thus, aromatase is ideally placed to drive the 
synthesis of estradiol both pre-/post-synaptically to regulate synaptic behaviour 





ROLE IN PLASTICITY 
 
The role of hippocampally synthesised estradiol in synaptic plasticity has been 
widely examined. Aromatase inhibition, via letrozole, decreases estradiol levels 
(Prange-Kiel et al., 2003) and also orchestrates the decrease in dendritic 
spines, synaptic protein levels of pre-synaptic synaptophysin and post-synaptic 
spinophilin and number of pre-synaptic boutons (Kretz et al., 2004; Prange-Kiel 
et al., 2006; Vierk et al., 2012; Zhou et al., 2010). Physiologically, letrozole 
impairs long term potentiation (LTP) in male and female rats (Vierk et al., 2012), 
a form of synaptic plasticity thought to underlie memory formation (Takeuchi et 
al., 2014). Behaviourally, letrozole impairs object recognition (OR) and object 
placement (OP) memory in OVX female mice (Tuscher et al., 2016a). Thus, 
hippocampally synthesised estradiol has been shown to contribute to mediate 
hippocampal structural plasticity, physiology and behaviour.  
   
Estrogen receptors in the hippocampus 
 
ERs AND THEIR LOCALISATION 
 
Local synthesis of estradiol and its ensuing local actions on structural plasticity 
suggest receptors specific for estradiol would also be appropriately localised. 
Estrogen receptors (ERs) alpha (ERα) and beta (ERβ), and the more recently 
identified G-protein coupled estrogen receptor 1 (GPER1; formally GPR30) 
have been implicated in mediating the rapid estrogen signalling in both cortex 
and hippocampus (Hughes et al., 2009; McEwen et al., 2001; Romano and 
Gorelick, 2018; Srivastava and Evans, 2013) and have received the most 
attention in research. It should be noted that there are other novel identified 
estrogen binding proteins that may be mediating estradiol’s effects such as ER-
X or Gq protein-coupled membrane-initiated estrogen receptor (Gq-mER) 
(Micevych and Dominguez, 2009).  
 
Classical, or nuclear, ERα and ERβ are structurally related and derive from the 
class I nuclear receptor superfamily acting as ligand-activated transcription 
factors (Hughes et al., 2009; Rainville et al., 2015). They are composed of 
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several functional domains: A/B or NH2-terminal domain; C or DNA-binding 
domain; and the D/E/F or ligand binding domains (Nilsson et al., 2001). Upon 
ligand binding, the nuclear ERs undergo conformational changes followed by 
dimerization, their subsequent translocation from the cytoplasm to the nucleus 
where they bind to estrogen response elements (ERE) in the promoters of 
genes thereby, mediating gene transcription (Hughes et al., 2009). In contrast, 
GPER1 is a seven-transmembrane G-protein coupled receptor (Waters et al., 
2015) and it has been suggested that its interaction with PSD-95 allows it to 
reside at the cell membrane (Akama et al., 2013). Interestingly, ERα and ERβ 
have also been found localised to the cell membrane (Micevych and 
Dominguez, 2009) and it is the membrane localised ERα and ERβ that are 
thought to contribute to the rapid effects of estradiol (Micevych and 
Mermelstein, 2008), which is discussed in the next sub-section. Razandi et al. 
(1999) demonstrated that membrane bound ERα and ERβ are derived from the 
same gene as nuclear ERα and ERβ in Chinese hamster ovary (CHO) cells. 
This suggests that the same nuclear-localised protein is capable of being 
targeted to the membrane. The mechanisms by which ERs are trafficked to cell 
membranes are not well understood nevertheless, two mechanisms have been 
thought to contribute to this (Almey et al., 2015). Studies have suggested post-
translation modifications such as palmitoylation, which is known to promote 
membrane localisation of proteins (Levin, 2010), play a pivotal role. 
Palmitoylation of cysteine sites in the ligand binding (E) domain of the ERs have 
been shown to be necessary for membrane localisation in human cancer cells 
(HeLa) (Acconcia et al., 2005) and CHO cells (Razandi et al., 2003). Other 
studies have shown that ERs interact with scaffolding proteins, caveolins, that 
are found within caveolae within the plasma membrane (Almey et al., 2015). In 
support, knocking down caveolin was found to decrease the expression of 
membrane ERα in the hypothalamus (Christensen and Micevych, 2012). It has 
been suggested that palmitoylation of ERα is what allows the association with 
caveolin and, its subsequent translocation to cell membranes (Pedram et al., 
2007). Although other mechanisms have been proposed, these two 
mechanisms have convincingly demonstrated how nuclear ERs may translocate 
to the cell membranes (Almey et al., 2015; Levin, 2010). A caveat of these 
studies is that the majority have focussed on ERα than both ERs and 
consequently, more research is warranted to confirm whether these 
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mechanisms dictate the trafficking of both ERs and if any other mechanisms are 
also necessary.   
 
ERα and ERβ have differential distribution in the brain between region, sexes 
and age between species (Hughes et al., 2009; Sellers et al., 2015a). ERα 
mRNA and protein expression have both been predominantly found in the 
hypothalamus and amygdala whereas, ERβ predominantly found in the 
hippocampus formation, cerebral cortex and thalamus (Gonzalez et al., 2007; 
Hughes et al., 2009; Mitra et al., 2003); their putative locations suggest they 
have distinct roles in the brain. GPER1 is also expressed highly in the cortex 
and hippocampus (Almey et al., 2015; Srivastava and Evans, 2013). All three 
have also been localised in glial cells suggesting estradiol also mediates non-
neuronal actions in the brain (Chaban et al., 2004; Waters et al., 2015). 
Critically, studies have denoted the presence of ERα, ERβ and GPER1 at 
synapses and other extra-nuclear locations such as, axon terminals within the 
hippocampus and cortex (Almey et al., 2015; Milner et al., 2001, 2005; Sellers 
et al., 2015b; Waters et al., 2015).  Additionally, all three receptors have also 
been localised to interneurons within the rodent hippocampus (Milner et al., 
2001, 2005; Waters et al., 2015). Thus, their localisation is ideal to rapidly 
regulate synaptic plasticity.  
 
ER SIGINALLING  
 
Traditionally, estrogen signalling was thought to be mediated by estrogens 
binding to classical ERα and ERβ, where the translocation to the nucleus result 
in the classical ‘genomic’ effects (Frick, 2015; Galea et al., 2017; Srivastava et 
al., 2013). These would take hours to days to manifest. Alternatively, the rapid 
effects or the ‘non-genomic’ effects are thought to be mediated by membrane, 
or extra-nuclear, ERs (Luine and Frankfurt, 2012; Srivastava et al., 2013). 
Employing specific ER agonists, investigations have uncovered specialised 
roles for the ERs within the hippocampus. Activation of specific ERs has been 
found to enhance synaptic plasticity within the hippocampus, and the cortex and 
improve hippocampal-dependent learning and memory (Choleris et al., 2012; 
Frick, 2015; Luine and Frankfurt, 2012; Sellers et al., 2015a; Srivastava et al., 
2013), which will be explored in the following sections. There is accumulating 
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evidence suggesting that estradiol can initiate membrane-signalling pathways 
via ERs within 5-10 minutes in vitro and in vivo in the cortex and hippocampus 
(Frick, 2015; Luine and Frankfurt, 2012; Sellers et al., 2015a). The activation of 
multiple kinase pathways is thought to be critical in mediating estradiol-
mediated enhancement of memory within the hippocampus (Frick and Kim, 
2018), which are discussed in greater detail later. However, it is also 
appreciated that ERα and ERβ can interact with other receptors such as group I 
metabotropic glutamate receptor (mGluR) and group II mGluR within female-
derived hippocampal neurons (Boulware et al., 2005). This study reported that 
whilst only ERα was found to activate group I mGluR signalling, both ERα and 
ERβ were found to activate group II mGluR signalling. ERs are therefore, ideally 
localised to rapidly regulate synaptic changes and activate membrane-initiated 
signalling cascades, which may contribute to hippocampal synaptic plasticity. 
As a consequence, a number of ERs may mediate estradiol signalling by 
coupling to different intracellular signalling cascades, directly or via other 
receptors leading to the activation of specific signalling proteins (Sellers et al., 
2015a). This could lead to a number of cellular effects driven either genomically 
through gene transcription or non-genomically such as, inducing local protein 
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Figure 1.1 Rapid estrogen membrane-signalling. The rapid effects of estradiol 
are mediated by a number of different estrogen receptors (ERs) such as, ERα, 
ERβ and GPER1. ERs couple to intracellular signalling cascades potentially 
directly or through the activation of other receptors. This leads to the activation 
of a number of kinases such as the extracellular signal-regulated kinase 1/2 
ERK1/2 (ERK), phosphatidylinositol 3-kinase (PI3K)/Akt (PKB) (P13/Akt) and 
mammalian target of rapamycin (mTOR). The subsequent activation can lead to 
the modulation of several cellular effects such as cytoskeletal reorganisation 
and trafficking of proteins. It can also lead to gene transcription or the regulation 
of local protein synthesis. Adapted from Sellers et al. (2015a).   
 
M O D U L A T I O N  O F  C O G N I T I O N  A N D  




One of the most studied effects of estradiol in the hippocampus is its beneficial 
effects on learning and memory (Frick, 2015; Luine and Frankfurt, 2012). There 
has been considerable evidence in OVX female rodents in comparison to the 
paucity of studies in male rodents. Nevertheless, estradiol-mediated 
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enhancement of memory is not unique to OVX females (Frick, 2015). A small 
number of studies have assessed memory in gonadally intact females largely 
because of the challenges faced between fluctuating hormone levels over the 
estrous cycle and the protocols for assessing memory that last over a few days 
(Tuscher et al., 2015). However, studies have illustrated enhanced performance 
on memory tasks during proestrous, where estradiol levels are high, compared 
to diestrus and estrus, when levels are lower in rats (Walf et al., 2006) and mice 
(Sánchez-Andrade and Kendrick, 2011). A myriad of studies has measured 
effects of estradiol on memory acquisition and consolidation mostly by 
employing OR, OP and social discrimination tasks, although other behavioural 
tasks have also been employed. These tasks comprise of two identical objects 
or conspecifics that rodents explore during the training period (T1). Following an 
inter-trial delay either: a new object is substituted for a new one (OR); one of the 
objects is moved to a different location (OP); or a conspecific is substituted for a 
novel one. Memory acquisition or consolidation is determined during the testing 
period (T2) measured by a greater exploration time with the novel/relocated 
object or novel animal (Ervin et al., 2015; Luine, 2014). Timing of estradiol 
administration and behavioural testing can categorise rapid or long-term effects 
of estradiol on memory (Paletta et al., 2018). Estradiol affects learning and 
memory via both ‘genomic’ and ‘non-genomic’ mechanisms and these 
mechanisms are not mutually exclusive (Sheppard et al., 2018). A number of 
studies that chronically applied estradiol days to weeks prior training found 
memory enhancements in a number of memory tasks in both gonadectomised 
(GDX) male (Luine and Rodriguez, 1994) and OVX females (Fonseca et al., 
2013; Jacome et al., 2010; Luine et al., 1998; Vedder et al., 2013). The time-
frame of these studies suggest that estradiol may utilise gene transcription to 
enhance memory. Historically, memory research was directed towards the 
genomic actions of estradiol however, the data pointing towards the rapid 
effects of estradiol in the hippocampus are plenteous. 
 
ACUTE ESTRADIOL TREATMENT ON MEMORY – ACQUISITION STUDIES IN 
OVX FEMALE RODENTS 
 
One of the first studies to illustrate rapid effects of estradiol on memory 
demonstrated that estradiol administered either 30 minutes before training or 
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immediately after enhanced OR and OP when tested 4 hours later in OVX 
female rats (Luine et al., 2003). This was recapitulated in a more rapid learning 
paradigm by administrating estradiol 15 minutes before training, followed by 
testing after 25 minutes in OVX female mice (Phan et al., 2012); enhanced 
social recognition was also observed within the same time-frame. This study 
was a first of its kind to illustrate improved learning within 40 minutes of 
estradiol administration with the advantage of using a time-frame where 
memory is reported to be independent of transcription (Phan et al., 2012). Thus, 
suggesting that these rapid estrogenic actions on learning are possibly non-
genomic.  
 
ACUTE ESTRADIOL TREATMENT ON MEMORY – CONSOLIDATION STUDIES 
IN OVX FEMALES RODENTS 
 
A number of studies from both Victoria Luine and Karyn Frick’s groups have 
assessed estradiol’s effects on memory consolidation by administering estradiol 
immediately after training, with varying inter-trial delays (Sheppard et al., 2018). 
Estradiol administration immediately after training, but not after a delay of 2 
hours (Luine et al., 2003) or 45 minutes (Inagaki et al., 2010) enhanced both 
OR and OP in OVX female rats. Other studies have reported that estradiol 
enhanced OR and OP when it was administered immediately (Walf et al., 2008) 
but not after 1 hour (Walf et al., 2006) or 1.5 hours (Frye et al., 2007) 
respectively in OVX female rats. The testing occurred 4 hours after training for 
all the investigations. Furthermore, these findings have been mirrored in OVX 
female mice. Estradiol enhanced OR when administered immediately after 
training (Fan et al., 2010; Fortress et al., 2013; Gresack and Frick, 2006) but not 
after 3 hours (Fernandez et al., 2008) when tested 24-48 hours after training. 
Critically, some studies have found no such effect of estradiol enhancing 
hippocampal memory in OVX female rats using other memory tasks, such as 
the radial arm maze task (Galea et al., 2001). Collectively, these studies report 
that estradiol enhances memory consolidation only when administered after 
training but that a delay of 45 minutes or longer has no effect. This provides a 




MEMORY STUDIES IN MALE RODENTS  
 
The rapid memory enhancing effects of estradiol has been investigated to a 
lesser extent in male rodents compared to females. A recent study has 
illustrated that estradiol administered post training enhanced OP in GDX male 
rats (Jacome et al., 2016). Other unpublished preliminary work from Karyn 
Frick’s laboratory suggests that both OR and OP are enhanced following 
estradiol administration after training in gonadally intact male mice (Koss and 
Frick, 2017). Other spatial memory tasks have shown estradiol-mediated 
enhancement in the Morris water maze task in gonadally intact male rats 
(Packard and Teather, 1997) and as previously mentioned, GDX male rats 
(Luine and Rodriguez, 1994). Critically, this enhancement was not observed in 
gonadally intact males more recently (Moradpour et al., 2006). Thus, a limited 
number of studies suggest estradiol can rapidly enhance memory consolidation 
in male rodents, but further research is warranted. Thus far, the rapid effects of 
estradiol has not been studied in the context of social discrimination however, 
many studies have looked the long-term effects of estradiol in a number of ER 
KO rodent models (Choleris et al., 2012). Although more research is warranted 
in the male hippocampus, estradiol seems to have a synonymous effect in 
enhancing memory as observed in OVX females.  
 
Overall, these studies show that estradiol has no effect when administered 45 
minutes after training, suggesting that estradiol is contributing to the memory 
consolidation quite rapidly. In support, paradigms where estradiol’s effects were 
observed after 40 minutes (Phan et al., 2012) occur in too rapid of a time-frame 
to be dependent on genomic effects (Paletta et al., 2018). Indeed, these 
enhancements are observed across different species, training protocols, routes 
of administration suggesting estradiol is reliably enhancing specific hippocampal 
memory (Frick and Kim, 2018). Overall, rodent studies have provided an insight 
into the rapid enhancing effects of estradiol in hippocampal memory 
consolidation; these studies are summarised in Figure 1.2. The underlying 
molecular mechanisms that mediate this rapid memory consolidation are 
however, unclear. More so, whether these mechanisms are synonymous 





Figure 1.2 Estrogen rapidly enhances memory in rodents. Diagram adapted 
from Dr. Deepak Srivastava (personal communication) showing a summary of 
different studies where estradiol has been shown to enhance object recognition 
(OR), object placement (OP) and social recognition memories. Two identical 
objects or conspecifics are presented to rodents during the training period (T1). 
Following an inter-trial delay either: a new object is substituted for a new one 
(OR); one of the objects is moved to a different location (OP); or a conspecific is 
substituted for a novel one. Studies where estradiol was administered 15-30 
minutes before, or immediately after training show an enhanced performance in 
OVX female rodents when tested 4-48 hours post-training. When administered 
after a delay post-training, estradiol has no enhancing effects on memory. 
 
Molecular mechanisms underlying memory enhancement 
 
ERs IMPLICATED IN ENHANCING HIPPOCAMPAL MEMORY  
 
Multiple lines of evidence have tried to tackle the question of which ER is 
required in mediating these memory enhancements. Although this has been 
investigated using rodent ER-specific KO models and specific ER agonist, a lot 
of this largely remains unclear. Much of the work using the rapid learning 
paradigm have shown ERα, through agonist 4,4',4''-(4-Propyl-[1H]-pyrazole-
1,3,5-triyl)trisphenol (PPT) (Gabor et al., 2015; Phan et al., 2012) and GPER1 
agonist rel-1-[4-(6-bromo-1,3-benzodioxol-5-yl)-3aR,4S,5,9bS-tetrahydro-3H-
Training (T1) Testing (T2)
Pre-Training Post-Training Delayed Post-Training 
Inter-trial delay 25 min-4 hrs
Luine et al., 2003;
Phan et al., 2012;
Boulware et al., 2013
Fan et al., 2010;
Fernandez et al., 2008
Fortress et al., 2013;
Frye et al., 2007;
Gresack and Frick, 2007;
Inagaki et al., 2010;
Luine et al., 2003;







cyclopenta[c]quinolin-8-yl]-ethanone (G1) (Gabor et al., 2015) to mediate 
memory enhancing effects of estradiol in OR, OP and social discrimination. 
Whereas, other studies administering agonists, including ERβ agonists 7-
Bromo-2-(4-hydroxyphenyl)-1,3-benzoxazol-5-ol (WAY 200070; 070) and 2,3-
bis(4-Hydroxyphenyl)-propionitrile (DPN), and specific antagonists immediately 
following training have implicated both ERα and ERβ (Boulware et al., 2013; 
Kim and Frick, 2017; Pereira et al., 2014; Walf et al., 2006). ER-specific KO 
models have suggested a more prominent role for ERβ (Liu et al., 2008; Walf et 
al., 2008). Collectively, these results allude to the role of both ERα and ERβ in 
enhancing memory. Nevertheless, more studies are warranted to confirm this. 
Furthermore, studies are also required to explore the role of GPER1 and 
investigate which ER is important in males. 
 
CELL SIGNALLING CASCADES REGULATING ESTRADIOL-INDUCED 
MEMORY CONSOLIDATION 
 
It can be reasoned that if estradiol is differentially employing ERs to mediate 
different types of memory, that different signalling pathways may also be 
involved in mediating different types of memory. Moreover, these pathways may 
not be synonymous in both sexes. Estradiol has been demonstrated to rapidly 
activate kinases that have been implicated in memory enhancement such as 
the extracellular signal-regulated kinase 1/2 ERK1/2 (ERK), phosphatidylinositol 
3-kinase (PI3K)/Akt (PKB) (P13/Akt) and mammalian target of rapamycin 
(mTOR) within 5 minutes in vivo (Fan et al., 2010; Fernandez et al., 2008; 
Fortress et al., 2013), in vitro (Briz and Baudry, 2014; Sarkar et al., 2010; 
Sellers et al., 2015b) and in various cell lines (Akama and McEwen, 2003; 
Sarkar et al., 2010). Activation of ERK signalling has been implicated in the 
consolidation of spatial (Blum et al., 1999) and recognition memories (Kelly et 
al., 2003). 
 
Majority of the studies have investigated the role of these kinases in the 
memory enhancing effects in the hippocampus and have implicated both ERK 
and P13/Akt pathways in OVX female rodents. ERK phosphorylation inhibitor, 
U0126, has been shown to prevent estradiol-mediated increase in OR 
(Fernandez et al., 2008; Fortress et al., 2013; Zhao et al., 2010) and OP (Kim et 
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al., 2016) when administered immediately after training in mice. Preliminary 
findings from Elena Choleris’ laboratory have demonstrated that ERK activation 
inhibition 15 minutes prior to training is sufficient to impair social recognition in 
mice (Sheppard et al., 2016). Thus, these results suggest that ERK activation is 
critical for estradiol’s effects on both acquisition and consolidation of memories. 
Additionally, the PI3K/Akt pathway has demonstrated to be critical in LTP and 
recognition memory (Horwood et al., 2006). Inhibiting the PI3K/Akt pathway has 
been shown to block the estradiol-mediated phosphorylation of ERK and 
memory enhancement (Fan et al., 2010; Fortress et al., 2013; Lewis et al., 
2008). Interestingly, Elena Choleris’ laboratory has demonstrated that 
LY294002, a PI3K inhibitor, administration 15 minutes prior to training blocks 
estradiol from enhancing social recognition (Sheppard et al., 2017). Thus, both 
ERK and PI3K/Akt signalling pathways are necessary for estradiol to promote 
memory acquisition and consolidation. Additionally, both ERK and PI3K 
signalling pathways activate mTOR and it is posited that mTOR may be the 
convergence point for both (Richter and Klann, 2009). mTOR was first 
demonstrated to be critical in contributing in NMDAR-dependent late-phase of 
LTP (L-LTP) (Tang and Schuman, 2002) since then, its role in synaptic plasticity 
is greatly appreciated specifically, it’s role in mediating local protein synthesis 
(Hoeffer and Klann, 2010) and memory enhancement (Bekinschtein et al., 
2007). Fortress et al. (2013) additionally found that estradiol-mediated 
enhancement of OR was blocked in the presence of mTOR inhibitor, rapamycin. 
This suggests that all these pathways work together to mediate memory 
enhancing effects of estradiol however, whether they work in parallel, or 
independently is currently unknown. However, this study postulated that 
estradiol may be engaging protein synthesis within spines to enhance memory 
consolidation in rodents. This remains to be tested, but there is evidence that 
estradiol engages protein synthesis machinery. 
 
Remodelling of synaptic structure and function  
 
The studies reported above detailing estradiol-mediated rapid memory 
enhancements suggest that estradiol may be remodelling synaptic structure and 
function within the same time-frame. Indeed, classic studies by Catherine 
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Woolley, Elizabeth Gould and Bruce McEwen demonstrating spine and synaptic 
remodelling in response to the estrous cycle and estradiol treatment paved the 
way for future studies to investigate this. Following this, a number of studies 
have illustrated that chronic estradiol treatment enhances dendritic spine 
density (Luine and Frankfurt, 2012). More recently, a number of laboratories 
including ours, have reported that estradiol rapidly promotes spinogenesis in 
vitro (Sellers et al., 2015b; Srivastava et al., 2008, 2010) and in vivo (Inagaki et 
al., 2012; MacLusky et al., 2005; Phan et al., 2011, 2012, 2015; Tuscher et al., 
2016b), within 30 minutes in both cortex and hippocampus. This increase is 
seen as early as 15 minutes in vitro but this was transient as spinogenesis 
returned back to basal levels after 45 to 60 minutes (Srivastava et al., 2008). 
Additionally, Srivastava et al. (2008) reported the internalisation of α-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor subunit GluA1, 
and subsequent insertion of NMDAR subunit GluN1 causing the presence of 
silent synapses, was found to accompany spinogenesis. The spine increase 
was transient but was sustained by subsequent NMDAR activation, which led to 
the two-step wiring plasticity model (Srivastava et al., 2008). The model 
suggests that the increase in spines and generation of silent synapses places 
the spines in a ‘primed’ state, ready to respond to stimuli with a greater efficacy 
(Sellers et al., 2015a). In the absence of a stimulus, the novel spines are 
eliminated. However, upon a stimulus, these novel spines are sustained 
causing an increase in synaptic connectivity and transmission. Thus, priming 
estradiol-induced spines may contribute to the estradiol-mediated memory 
enhancements seen within 40 minutes (Sellers et al., 2015b). Indeed, enhanced 
performance in memory tasks was reported to be accompanied by increased 
spinogenesis within 40 minutes estradiol treatment (Phan et al., 2012). 
Therefore, suggesting a potential role for spinogenesis contributing to the 
estradiol-mediated acquisition of new memories. Interestingly, this initial 
increase in spine density at 30 minutes has been demonstrated to be 
independent of protein translation (Srivastava et al., 2008) but these spines 
encompass the molecular machinery needed to be functional (Sellers et al., 
2015b). In contrast to what is seen in the cortex in vitro, estradiol-mediated 
spinogenesis is still observed after 2 hours in the hippocampus in vivo (Mukai et 
al., 2007; Murakami et al., 2015). Consistent with this, estradiol enhances LTP 
in the hippocampus within 2 hours (Liu et al., 2008). In vitro, ERβ has been 
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implicated in increasing spines (Srivastava et al., 2010) within the cortex 
whereas, in vivo it is ERα that has been implicated in the hippocampus (Mukai 
et al., 2007; Murakami et al., 2015; Phan et al., 2011). Thus, different ERs may 
be important in mediating spine changes within the cortex and hippocampus 
thereby, suggesting that different signalling pathways may be important in 
mediating these effects. Studies from our laboratory have shown that both ERK 
and PI3K/Akt, but not mTOR, are needed for estradiol-mediated increase in 
spines after 30 minutes within the cortex whereas, mTOR and ERK are both 
necessary for estradiol to increase after 2 hours in the hippocampus (Tuscher et 
al., 2016b). Given that mTOR has been implicated in local protein synthesis, 
estrogenic activation of mTOR-mediated protein synthesis may play a role in 
supporting the maintenance of new spines. 
 
A role for local protein synthesis  
 
The study by Fortress et al. (2013) was the first study to highlight a role for 
mTOR-dependent protein synthesis to contribute to the memory enhancing 
effects of estradiol. Particularly, they found that estradiol activated mTOR, 
through ERK and P13/Akt, which led to an increase in the phosphorylation of 
both p70 ribosomal S6 kinase (S6K) and eukaryotic initiation factor 4E-binding 
protein 1 (4EBP1) within 5 min in dorsolateral hippocampal slices, both of which 
are implicated in regulating local protein synthesis (Costa-Mattioli et al., 2009; 
Hoeffer and Klann, 2010). Estradiol’s rapid activation of local protein synthesis 
machinery has been reported multiple times both in vitro (Akama and McEwen, 
2003; Sarkar et al., 2010) and in vivo (Fortress et al., 2013). Akama and 
McEwen (2003) have previously reported increased new protein synthesis of 
PSD-95 along dendrites of a differentiated hormone-responsive neuroblastoma 
cell line, NG108-15 (d-NG108-15) after 6 hour estradiol treatment. However, 
Sarkar et al. (2010) reported increased mRNA translation of a GFP expression 
based on a CAMKIIα 3’ untranslated region (UTR) reporter in dendrites over 1 
hour in primary neurons. These studies suggest that estradiol could be 
engaging local protein synthesis machinery both in vivo and in vitro to mediate 
increased dendritic translation over 1 hour and that PSD-95 could be a potential 
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target to investigate. To date, estradiol signalling has not been directly linked to 
protein synthesis although, some studies suggest this may be the case.   
 
A consideration for sex differences 
 
Multiple lines of evidence presented in the previous sections have outlined the 
molecular mechanisms that contribute to the effect of estradiol on structural 
plasticity and enhancing memory. However, there is a gap in the literature when 
it concerns what is known about which signalling pathways or ERs are involved 
in mediating structural plasticity and enhancing memory in males. Specifically, 
Oberlander and Woolley (2016) have shown that estradiol utilises two different 
receptors in males and OVX females to modulate the same synaptic plasticity. 
In support, biological differences between males and females are found at 
multiple levels, and within the hippocampus (Choleris et al., 2018), which could 
have differential implications in cognition and behaviour. Thus, there is a need 
for more studies to consider both sexes when assessing estradiol’s effects on 
neuronal transmission, structural plasticity or memory. In doing so, our 
knowledge of estradiol’s effects in the male and female brain separately will be 
greater. 
 
L O C A L  P R O T E I N  S Y N T H E S I S  
 
Local vs. global protein synthesis 
 
Synaptic type and strength is dependent on the synaptic proteome and thus, the 
regulation of the proteins that inhabit synapses can drive synaptic plasticity and 
general neuronal homeostasis (Hafner et al., 2018). This can be achieved 
through the degradation of proteins or the synthesis of new proteins. Protein 
synthesis allows the replenishment of the proteome in subcellular 
compartments within the neuronal cell in for example, at synapses. Recently, 
the complexity of the synaptic proteome was elegantly demonstrated by 
Dörrbaum et al., (2018) by illustrating the half-life of proteins present at both 
excitatory and inhibitory synapses in the hippocampus in vitro (Figure 1.3). A 
number of proteins at the PSD demonstrated short half-lives, compared to those 
38 
 
at the excitatory pre-synaptic or inhibitory post-synaptic compartments. This 
highlights the dynamic changes that PSD would endure and the need for protein 
replenishment. New protein synthesis is thought to control dendritic processes, 
such as synaptic plasticity, that have been thought to underlie or contribute to 
memory (Sutton and Schuman, 2006). Others have shown protein synthesis 
contributes to other neuronal processes such as axonal growth cone navigation 
and neuronal differentiation and has also been shown to occur in non-neuronal 
cells such as astrocytes (Vlatkovic and Schuman, 2016). However, why protein 
synthesis is so important in many neuronal and specifically, synaptic processes 
is still not fully understood.   
 
Figure 1.3 The complexity of the synaptic proteome. A number of proteins have 
been identified to be localised to and important for the functioning of 
glutamatergic (A) or glycinergic/GABAergic (B) synapses. The half-lives of 
these proteins are presented, and colour coded by red representing more short-
lived and green representing more long-lived proteins (C). This highlights the 
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dynamic changes that occur to the synaptic proteome. From Dörrbaum et al., 
(2018). 
 
The process of protein synthesis follows the transcription of messenger RNA 
(mRNA) and involves the initiation, elongation and termination of polypeptide 
chains of amino acids (Sonenberg and Hinnebusch, 2009). The dogma that 
protein synthesis was restricted to the cell soma had been challenged and a 
plethora of studies have followed since polyribosomes, the machinery that 
drives the translation of mRNAs, were discovered in dendrites (Steward and 
Levy, 1982). The ability for neurons to locally control proteome remodelling 
circumvents the communication required between the nucleus and synapse to 
organise the synthesis and transportation of proteins, which can take from 
hours to days as dendrites are remote from the cell body (Rangaraju et al., 
2017). Thus, local protein synthesis can establish and maintain proteins at 
synapses independently. A number of studies have demonstrated local protein 
synthesis to occur along dendrites (Pfeiffer and Huber, 2006; Steward and 
Schuman, 2001) and fewer have also shown this in axons (Lin and Holt, 2007) 
and astrocytes (e.g. Sakers et al., 2017). A number of studies by Christine Holt, 
and others, have implicated axonal local protein synthesis in the regulation of 
growth cone navigation; one such illustrating this retinal axons of the Xenopus 
(Campbell and Holt, 2001). A later study by Leung et al. (2006) identified β-actin 
as one of the proteins that is translated and contributes to this. Indeed, if protein 
synthesis is occurring in distal parts of the neuron, the presence of the 
appropriate machinery and substrate are necessary.   
 




Succeeding the earlier findings of Steward and Levy (1982), other machinery 
necessary for protein translation initiation was also discovered to be localised to 
dendritic compartments. These included transfer RNA (tRNA) and aminoacyl-
tRNA synthetases, which both aid in the transport of mRNA to the ribosome, in 
primary hippocampal neurons (Tiedge and Brosius, 1996). They also reported 
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the presence of initiation and elongation factors such as eukaryotic initiation 
factor 2 (eIF2) and eukaryotic elongation factor 2 (eEF2) along dendrites. 
Others have reported the presence of other elongation factors such as 
eukaryotic translation initiation factor 4E (eIF4E) (Tang et al., 2002). In addition 
to the machinery, the substrates to initiate protein translation have also been 
identified at dendrites.  Bagni et al., (2000) found that specific mRNA transcripts 
for calcium/calmodulin-dependent kinase II α subunit (CAMKIIα), Arc and 
InsP3R12 mRNA were all associated with polyribosomes in cortical 
synaptosome preparations. Since, studies have demonstrated large pools of 
dendritically localised mRNA (Poon et al., 2006; Zhong et al., 2006). More 
recently, approximately 2’550 mRNA were identified to be dendritically localised 
through deep RNA sequencing in both primary hippocampal neurons and 
hippocampal sections (Cajigas et al., 2012) (Figure 1.4). Among which were 
transcripts encoding proteins involved in synaptic plasticity such as PSD-95, 
GluA1, Homer 1, and Shank 1. Interestingly, the mRNA encoding for proteins 
that regulate protein translation initiation and elongation such as eIF4E and 
eEF2, and RNA binding proteins such as fragile X mental retardation protein 
(FMRP) were also identified. Thus, not only proteins implicated in synaptic 
proteins can be replenished locally, but also those that regulate protein 
translation. Evidence that local translation occurs was provided by Rao and 
Steward (1991) at synapses using synaptosome preparations. Following this, 
Torre and Steward (1992) demonstrated that protein synthesis specifically 
occurred at dendrites. Thus, the presence of translation machinery and a 
number of transcripts highlights the importance of local protein synthesis in a 
number of neuronal, specifically synaptic, function. 
 
                                            





Figure 1.4 The population of mRNA transcripts found in synaptic 
compartments. A schematic from Cajigas et al., (2012) highlighing the mRNA 
trascripts coding proteins important in synaptic function and protein translation 





The wealth of data implicating protein translation machinery is greater in 
dendrites than axons. Nevertheless, evidence from squid giant axons 
demonstrated that mRNA, ribosomal RNAs (rRNAs) and actively translating 
polyribosomes are all present (Jung et al., 2012). Ribosomes have also been 
localised in mammalian mature axons (Koenig et al., 2000) and polyribosomes 
have been found in growth cones (Bassell et al., 1998). This suggests that 
axons may encompass the machinery to coordinate protein synthesis. In 
support, a recent study performed a deep sequencing analysis of ribosome-
bound mRNA in developing and mature retinal axons and found transcriptomes 
involved in synapse function such as glutamate receptors, SNARE proteins, 
axonal survival and guidance (Shigeoka et al., 2016). Thus, both the machinery 
and substrate needed for translation can be found within the axonal terminal. 
Interestingly, Shigeoka et al.’s (2016) data showed that mature axons translate 
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mRNA for synaptic transmission and thus, pre-synaptic local protein synthesis 
could contribute to post-synaptic maintenance.    
 
Role in synaptic plasticity and memory 
 
Local protein synthesis at dendrites is deemed a critical component of long-
lasting changes in synaptic plasticity (Klann et al., 2004). Two forms of synaptic 
plasticity, LTP and long-term depression (LTD) consist of two phases, an early 
phase that is independent of protein synthesis and a more persistent late phase 
dependent on protein synthesis (Sutton and Schuman, 2006). Thus, new 
proteins are required for long lasting changes. Early studies using protein 
synthesis inhibitors illustrated a decay in the early phase of LTP (E-LTP) in vitro 
(Stanton and Sarvey, 1984) and in vivo  (Frey et al., 1988) upon administration. 
However, it was thought that new proteins were a result of newly transcribed 
mRNA (Pfeiffer and Huber, 2006). It was a series of experiments by Kang and 
Schuman (1995, 1996) who provided evidence that it was local protein 
synthesis that was critical for synaptic enhancement. Upon the application of 
protein synthesis inhibitors, anisomycin and cyclohexamide, the increase in 
synaptic potentiation induced by brain-derived neurotrophic factor (BDNF) and 
neurotrophin-3 (NT-3) were blocked in CA1 dendrites severed from the cell 
body. This suggested that protein synthesis in distal parts of the cell could 
contribute to synaptic plasticity. Another study from Erin Schuman’s laboratory 
showed BDNF-induced protein synthesis of a green fluorescent protein (GFP) 
reporter flanked by the 5’ and 3’ UTRs of CAMKIIα in severed dendrites in vitro 
(Aakalu et al., 2001). Thus, providing a direct visualisation of new CAMKIIα 
protein synthesis within dendrites. Consistent with this, Bradshaw et al. (2003) 
locally applied protein synthesis inhibitors to CA1 dendrites during LTP 
induction subsequently blocking L-LTP. In support, Vickers et al. (2005) found 
that L-LTP could be still be induced in dendrites isolated from the soma and 
subsequently blocked with protein synthesis inhibitors in hippocampal slices. 
mGluR activation also facilitates LTP persistence, which has been shown to be 
dependent on protein, but not mRNA, synthesis (Raymond et al., 2000). mGluR 
activation also contributes to a form of LTD (mGluR-LTD). Huber et al. (2000) 
demonstrated that mGluR agonist, (RS)-3,5-Dihydroxyphenylglycine (DHPG), 
43 
 
application on severed dendrites of CA1 induced LTD, which was blocked in the 
presence of protein synthesis inhibitors. Collectively, these studies exhibit the 
critical role of local protein synthesis in modulating synaptic plasticity. LTP is 
thought to underlie memory formation (Takeuchi et al., 2014) and so it can be 
reasoned that local protein synthesis could contribute to different types of 
memory. Very few have directly measured the necessity for local protein 
synthesis in memory enhancement. Nevertheless, Miller et al., (2002) employed 
a CAMKIIα mRNA deficient mouse to test whether this would consequently 
disrupt memory; the dendritic localisation was interfered by mutating its 3’ UTR. 
This was upon the notion that CAMKIIα has been considered necessary for LTP 
(Lisman et al., 2002). Compared to their wild type (WT) counterparts, the 
performance of the CAMKIIα deficient mice was impaired in the hippocampal 
dependent tasks, Morris water maze and OR and the amygdala dependent 
task, contextual fear conditioning. Thus, suggesting new CAMKIIα synthesis is 
critical in mediating these specific memories.   
 
Regulation of local protein synthesis 
 
SIGNALLING PATHWAYS  
 
Two signalling pathways that have received a lot of attention in contributing to 
the regulation of protein synthesis are the mTOR and ERK signalling pathways. 
These pathways activate several downstream signalling molecules that play a 
role in protein translation initiation and regulation. Studies have also shown that 
ERK can activate mTOR (Winter et al., 2011) and also regulate translation 
machinery via mTOR (Roux et al., 2007; Tsokas et al., 2007; Winter et al., 
2011). Thus, it is not clear whether these pathways act in parallel, or 
sequentially to regulate protein synthesis machinery. However, mTOR and ERK 
can both regulate various aspects of translation initiation. 
 
The mTOR pathway stimulates local protein synthesis by phosphorylating key 
downstream translational targets including S6K1/2 and 4EBP1 (Costa-Mattioli et 
al., 2009; Hoeffer and Klann, 2010; Lipton and Sahin, 2014). Each of these 
regulates protein synthesis through different mechanisms. Activation of S6K1/2 
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promotes the phosphorylation of ribosomal protein S6 (RPS6), a member of the 
small 40S ribosomal complex. Its phosphorylation has been implicated in having 
a regulatory role in translation initiation (Thomas et al., 1982), required for L-
LTP (Panja et al., 2009; Tsokas et al., 2005), and has recently been detected 
near active synapses (Pirbhoy et al., 2017). Interestingly, this activation near 
active synapses was demonstrated to be MAPK/ERK dependent. Thus, 
suggesting a point of convergence for both mTOR and ERK signalling 
pathways.    
 
mTOR phosphorylation can additionally hyperphosphorylate 4E-BP1, which 
upon activation releases the translation repression on the cap binding protein 
eIF4E (Klann et al., 2004). 4EBP1 is typically bound to eIF4E and once 4EBP1 
is phosphorylated, eIF4E is free to complex with eIF4G and other initiation 
proteins. Within the complex, eIF4E then directly binds with ‘the cap’ structure 
found on mRNAs - a methylated guanosine repeat at the 5’ UTR on the majority 
of eukaryotic mRNAs (Lipton and Sahin, 2014). eIF4E subsequently helps 
mRNAs to be recruited to ribosomes (Gingras et al., 1999). Phosphorylation of 
eIF4E has been demonstrated to increase translation of a subset of mRNAs 
that play a role in memory formation (Bramham et al., 2016). eIF4E has 
previously been demonstrated to co-localise with post-synaptic markers (Tang 
and Schuman, 2002) and translocate to dendritic spines following BDNF 
stimulation (Smart et al., 2003). BDNF stimulation has shown eIF4E to be 
phosphorylated in a mTOR-4EBP1 dependent manner in isolated dendrites 
(Takei et al., 2004) highlighting the importance of mTOR-dependent translation 
activation in local protein synthesis. Indeed, studies using mTOR inhibitor, 
rapamycin, have shown impairments in L-LTP (Tang and Schuman, 2002), 
BDNF-induced stimulation (Tang et al., 2002) and mGluR-LTD (Huber et al., 
2001) implicating a critical role for mTOR in synaptic plasticity. Critically, BDNF 
stimulation also phosphorylates eIF4E in an ERK-dependent manner (Kelleher 
et al., 2004). Indeed, eIF4E itself can be phosphorylated by ERKs downstream 
targets MNK1/2 kinases at Serine 209 (Ser209) (Banko et al., 2004; Waskiewicz 
et al., 1999). Thereby, suggesting an additional convergence for both mTOR 
and ERK signalling pathways. Interestingly, recently it has been shown that 
phosphorylation deficits in eIF4E triggers depression like phenotypes in male 





MiRNAs are small non-coding RNA molecules that act as post-transcriptional 
regulators of gene transcription (Bartel, 2009). miRNAs bind to the 3’UTR of the 
target mRNA and induces the reduction or repression of translation of the 
transcript (Schratt et al., 2006), a process recently found to be important in 
regulating protein synthesis at dendrites (Rajgor et al., 2018). MiRNA 
biogenesis involves the cleavage of the primary mRNA (pri-mRNA) in the 
nucleus by an enzyme complex including the nuclear ribonuclease III (RNAseIII) 
enzyme, Drosha, and a double-stranded RNA-binding domain protein, Pasha, 
to yield the precursor mRNA (pre-mRNA) (Kosik, 2006). The pre-mRNA is then 
transported to the cytoplasm and cleaved by RNAseIII enzyme, Dicer, resulting 
in mature miRNA (Kosik, 2006). MiRNAs associate with argonaute (Ago) 
proteins to form the RNA-induced silencing complex (RISC), which is then 
guided to the target mRNA for repression (Kosik, 2006).  
 
Neuronal miRNAs have been demonstrated to be involved in neuronal 
development, spinogenesis and synaptic function and plenteous have been 
reported to be enriched in dendrites and at synapses (Schratt, 2009). They 
have also been localised to axons (Sasaki et al., 2014). Regulating miRNA 
activity contributes to controlling the synthesis of specific proteins that in turn 
regulate dendritic spine morphology, function, maintenance and thereby, 
synaptic plasticity. For example, Schratt et al. (2006) reported miR-134 
localised at dendrites in primary rat hippocampal neurons and found it to 
repress the expression of synaptic protein Limk1, which regulates the actin 
cytoskeleton thereby, negatively controlling spine maturation; some miRNAs 
also positively regulate spine maturation such as miR-125a that targets PSD-95 
mRNA (Rajgor and Hanley, 2016).  Recently, Rajgor et al. (2018) proposed a 
mechanism for this; Limk1 translation is occluded at dendrites by miR-134 via 
the phosphorylation of Ago2 specifically through the Akt signalling pathway in 
response to NMDA stimulation which, resulted in spine shrinkage. Many other 
miRNAs have since been dendritically localised and associated with regulating 
mRNA translation of synaptic proteins (Rajgor and Hanley, 2016; Rajman and 
Schratt, 2017). However, how this process is regulated to control synaptic 




Evidence posits that miRNAs regulate gene expression specifically at the 
synapse (Schratt, 2009); the machinery to process miRNAs such as Dicer (Lugli 
et al., 2005) and pre-miRNAs (Bicker et al., 2013) have also been illustrated to 
localise near synapses suggesting that miRNAs could be generated locally near 
synapses. Sambandan et al. (2017) elegantly illustrated the generation miR-
181a directly in dendritic spines by stimulating individual synapses via uncaging 
glutamate. What is more, a decrease in newly translated CAMKIIα, a target of 
miR-181a, was reported near the regions of pre-miR-181a. Sambandan et al. 
(2017) also document that pre-miRNA processing can by stimulated by neural 
activity specifically at individual synapses initiating a local decrease in protein 
synthesis of their target protein at that very synapse. Thereby, miRNAs can be 
generated quite rapidly and can contribute to the silencing of synaptic proteins 
during synaptic plasticity. In support, Hu et al. (2014) reported the upregulation 
of miR135 and downregulation of miR191 and therefore, protein translation 
were required for persistent changes in spine remodelling in LTD. There is still 
the need to understand how miRNAs orchestrate local mRNA translation in 
response to synaptic activity and whether it utilises similar mechanisms to that 
reported by Sambandan et al. (2017). Nevertheless, miRNAs play an important 
role in regulating protein synthesis to regulate various forms of synaptic 
plasticity.    
 
CONTRIBUTION OF PRE-SYNAPTIC STRUCTURES 
 
There is sufficient evidence for the occurrence of protein synthesis at post-
synaptic regions of neurons in mediating changes in synaptic plasticity. 
However, very little is known about any contribution of the pre-synaptic 
structures. Interestingly, a first of its kind study by Hafner et al. (2018) have 
illustrated rapid translation occurring in both pre- and post-synaptic 
compartments within the hippocampus in vitro. They report that >100 mRNAs 
and an abundance of ribosomes were found to be localised within excitatory 
and inhibitory pre-synaptic compartments moreover, these compartments were 
found to be actively translating proteins in addition to the excitatory post-
synaptic compartment. Critically, different forms of plasticity exhibited 
differential patterns of pre- and post-synaptic translation. Thus, this is the first 
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study to suggest that both pre- and post-synaptic compartments contribute to 
different types of synaptic plasticity and both should be considered when 
investigating the underlying molecular mechanisms.    
 
A I M S  A N D  H Y P O T H E S E S  
 
The literature presented here demonstrates that estradiol can rapidly modulate 
hippocampal memory in both male and female rodents. Studies have presented 
ERs and signalling pathways that may implicate this. Indeed, estradiol has been 
illustrated to reorganise the neural circuitry within the same time-frame. But the 
underlying molecular mechanisms of this enhancement are not fully understood. 
Corroborating the findings that demonstrate estradiol’s rapid actions on 
activating protein translation initiation machinery, and studies that show rapid 
dendritic translation, it can be reasoned that estradiol may rapidly increase 
protein synthesis, and this could contribute to its memory enhancing effects. 
 
The following chapters will investigate the role of acute estrogen signalling in 
regulating local protein synthesis within the hippocampus. The hypothesis of 
this project therefore, is that estradiol will increase protein synthesis in a 
local protein translation dependent manner. Acute hippocampal slices from 
both male and OVX female mice and primary hippocampal neurons will be used 
in this study as majority of the literature implicates profound effects of estradiol 
in the hippocampus. Moreover, in light of the previous studies presented, there 
is a huge gap in the literature investigating the role of estradiol in the male 
hippocampus for example, the signalling pathways and ERs implicated in 
regulating estradiol-mediated memory are unknown. Thus, it was important to 
consider both sexes within this current investigation, as memory enhancing 
effects of estradiol can be observed in both sexes. The aims of this investigation 
therefore, are to:  
1. Establish whether estradiol increases protein synthesis in the male and 
OVX female hippocampus; 
2. Determine if both sexes use the same signalling pathway;   
3. Identify which proteins may be locally translated;  
4. Investigate which subcellular compartment the newly synthesised 
proteins are targeted to following estradiol treatment.  
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C H A P T E R 2   
 
M A T E R I A L S  A N D  M E T H O D S 
 
 
A N I M A L S   
Mixed sex cortical and hippocampal cultures were prepared from Sprague-
Dawley rat E18 embryos as previously described (Srivastava et al., 2008). The 
rats were obtained from Charles River Laboratories, United Kingdom, and 
habituated for 3 days before experimental procedures were carried out in 
accordance with the Home Office Animals (Scientific procedures) Act, United 
Kingdom, 1986.  
All acute cortical and hippocampal slices were prepared from C57BL/6J mice 
between the ages of 10-12 weeks obtained from The Jackson Laboratory, 
Maine, United States. Both intact male and OVX female mice were used in the 
experimental procedures. The female mice were ovariectomised by the vendor 
at 10 weeks and transported after 1 week of recovery; intact male mice were 
transported at 10 weeks. All mice were habituated for 3 days before 
experimental procedures were carried out. It should be noted that the age of 
ovariectomy of the female mice was kept constant throughout the experiment. 
Additionally, the time of experiment post ovariectomy and transportation was 




P R I M A R Y  N E U R O N A L  C U L T U R E  
Primary rat cortical and hippocampal neurons were seeded onto 0.2 mg/mL 
Poly-D-lysine (PDL; Sigma: P0899) coated 6-well Nunc plates or 60 mm Nunc 
dishes for biochemistry and RNA isolation or 18 mm coverglass (VWR 
international: 630-2200) for immunocytochemistry. Neurons were cultured in 
feeding media, where all reagents were purchased from Life Technologies: 
neurobasal medium (21103049) supplemented with 2% B-27™ (17504044), 0.5 
mM L-glutamine (25030024) and 1% penicillin:streptomycin (pen/strep; 
15070063). Cortical neuron cultures were maintained in the presence of 200 µM 
D, L-aminophosphonovalerate (D, L-APV; Abcam: ab120004) from DIV (days in 
vitro) 4 to ensure the reduction of cell death as a result of excessive calcium 
cytotoxicity by over active NMDA receptors in high density cultures (Srivastava 
et al., 2011); this is particularly advantageous for long-term culturing however, 
this was not necessary for hippocampal neuron cultures. Half media changes 
were performed twice a week until desired age of experimentation, DIV 25-29 
(cortical) or DIV 20-21 (hippocampal); these ages were favoured as it has been 
suggested that from DIV 21, neurons express mature dendritic spines 
(Srivastava et al., 2008, 2010). 
A C U T E  S L I C E  P R E P A R A T I O N  
Mice, both male and OVX female, were anaesthetised with isoflurane, followed 
by decapitation. Brain tissue was then rapidly removed and sliced 350 µm thick 
coronally in carbo-oxygenated (95% oxygen, 5% carbon dioxide), ice cold 
cutting solution using a Leica VT1000 vibratome. Hippocampi were rapidly 
dissected from the slices and maintained in a recovery chamber with carbo-
oxygenated Ringer’s solution for 1 hour at 32°C. Slices were then transferred 
into 6-well plates containing 5-10 mL of freshly carbo-oxygenated Ringer’s 
solution in the presence of various drugs. Slices were collected and frozen at -
80°C until lysing. All reagent compositions can be found in Table 2.1.  
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P L A S M I D  D N A  T R A N S F E C T I O N  
Primary rat hippocampal neurons were transfected at desired ages by coupling 
target plasmid DNA with Lipofectamine 2000 (LF2K) (Life Technologies: 
11668027). Pre-optimised concentrations of DNA were mixed with LF2K in 
Dulbecco’s Modified Eagle’s medium (DMEM; Sigma: D6421) pH buffered with 
15 mM HEPES (Fisher Scientific Ltd: 10041703) and left in a 5% CO2 incubator 
at 37°C for 20 minutes with open caps for the DNA-LF2K complex to form. The 
complex was thereafter, added dropwise to the neurons and left to incubate 
overnight (cortical neurons) or 3-4 hours (hippocampal neurons) at 37°C with 
5% CO2. Transfections were carried out in transfection media (neurobasal 
medium supplemented with 2% B-27 and 0.5 mM L-glutamine) in a new plate. 
Following transfection, neurons were returned to their old feeding media.   
Enhanced Green Fluorescent Protein (eGFP) DNA constructs were used to 
visualise and isolate the structure of neurons including the dendritic spines for 
these investigations. Hippocampal neurons were transfected with peGFP-C1 
(Clontech). 2µg eGFP-C1 was coupled with 4 µL LF2K and introduced to 
neurons between DIV 12-14, the neurons were then left for 5-7 days before 
pharmacological treatments were initiated between DIV 20-21.   
P H A R M A C O L O G I C A L  T R E A T M E N T S  
All pharmacological treatments were carried out in artificial cerebral spinal fluid 
(aCSF; Table 2.1) for primary cortical and hippocampal neurons, and Ringer’s 
solution for hippocampal slices. Neurons were pre-treated in aCSF and slices 
were recovered in for 1 hour prior to application of the drug compounds (Figure 
2.1). If inhibitors were relevant to the experiment, then neurons were pre-
incubated for 30 minutes after which the inhibitors would be added for 30 
minutes followed by the addition of vehicle or estradiol. For slices, the inhibitors 
were added after 1 hour recovery for 30 minutes. All compounds were diluted in 
dimethyl sulfoxide (DMSO) and, serially diluted to a 10x working concentration 
in aCSF (neurons) or Ringer’s solution (slices). Table 2.2 depicts the final 
concentrations used for each compound. The concentration used for estradiol 
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has previously been optimised to study rapid estrogenic signalling by our lab 
and many other groups. Vehicle controls were made up of solvent (DMSO) 
lacking the compounds and diluted as test compounds; the solvent was diluted 
to at least 0.1%. Treatments were allowed to continue for the specified times 







Figure 2.1 Schematic of pharmacological treatment timeline in primary rat 
neurons and acute slice preparations from mice within this study. Primary 
neurons and acute slice preparations were treated or recovered in artificial 
cerebrospinal fluid (aCSF) or Ringer’s solution, respectively. Pharmacological 
treatments commenced following this and after the appropriate time, primary 
neurons were either lysed for western blotting, or fixed for immunocytochemistry 
(ICC); acute slices were solely lysed for western blotting.  
 
L Y S A T E  P R E P A R A T I O N  
Whole cell lysates   
Primary cortical and hippocampal neurons were collected in ice cold Triton-lysis 
buffer: 20 mM Tris pH 7.2; 150 mM NaCl; 1% Triton X-100; and 5 mM EDTA pH 
8 in the presence of protease (AEBSF, aprotinin, leupeptin, pepstatin A), and 
phosphatase inhibitors (sodium fluoride, sodium orthovandate, phosphatase 
cocktail 3 (Sigma: P0044)) and incubated on ice for 30 minutes. Lysates were 
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hereafter sonicated with 8-10 pulses at 40% power and centrifuged at 15’000 
rpm for 15 minutes at 4°C to pellet out residual membranes, and supernatant 
collected. 
For acute hippocampal slices, the dry weight was initially acquired per sample 
and lysed 10 x v/w in ice cold lysis buffer: 50 mM NaPO4; 40 mM NaCl, 5 mM 
EDTA; 5 mM EGTA; 1% Tritr in the presence of the same protease and 
phosphatase inhibitors. Lysates were then sonicated with 20 pulses at 30% 
power, before being eluted for 2 hours on a rotor at 4°C. Hereafter, samples 
were centrifuged at 12’800 x g for 20 minutes at 4°C to pellet out residual 
membranes, and supernatant collected. 
The total concentration of all samples was measured at 562 nm using the 
Pierce Bicinchoninic acid (BCA) protein assay kit (Thermo Scientific; 10678484) 
and approximately 5-20 µg protein was loaded for western blotting. Primary 
cortical and hippocampal neuron lysates were mixed with 2 x laemmli sample 
buffer (Bio-Rad Laboratories; 161-0737) with 355 mM β-mercaptoethanol and 
denatured for 5 minutes at 95°C. Alternatively, hippocampal slice lysates were 
mixed with NuPage LDS 4 x sample buffer (Thermo Scientific: NP0007) with 0.1 
mM dithiothreitol (DTT) and denatured for 10 minutes at 70°C. 
Crude synaptosomal preparation 
Primary hippocampal neurons were collected in 150 µL ice cold homogenisation 
buffer: 320 mM sucrose; 5 mM Na4P2O7; 1 mM EDTA pH 8; and 10 mM HEPES 
pH 7.4 in the presence of protease and phosphatase inhibitors and 
homogenised by passage through a 25-gauge needle 12 times. The lysate was 
centrifuged at 800 x g for 10 minutes at 4°C to yield the P1 fraction (nuclear and 
large organelles) and S1 fraction (extra-nuclear). A fraction of S1 was retained 
separately (30 µL) and the remainder was centrifuged at 15’000 x g for 20 
minutes at 4°C to yield the P2 fraction (crude synaptosomes) and S2 fraction 
(cytosolic). The P2 fraction was resuspended in 30 µL ice cold RIPA buffer: 10 
mM Tris pH 7.2; 150 mM NaCl; 1% Triton-x100; 0.1% SDS; 1% deoxycholate; 
and 5 mM EDTA pH 8 in the presence of protease and phosphatase inhibitors.   
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Western blotting  
Primary cortical neuron lysates were separated on 4-20% acrylamide gels (Bio-
Rad: 456-1094). Primary hippocampal neuron lysates and hippocampal slice 
lysates were separated on 10% in-house made acrylamide gels through 
electrophoresis. The separated proteins were then transferred onto 
polyvinylidene difluoride (PVDF) at 78 mA for 990 minutes at 4°C. 
Subsequently, membranes were blocked for 1 hour in TBS-T (with 0.1% tween) 
containing 5% bovine serum albumin (BSA) (Sigma: A7906) followed by an 
overnight incubation of specific primary antibodies in the same blocking solution 
at 4°C with agitation. Following 3 x 15 minute TBS-T washes, specific 
secondary HRP antibodies were incubated in the blocking solution for 2 hours 
at room temperature. Finally, membranes were incubated in Clarity Western 
ECL substrate (Bio-Rad: 170-5061) for 5 minutes before protein detection using 
the ChemiDoc XRS+ imaging system (Bio-Rad: 170-8265) running ImageLab™ 
software version 5.2.1 (http://www.bio-rad.com/en-uk/product/image-lab-
software) (Bio-Rad). All proteins of interest and puromycin, for SUnSET, were 
normalised to the house keeper β-actin whereas, the phosphorylation of 
proteins were normalised to its respective total protein. See Table 2.1 for the 
composition of all the solutions essential for western blotting, and Tables 2.3 
and 2.4 for the antibodies used within this investigation.  
QUANTIFICATION OF WESTERN BLOTS  
All images were taken in the linear range, to allow an accurate representation of 
the data. Acquired images were exported for analysis as a Tagged Image File 
Format (TIFF) and subsequently analysed using Image Studio™ Lite software 
version 5.2 (https://www.licor.com/bio/products/software/image_studio_lite) (LI-
COR). For an image, the integrated density (ID) was measured per band or 
smear (for Surface Sensing of Translation; SUnSET) and a background 
correction calculated per band. A narrow strip on the top and bottom of the box 
drawn around the band was used to calculate the background correction as the 
median of the pixels within the band. For SUnSET, the narrow strip selection 
was left and right of the selection box. These ID values were exported to 
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Microsoft Excel and the target protein was normalised to a housekeeper by 
dividing the ID value of the target protein by the ID value of the housekeeper, 
per condition within a biological replicate. The data set from all biological 
replicates within an experiment was then further normalised in the following 
way. Firstly, all ID values were summed for each condition across all biological 
replicates. Secondly, the ID values from each condition were then divided by 
these summed ID values. This produced a transformed set of data where each 
datum was relative to the sum of all conditions across the biological replicates. 
This method of normalisation was selected from Degasperi et al., (2014) to 
account for differences in antibody staining, washing and developing produced 
in the western blotting technique when comparing biological replicates from the 
same experiment across different western blots. Finally, the mean of all the 
vehicle ID values was taken and used to transform all the data points around 
the value of 1 to easily represent the fold change in protein expression after a 
drug treatment, for example: (1/mean of vehicles) x each datum.  
R N A  I S O L A T I O N  
RNA extraction  
Primary hippocampal neurons were collected in 1 mL TRIzol reagent (Life 
Technologies: 15596026) and stored at -80°C until processing. RNA was 
extracted according to the manufacturer’s protocol. Briefly, cells lysed in Trizol 
were thawed at room temperature (RT) and subsequently mixed with 100 µL 1-
bromo-3-phenolpropane (BCP), followed by 15 minute incubation. This solution 
was centrifuged at 13’000 x g for 15 minutes at 4°C. The top aqueous phase 
was collected and transferred into new tubes, to which 500 µL isopropanol was 
added per sample to precipitate the DNA; these were incubated at RT for 10 
minutes and then centrifuged as before. The isopropanol supernatant was 
discarded, and the RNA pellets washed with molecular grade 75% ethanol, then 
centrifuged for 13’000 x g for 5 minutes; this was repeated 3 times. The 
supernatants were discarded, and the pellets were left to air dry for 
approximately 10-15 minutes. Nuclease free H2O was added to each sample; 
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absorbances were measured per sample using a Nanodrop spectrophotometer 
ND-1000.  
cDNA synthesis  
The RNA was then treated with TURBO DNA-free™ kit (Thermo 
Fisher:AM1907) to remove any residual genomic DNA according to the 
company’s manual. Firstly, total RNA from each extraction was incubated with 2 
units of Turbo DNAse in 1 x Turbo DNAse at 37°C for 30 minutes. Next, DNAse 
Inactivation Reagent was added to the RNA and incubated at RT for 5 minutes. 
The mixture was then centrifuged at the max speed for 3 minutes and 
supernatant collected. Reverse transcription was carried out on the RNA using 
Superscript III™ Reverse Transcriptase (SSIII) (Thermo Fisher Scientific:18080-
044) according to the manufacturer’s protocol. The reaction was prepared in 
two steps: primarily, a mixture (A) was made containing RNA, random 
decamers and dNTPs, which was heated to 65°C for 5 minutes and cooled on 
ice for approximately 1 minute. Following this, a second mixture (B) was made 
containing 5 X First-Strand Buffer, DTT, RNaseOUT™ Recombinant 
Ribonuclease Inhibitor and SSIII. This was added to mixture A producing a 20 
µg final volume reaction of: approximately 907 ng RNA; 5 µM random 
decamers; 500 µM dNTPs; 5 mM DTT; 40 units RNaseOUT; 200 units SSIII in 1 
x First-Strand Buffer. The reaction was incubated in a GS4 Thermocycler (G 
Storm; Pendragon Scientific Ltd.:GT-40364) following a pre-set protocol as 
followed: 25°C for 25 minutes; 50°C for 60 minutes; 55°C for 30 minutes; and 
70°C for 15 minutes. Finally, cDNA was diluted to approximately 6 ng/µL and 
stored at -20°C. 
Quantitative reverse transcription polymerase chain reaction (RT-qPCR)  
Expression of DLG4, GRIN2B and GRIA1 was assessed using RT-qPCR, to 
identify potential changes in transcript abundance following acute estradiol 
treatment. Primers were designed using Primer3 and purchased from Integrated 
DNA Technologies (Table 2.5). PCR amplification of cDNA was carried out in a 
total volume of 12 µL using HOT FIREPol DNA Polymerase (Solis BioDyne:01-
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02-01000). This reaction contained ~27ng cDNA; HOT FIREPol DNA 
Polymerase 1x; and 200 nM primers, and it was carried in a QuantStudio 7 Flex 
and the QuantStudio Real-Time PCR Software (Thermo Fisher Scientific). The 
following protocol was used: 95°C for 15 minutes (hot start); 40 cycles of 95°C 
for 20 seconds, 60°C for 20 seconds, 72°C for 20 seconds; and a continuous 
melting curve analysis of the amplicons from 60-95°C, which revealed single 
peaks, thus confirming specificity of the oligonucleotides used. Gene expression 
quantification was calculated relative to a standard curve of five 1:2 dilution 
points (quantity), and this value was further normalised to the geometric mean 
of the quantity of the three housekeeping/reference genes, per condition 
(ACTB, GUSB, B2M). 
I M M U N O C Y T O C H E M I S T R Y  
Primary cortical or hippocampal neurons were washed in cold phosphate 
buffered saline (PBS) post treatment, but before fixation. Neurons underwent 
one of the following fixation methods: 10 minute fixation with 4% formaldehyde 
in a 4% sucrose in PBS solution at RT, then 10 minute fixation with 100% 
methanol on ice (double fixation) at RT; or 10 minute fixation with 4% 
paraformaldehyde in a 4% sucrose in PBS solution (single fixation; PFA-
sucrose) at RT. Neurons were then washed 2 x in PBS and then permeabilised 
and blocked simultaneously in PBS containing 0.1% Triton-x100 and 2% 
Normal Goat Serum (NGS; Cell signalling: 5425S) for 1 hour at RT unless 
otherwise indicated. Subsequently, primary antibodies were added in PBS 
containing 2% NGS and left overnight at 4°C. This was followed by 3 x 15 
minute PBS washes. The neurons were then incubated in Alexa Fluor® 
secondary antibodies in PBS containing 2% NGS for 1 hour at RT; dyes were 
selected according to species in the following wavelengths: 405; 488; 568; or 
647, see Table 2.4. This was again followed by 3 x 15 minute PBS washes with 
a 5 minute incubation with PBS containing 0.1% the nuclear stain 4′,6-
diamidino-2-phenylindole (DAPI) (Life Technologies: D1306) unless otherwise 
stated. Finally the neurons were mounted with ProLong™ Gold antifade 
mountant (Life Technologies: P36930). A list of primary antibodies used in this 
investigation can be found in Table 2.3. 
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D E T E C T I O N  O F  P R O T E I N  S Y N T H E S I S  
Surface Sensing of Translation (SUnSET)  
Puromycin (Sigma; P8833) is an aminonucleoside antibiotic produced by 
Streptomyces alboniger. It is a recognised protein synthesis inhibitor; the 
structure of puromycin is analogous to that of tRNA and typically incorporates 
onto nascent polypeptide chains thereby, inhibiting the elongation of amino 
acids and thus, the translation of proteins. Using this mechanism as an 
advantage, an assay termed surface sensing of translation, or SUnSET, was 
developed (Schmidt et al., 2009). This assay employs puromycin as an indicator 
of the rate at which protein synthesis is occurring within a cell, if it is used at a 
low concentration for a short period of time (Schmidt et al., 2009). This 
approach can be utlilised to determine the effect of a pharmacological treatment 
on the rate of protein synthesis by adding puromycin just before the end of the 
treatment to allow incorporation into nascent polypeptide chains. Subsequently, 
an antibody against puromycin is used to detect the puromycin incorporation 
post lysing or fixation (Figure 2.2). The level of puromycin is indicative of the 
rate of protein synthesis occurring.  
Puromycin treatments were added at the last 10 minutes (neurons) or the last 
30 minutes (slices) of pharmacological treatments at the final concentrations of 
10 and 5 µg/ml respectively (Figure 2.3) The concentrations and treatment 
times were previously optimised for primary neurons (Schmidt et al., 2009) and 
acute slice preparations (Ma et al., 2013) to directly visualise the rate of 
translation occurring using SUnSET. The neurons or slices were then lysed for 
biochemistry or PFA-sucrose fixed for ICC. An antibody against puromycin was 
used for western blotting (Kerafast: EQ0001; SUnSET-WB) or 
immunocytochemistry (Milipore: MABE343; SUnSET-ICC) to visualise 










Figure 2.2 Schematic of the Surface Sensing of Translation (SUnSET) assay to 
measure the rate of protein translation. Puromycin incorporates onto nascent 
polypeptide chains inhibiting the elongation of amino acids and therefore, the 
translation of proteins. When used at a low concentration for a short period of 
time, the rate of translation can be visualised by using an antibody against 
puromycin through western blotting or immunocytochemistry (ICC). Figure 
adapted from Goodman and Hornberger, (2013). 
 
Figure 2.3 Schematic of puromycin (SUnSET assay) treatment timeline in 
primary rat neurons and acute slice preparations from mice within this study. 
Acute slices were recovered for 1 hour after which, if relevant to the experiment, 
specific inhibitors were added 30 minutes prior to the estradiol treatment (10 
nM), which occurred over 2 hours. Puromycin was added in the last 30 minutes 




























neurons were pre-treated in artificial cerebrospinal fluid (aCSF) for 1 hour 
followed by a 2 hour estradiol (10 nM) treatment. If inhibitors were relevant for 
the experiment, primary neurons were pre-treated for only 30 minutes and 
inhibitors added for further 30 minutes followed by a 2 hour estradiol treatment. 
Puromycin was added in the last 10 minutes of the experiment at 10 µg/mL 
followed by lysing for western blotting or fixing for immunocytochemistry (ICC).      
Fluorescent noncanonical amino acid tagging (FUNCAT)  
Fluorescent noncanonical amino acid tagging, or FUNCAT, is an alternative 
method to detect newly synthesised proteins using fluorescent labelling via 
copper catalysed click chemistry. The assay involves the presentation of azide-
bearing or alkyne-bearing analogs of amino acids respectively, 
azidohomoalanine (AHA) or homopropargylglycine (HPG), into neuronal 
medium which, are then incorporated into nascent proteins. Referred to as 
methionine surrogates (tom Dieck et al., 2012), AHA or HPG is incorporated at 
methionine codons into live cells or slices and are subsequently covalently 
reacted to an alkyne or azide fluorophore, respectively, through a copper 
catalysed click reaction. Whilst SUnSET provides information about the rate 
(SUnSET-WB) or site (SUnSET-ICC) of translation, FUNCAT shows newly 
synthesised proteins. Thus, combining both techniques provides information 
about the amount of translation and where nascent proteins are targeted 
following a pharmacological treatment.   
Primary cortical and hippocampal neurons were treated with 4 mM AHA (Life 
Technologies: C10102) for 2 hours following an optimisation experiment to 
illustrate the treatment time that would be optimal to visualise newly synthesised 
proteins along the dendrites. The concentration of AHA was chosen in 
accordance to the published protocol by Daniela Dieterich and Erin Schuman 
(tom Dieck et al., 2012). Additionally, the treatment time was chosen based on 
an optimisation on an earlier published paper (Dieterich et al., 2010). The 
concentration and treatment times were verified to determine if AHA staining 
could be visualised within secondary and tertiary dendrites (Appendix 3A). 
Primary neurons were initially pre-incubated in aCSF for 60 minutes then 
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treated simultaneously with estradiol and AHA; these were incubated for 2 
hours at 37°C with 5% CO2. The published protocol (tom Dieck et al., 2012) was 
followed with minor adjustments. Primary neurons were thereafter briefly 
washed in PBS-MC (PBS pH 7.4, 1 mM MgCl2; 0.1 mM CaCl2) followed by a 10 
minute PFA-sucrose fixation at RT. These were washed 3 x in PBS pH 7.4 then 
simultaneously permeabilised and blocked in PBS containing 0.1% Triton-x100 
and 2% NGS for 1.5 hours at RT. The neurons were washed 3 x in PBS pH 7.8 
and incubated upside down in the FUNCAT reaction mix (PBS pH 7.8, 0.2 mM 
TBTA1, 0.5 mM TCEP2, 0.2 µM Alexa Fluor 555-Alkyne tag, 0.2 mM CuSO4) 
overnight at RT. The following day, the neurons were washed face up 3 x for 10 
minutes in FUNCAT wash buffer (PBS pH 7.8, 0.5 mM EDTA, 1% Tween-20) 
and 2 x for 10 minutes in PBS pH 7.4. The neurons were then incubated in 
primary antibodies overnight at 4°C and fluorescent secondaries as per the 
protocol described previously. For the purposes of these experiments, no DAPI 
incubation was implemented. The full protocol and recipe for all components 
can be found in tom Dieck et al. (2012). Figure 2.4 depicts the pharmacological 
treatment time-line. 
 
                                            
1 Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine 




Figure 2.4 Schematic of azidohomoalanine (AHA) treatment and subsequent 
fluorescent non-canonical amino acid tagging labelling (FUNCAT) protocol 
timeline in primary rat neurons within this study. Primary neurons were pre-
treated in artificial cerebrospinal fluid (aCSF) for 1 hour. Following this, estradiol 
(10 nM) and AHA (4 mM) were simultaneously added onto the neurons for 2 
hours. These were then fixed in 4% paraformaldehyde in a 4% sucrose in PBS 
solution (single fixation; PFA-sucrose) for 10 minutes and simultaneously 
permeabilised and blocked in PBS containing 0.1% Triton-x100 and 2% normal 
goat serum (NGS) for 1.5 hours. The FUNCAT reaction (PBS pH 7.8, 0.2 mM 
TBTA, 0.5 mM TCEP, 0.2 µM Alexa Fluor 555-Alkyne tag, 0.2 mM CuSO4) was 
then applied overnight to the neurons. Immunocytochemistry (ICC) was carried 
out the next day as normal.  
 
M I C R O S C O P Y  A N D  I M A G E   
A C Q U I S I T I O N S  
Epifluorescence imaging and confocal microscopy 
Epifluorescence imaging was used for puromycin optimisation (Appendix 1C). 
Representative images were taken on a Zeiss Axio Imager Z1 acquired using a 
40x objective (Numerical Aperture [N.A] 0.8). Representative images for AHA 
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treatment optimisation (Appendix 3A) were taken using a Leica SP5 inverted 
confocal microscope acquired with 20x objective (N.A. 0.7). Confocal images 
were taken as a Z-series (z-step= 0.5 µm). All representative images from 
Chapter 4 and Chapter 5 (Figures 5.4-5.5) and Appendix 3B were acquired 
by a Nikon A1R inverted confocal with 60x oil-immersion objective (N.A. 1.4) at 
the Wolh Cellular Imaging Centre. All images were taken as a Z-series (z-step= 
0.15 µm). Both epifluorescent and confocal images were exported to Fiji 
(https://fiji.sc/) where two-dimensional maximum projections reconstructions 
were generated. The appendix images (Appendix 1C, 3A-B) were appropriatly 
adjusted for brightness and contrast or pseudocoloured to emphasise areas of 
high staining intensities on Fiji. All confocal images for Chapters 4 and 5 were 
further processed using MetaMorph software (Universal Imaging Corporation). 
Each image was background subtracted via a statistical correction. All images 
were taken in the linear range, to allow an accurate representation of the data. 
The image acquisition parameters were the same for all images within an 
experiment to allow comparison.  
Structural Illumination Microscopy (SIM)  
SIM imaging for Chapter 5 (Figures 5.8-10) was performed on a Nikon iSIM 
super-resolution microscope at the Wolh Cellular Imaging Centre. Images were 
acquired using a 100x oil-immersion objective (N.A. 1.49TIRF) with 51 z-steps 
(z-step= 0.12 µm). Raw images were acquired and deconvolved using a 3D 
blind algorithm specific to the iSIM to increase resolution using the NIS-
Elements Advanced Research software (Nikon, version 5.01.00). All images 
were exported to Fiji where maximum projections were generated and 
subsequently analysed for puncta size, area and co-localisation, detailed below. 
The image acquisition parameters were the same for all images within an 
experiment.     
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Quantitative analysis of dendritic spine morphology and 
immunofluorescence   
Dendritic spine morphology was all carried out using MetaMorph as previously 
detailed (Srivastava et al., 2011) and all subsequent analysis of the data was 
done on Microsoft Excel. The analysis was carried out using images taken on 
the A1R inverted confocal with a 60x oil-immersion objective (N.A. 1.4), with at 
least 3 to 4 neuronal cells per condition over 4 biological replicates. Figure 2.5 
depicts the workflow of the analysis. Per neuronal cell, two separate pieces of 
dendrites, secondary and tertiary branches, were traced manually to total to 
approximately 100 µm in length (Figure 2.5A, B, G). Using these lengths, 
regions were manually traced on either side of the dendrite separating the 
dendritic spine regions on either side along the dendrites (Figure 2.5C). The 
dendritic spines on either side were then thresholded by MetaMorph in a 
manner that outlines the spines and preserves the morphology (Figure 2.5D). 
Each spine was then saved as a separate region to assess morphologies per 
condition (Figure 2.5E+F). This method was also used to assess the average 
intensity of PSD-95, GluN2B and AHA within spines following estradiol 
treatment. The spine regions created as detailed above were then projected into 
the protein of interest/AHA channels of the corresponding image set to assess 
the average intensity within spines. Additionally, from the same 100 µm regions, 
the dendrites were thresholded by MetaMorph (Figure 2.5H) and the dendritic 
region created (Figure 2.5I). The dendritic regions were then placed in the 
channel of interest to measure average intensity. Figures 2.5J-L depict 
exemplar spine morphologies that can typically occur: stubby structure (J); 
lollipop structure (K); and mushroom structure (L); the spines come from a DIV 
27 primary cortical neuron imaged by SIM by Iain Watson, a member of the 




Figure 2.5 Analysis of dendritic spine morphology in cultured primary neurons 
using Metamorph. (A) Confocal image (60x) of DIV 21 cultured hippocampal 
neuron expressing eGFP. Dendritic spine analysis, (B) Dendrites were traced 
manually totalling to 100 µm and (C) used to create regions either side of the 
dendrite. (D) Dendritic spines on either side were then thresholded by 
Metamorph and (E) recognised as regions of interests to assess number and 
morphology. Dendrite analysis, (G) As B, the dendrite was traced manually and 
(H) thresholded by Metamorph. (I) Dendritic region was isolated and created. 
(J-L) Super resolution images kindly provided by Iain Watson (Srivastava lab) 
acquired by SIM (100x) of typical dendritic spine morphology found on primary 
neurons. From left to right: stubby structure; lollipop structure; and mushroom 
structure. Yellow dashed box denotes section of dendrite displayed in inset. 













Analysis of new protein expression using FUNCAT  
As above, the analysis of AHA along dendrites and within dendritic spines was 
carried out using images taken on the A1R inverted confocal with a 60X 
objective. For each image, the dendrite and spine regions would be identified 
and isolated and placed into the AHA channel to measure average intensity of 
AHA. As AHA intensity represents newly synthesised proteins, there can be 
variability to the staining as AHA-tagged nascent proteins can also be those that 
have been translated in the cell soma. Inconsistent measurements incorporating 
the primary dendrite from the soma compared to tertiary dendrite could 
confound any changes between conditions. Thus, per cell, secondary and 
tertiary dendrites were equally chosen for analysis as depicted in Figure 2.6. 







Figure 2.6 Analysis parameters for AHA-tagged newly synthesised proteins in 
cultured primary neurons. Confocal image (20x) of DIV 21 cultured hippocampal 
neuron expressing eGFP, treated with AHA, and subsequently tagged with 
Alexa Fluor 555-Alkyne tag. Only secondary and tertiary dendrites were 
consistently chosen and traced per cell for analysis of AHA intensity across 
conditions and over biological replicates. Yellow dashed box denotes section of 
dendrite displayed in inset. Red dashed boxes denote regions of measurement. 
Scale bars = 100 µm, inset 50 µm.  
GFP AHA GFP AHA
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Analysis of puncta co-localisation  
Images stained for neuronal marker MAP2, puromycin (SUnSET-ICC) and 
ribosomal proteins S10 (RPS10) acquired from SIM and processed through 
deconvolution were measured for co-localisation in Fiji. For each cell, 50 µm in 
length was traced along two or more separate pieces of dendrites within the 
MAP2 channel. As dendritic spines cannot be visualised with MAP2 staining, 
2.5 µm either side of the dendrite was traced to create ‘spine regions’ that would 
encompass all the dendritic spines along that portion of that dendrite. 
Specifically 2.5 µm either side of the dendrite was selected, as dendritic spine 
lengths have typically been reported to average between 1-1.5 µm in length in 
2-3 week old cultures (Boyer et al., 1998). Capturing 2.5 µm either side of the 
dendrite allows for any variability within dendritic spine lengths ensuring some 
spines are not cut off within the analysis. It is important to emphasise that these 
are crude analyses of ‘spine regions’, as the spine regions are estimations 
using the MAP2 staining as opposed to identified spines via diffused GFP 
overexpression. Thus, the ‘dendrite region’, the ‘spine region’, and these 
regions together termed ‘crude synaptic region’ were all assessed for puncta 
co-localisation (Figure 2.7). Images in the RPS10 staining channels were 
thresholded and particle analysis was performed on the regions of interest 
(ROI) within the puromycin channel to determine how many puromycin puncta 
would co-localise with RPS10 puncta. Expression within a region of interest was 
determined by whether staining intensity was greater than 25% of the maximum 
staining intensity.  
The approach of co-localisation adapted within the current study assumes that 
the images acquired have little background noise therefore, thresholding puncta 
can be problematic if they are not clearly identifiable. An alternative method to 
analyse colocalization is Pearson’s co-localisation co-efficient, which can be 
used to determine the degree of linear relationship of fluorescent intensities 
between two different channels (Dunn et al., 2011). A disadvantage is that it is 
sensitive to background therefore, Pearson’s co-localisation co-efficient may 
identify a false correlation in images with high backgrounds (Adler & Parmryd, 
2010). Nevertheless, if the images have very little background, the sensitivity in 
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identifying a correlation is good. Pearson’s co-localisation co-efficient assumes 
a simple linear relationship and is not sensitive to differences in signal intensity 
of different channels (Dunn et al., 2011). Indeed, there are other methods to 
analyse co-localisation such as Manders Overlap Co-efficient as it measures 
the fraction of pixels with positive values that occur in both channels thereby, 
measuring absolute intensities; these methods are reviewed in Adler & Parmryd 
(2010). It is key to note that each method has its advantages and 
disadvantages and that the quality of image is also a determinant of which 
method may be better. It may be advantageous to employ multiple methods to 
report co-localisation to avoid reporting false-positive correlations. Furthermore, 
determining co-localisation can be problematic when puncta are numerous and 
overlapping. This can lead to interpretations that puncta may be clustering with 
each other or with puncta from other proteins when in fact they may not be, 
leading to incorrect conclusions. Moreover, if puncta from one channel are 
overlapping, this can lead to interpreting this as an individual punctum rather 
than multiple puncta. Images are acquired from a 3D environment and 
processed to produce 2D images whereby, a 2D co-localisation analysis is 
performed where numerous information may be lost or misinterpreted. A 3D 
analysis tool should be considered such as, the novel plugin DiAna for ImageJ 
as an alternative method for distance analysis in 3D (Gilles et al., 2016). The 
plugin allows to report in depth how much two objects may co-localise 
measuring: the distance from the centre of each puncta; the distance from the 
edge of each puncta; the distance from the centre of each puncta; and how 
much both puncta overlap (Figure 2, Gilles et al., 2016) providing a greater 
wealth of information.   
 
Figure 2.7 Analysis parameters for determining spine and dendritic regions for 
puncta analysis in MAP2 positive neurons. Dendritic regions were traced, and 
regions 2.5 µm either side were selected to encompass dendritic spines in 
MAP2 positive neurons. Collectively, these were termed ‘crude synaptic 
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regions’ encompassing both dendrites and dendritic spine regions. Puncta and 
puncta co-localisation were measured in crude synaptic regions, dendrites and 
dendritic spines regions. The black lines represent what regions were measured 
within each heading. This figure was kindly provided by Iain Watson.  
S T A T I S T I C S 
All statistical analysis was performed on Graphpad Prism 6. For all graphs, bars 
represent the mean average and error bars are presented as standard error of 
the mean (SEM). To identify differences between vehicle and pharmacological 
treatments, unpaired Student’s t-test with Welch’s correction was performed; 
the Mann-Whitney test was chosen for non-parametric data. A one-way ANOVA 
was employed for comparisons between multiple conditions; Bonferroni’s post-
hoc analyses were performed to correct for multiple comparisons of parametric 
data. The Kruskal Wallis test by ranks corrected by Dunn’s multiple 
comparisons test was performed on non-parametric data. An online Grubb’s 
test was used to identify any significant outliers 












Table 2.1 Composition of common solutions. 
 
 
Table 2.2 Drug compounds, and their final concentrations, used in 
pharmacological treatments in both primary neurons and acute slices. 







(in mM): 125 NaCl; 2.5 KCl; 26.2 NaHCO3; 
1 NaH2PO4; 11 glucose; 5 HEPES pH 7.4; 
2.5 CaCl2; 1.25 MgCl2; 0.2 APV (no APV 





(in mM): 87 NaCl; 3 KCl; 7 MgCl2; 1.25 
NaH2PO4; 0.5 CaCl2; 50 sucrose; 25 
glucose; 25 NaHCO3 
Ringer’s 
solution 
(in mM): 126 NaCl; 10 glucose; 2 MgCl2; 2 
CaCl2; 2.5 KCl; 1.25 NaH2PO4; 1.5 mM 
C3H3NaO3; 1 L-glutamine; 2.6 NaHCO3 




(in g): 15.1 tris(hydroxymethyl) 






(in g): 30.3 trizma base; 151.6g glycine – 
diluted to 1X with 20% methanol 
TBS (10X) 
pH 7.5 
(in g): 60 tris(hydroxymethyl) 
aminomethane; 87 NaCl – diluted to 1X 




(in mM): 137 NaCl; 2.7 KCl; 10 NaH2PO4; 
1.8 KH2PO4  
Drug/compound Company Catalogue no. Final concentration 
Estradiol Sigma  E8875 10 nM  
Rapamycin Cell Signaling 9904 
10 µM (neurons)  
1 µM (slices) 
Anisomycin Sigma A9789 40 µM 
Actinomycin D  Sigma A4262 
20 µM (neurons)  
25 µM (slices) 
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Table 2.3 List of primary antibodies used within the investigation. Abbreviations: WB = western blotting; ICC = immunocytochemistry. 
Antibody Species Company Catalogue number Dilution 
WB ICC 
PSD-95 Mouse Neuromab 75-028 1:1000 - 
GluA1 Mouse Neuromab 75-327 1:1000 - 
GluN1 Mouse Biolegend 818601 1:1000 - 
GluN2A Rabbit Cell Signaling 4205 1:1000 - 
GluN2B 
Rabbit Cell Signaling 4207 1:500 - 
Rabbit Alomone Labs AGC-003 - 1:300 
Synapsin 1 Rabbit Cell Signaling 5297 1:2000 - 
Snap25 Mouse Biolegend 836304 1:1000 - 
SV2A Rabbit Abcam ab32942 1:2000 - 
Gephyrin Rabbit Millipore AB5725 1:1000 - 
Neuroligin 2 Mouse Synaptic Systems 129 511 1:1000 - 
VGAT Rabbit Synaptic Systems 131 013 1:2000 - 
GAD 65/67 Rabbit Millipore AB1511 1:1000 - 
Puromycin 
Mouse Millipore MABE343 - 1:5000 
Mouse Kerafast EQ0001 1:1000 - 
GFP Chicken Abcam ab13970 - 1:10000 
MAP2 Chicken Abcam ab92434 - 1:1000 
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β-actin Mouse Sigma A1978 1:10000 - 
phospho-mTOR 
(Ser2448) 
Rabbit Cell Signaling 5536 1:1000 - 










Rabbit Cell Signaling 5364 1:1000 - 
S6 ribosomal 
protein 
Mouse Cell Signaling 2317 1:1000 - 
Ribosomal protein 
S10 







Table 2.4 List of secondary antibodies used within the investigation. 
Abbreviations: WB = western blotting; ICC = immunocytochemistry.  






















Goat anti-rabbit  
Alexa Fluor 488 
A11034 1:750 
Goat anti-mouse  
Alexa Fluor 568 
A11031 1:500 
Goat anti-chicken 




Alexa Fluor 405 
Ab175661 1:750 
Goat anti-rabbit 





Table 2.5 Primer sequences used within the investigation. 
Primer Forward 5’-3’ Reverse 5’-3’ 
DLG4  AGTGGATGTTCGGGAGGTGA GGTTTCCGGCGCATGACATA 
GRIN2B  AGCAAAGAAGGCCCACACTG GGCCCATCTTTCACCATCGG 
GRIA1 GGCAATGACCGCTATGAGGG AAGCCTTTGTGTCGGGATCC 
ACTB GTACCCCATTGAACACGGCA CTTAGGGTTCAGAGGGGCCT 
GUSB TCGGGGCAAATTCCTTTCGT ACACCGGGACACTCATCGAT 




C H A P T E R  3   
 
A C U T E  E S T R O G E N  S I G N A L L I N G  
R E G U L A T E S  S Y N A P T I C  P R O T E I N  
E X P R E S S I O N  I N  A  S E X U A L L Y  




S U M M A R Y   
 
Employing acute hippocampal slice preparations from both male and OVX female 
mice, this chapter aimed to biochemically investigate the expression profile of key 
excitatory and inhibitory synaptic proteins following a 2 hour estradiol treatment. 
The data demonstrated that estradiol regulates the expression of excitatory and 
inhibitory synaptic proteins differentially. Crucially, this chapter provides an 
insight into how estradiol regulates synaptic protein expression in a sexually 
dimorphic manner. This is the first study to investigate and report protein 
expression differences in both sexes using a wide array of key synaptic proteins. 
As sex differences are observed in hippocampal morphology, functioning, 
physiology and hippocampal-driven behaviour, dissecting the mechanisms by 
which estradiol contributes to these sex differences may provide valuable insights 
into understanding the biology of diseases and the need for sex specific 
treatments. 
 
I N T R O D U C T I O N   
 
Estrogens, particularly estradiol, have repeatedly been implicated in contributing 
to long-lasting influences over learning and memory (Frick, 2015; Srivastava et 
al., 2013; Woolley, 2007). These long-lasting effects infer that an alteration of 
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specific components of the neuronal architecture is occurring. The mechanisms 
underlying these long-lasting changes are, in part, orchestrated by estradiol’s 
ability to regulate synaptic plasticity in the hippocampus (Woolley, 2007). 
Evidence suggests that estradiol is able to trigger alterations in distinctive 
elements of the hippocampal circuitry such as, modulating excitatory synaptic 
transmission and dendritic spine density (Liu et al., 2008; Srivastava et al., 2013; 
Woolley, 2007). However, the molecular signature driving estradiol-mediated 
synaptic plasticity, and enhanced cognition, has yet to be fully elucidated.      
 
A myriad of studies has demonstrated that estradiol regulates plasticity in the 
mammalian hippocampus employing a number of mechanisms. For example, 
estradiol has been shown to increase the formation of new dendritic spines in the 
hippocampus in vivo (Gould et al., 1990; Woolley and McEwen, 1994) and in 
cultured hippocampal neurons (Korkotian and Segal, 2001; Murphy and Segal, 
1996; Murphy et al., 1998a). Recently, it has been found that estradiol increases 
spinogenesis rapidly, within minutes, in the hippocampus (Inagaki et al., 2012; 
Phan et al., 2012; Tuscher et al., 2016b) and the cortex (Inagaki et al., 2012; 
Sellers et al., 2015b; Srivastava et al., 2008). Estradiol also increases excitatory 
synapses specifically in the dorsal hippocampus (Woolley and McEwen, 1992), 
and potentiates EPSPs in excitatory synapses within the hippocampus of both 
sexes (Teyler et al., 1980; Wong and Moss, 1992). It has recently been 
demonstrated that this is mediated by distinct ERs in the male and female rat 
hippocampus (Oberlander and Woolley, 2016). Furthermore, estradiol enhances 
LTP and NMDA mediated synaptic transmission in the hippocampus (Good et al., 
1999; Smith and McMahon, 2006; Warren et al., 1995; Woolley et al., 1997). This 
augmentation in hippocampal LTP has been observed as early as 2 hours 
following the activation of ERβ in the male mouse hippocampus (Kramár et al., 
2009; Liu et al., 2008). Estradiol-mediated enhancement of LTP is deficient in 
ERβ KO mice (Liu et al., 2008), indicating a critical role for this receptor. 
Additionally, estradiol has been shown to modulate LTD, via ERα, in the male rat 
hippocampus (Mukai et al., 2007). Thus, it is appreciated that estrogens regulate 
complex actions at the synaptic architecture leading to enhanced synaptic 
transmission in the hippocampus and several studies have started to uncover the 




A potential mode of action estradiol may employ to regulate synaptic plasticity is 
by modulating the proteins prominently found at synapses. Excitatory and 
inhibitory synapses are organised on pre- and post-synaptic sides to induce 
specific protein and receptors that establishes their identity (Gerrow et al., 2006; 
McAllister, 2007). The majority of studies have focused on the estrogenic-
regulation of excitatory post-synaptic proteins. Studies from our lab have shown 
that key proteins present at excitatory PSDs such as, PSD-95, adhesion protein 
Neuroligin 1 (Nlgn1) and GluN1 are rapidly recruited to nascent synapses 
following 30 minute estradiol treatment in primary rat cortical neurons (Sellers et 
al. 2015b). This suggests that estradiol-induced dendritic spines encompass the 
molecular machinery needed for synaptogenesis. Additionally, our collaborators 
have previously shown an increase in PSD-95 and GluA1 expression levels 
following a 4 hour in vivo application of estradiol in the OVX female rat, which 
was recapitulated in the female mouse hippocampus via ERβ (Liu et al., 2008). 
These studies thus, indicate that estradiol can rapidly reorganise excitatory 
synapses by increasing the expression of key post-synaptic proteins. 
 
There is evidence that post-synaptic changes are often accompanied by pre-
synaptic changes. Limited studies have looked at pre-synaptic changes in 
response to estradiol.  Nevertheless, the enzyme that drives the synthesis of 
estradiol, aromatase, is localised pre-synaptically (Cornil et al., 2012; Naftolin et 
al., 1996; Remage-Healey et al., 2011; Srivastava et al., 2010) in addition to 
receptors ERα (Hart et al., 2007), ERβ (Milner et al., 2005) and GPER1 (Waters 
et al., 2015). Pre-synaptic proteins have been shown to fluctuate in expression 
during the estrous cycle (Crispino et al., 1999). Consistent with this, a number of 
studies have reported changes in pre-synaptic protein expression following 
chronic exposure to estradiol. Increases in vesicular glutamate transporter 1 
(vGlut1) (Jelks et al., 2007), syntaxin (Brake et al., 2001) and synaptophysin 
(Rune et al., 2002) have previously been observed. Expression changes in a 
more rapid time-frame have also been reported in both synaptophysin (Liu et al., 
2008) and synaptosomal associated protein 25 (SNAP 25) (Pechenino and Frick, 
2009). Studies from Catherine Woolley’s lab have implicated a pre-synaptic 
mechanism contributing to estradiol-mediated EPSCs. Estradiol was found to 
increase the probability of glutamate release at synapses within 30 minutes 
through ERβ in the OVX female hippocampus (Smejkalova and Woolley, 2010). 
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Moreover, studies have shown that estradiol increases the frequency of multiple 
synapse boutons in hippocampal CA1 (Woolley et al., 1996; Yankova et al., 
2001), where pre-synaptic boutons can synapse with multiple dendritic spines 
(Harris, 1995). Conversely, aromatase inhibition decreases the number of 
presynaptic boutons (Kretz et al., 2004). Interestingly, this also decreased 
synapses on dendritic spines but not those on the dendritic shaft suggesting a 
consequential post-synaptic effect. These studies propose that estradiol is able 
to mediate changes at excitatory pre-synaptic terminals that may contribute to 
post-synaptic changes and consequently, synaptic neurotransmission in the 
hippocampus.     
 
Estradiol’s influence on excitatory neurotransmission in the hippocampus is well 
documented whereas, much less is known about its role in regulating inhibitory 
neurotransmission. Nevertheless, ERα (Milner et al., 2001; Murphy et al., 1998b), 
ERβ (Milner et al., 2005) and GPER1 (Waters et al., 2015) have all been localised 
to interneurons within the rodent hippocampus suggesting estrogenic signalling 
can be mediated within inhibitory neurons. Previous studies have demonstrated 
a decrease in pre-synaptic glutamic acid decarboxylase 65 and 67 (GAD-65/67) 
protein expression and GAD positive interneurons following 12 and 24 hour 
estradiol treatments, respectively (Murphy et al., 1998b). Estradiol has also been 
shown to differentially regulate their respective mRNA levels in distinct brain 
regions (McCarthy et al., 1995). Given that GAD-65/67 is responsible for GABA 
synthesis it is feasible that estradiol may be regulating inhibitory 
neurotransmission. In support, previous research has shown that estradiol (10 or 
100 nM) suppressed inhibitory neurotransmission in OVX female, but not male, 
hippocampus through ERα within 10 minutes (Huang and Woolley, 2012). A 
follow up study suggested a pre-synaptic mechanism underlying this estradiol-
induced inhibition involving group I mGluR1 signalling inducing a subsequent 
suppression of GABA release (Tabatadze et al., 2015). To fully understand how 
estradiol may be interacting with proteins inhabiting inhibitory synapses, our 
collaborators investigated the relationship of estradiol with postsynaptic 
scaffolding protein gephyrin and its interactions with various GABA-A receptors 
(GABAAR). They have recently shown that 2 hour estradiol treatment reduced the 
stability of inhibitory synapses, with a concurrent reduction in the amplitude of 
miniature inhibitory synaptic currents (mIPSCs) and spontaneous inhibitory 
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synaptic currents (sIPSCs) in primary rat cortical neurons and male mouse 
hippocampal slice preparations, respectively (Mukherjee et al., 2017). Critically, 
they report that estradiol disrupted synaptic clusters of GABAAR synaptic 
subunits alpha-2 (α2) and gamma-2 (γ2) with gephyrin within the same time-
frame. Additionally, they showed that estradiol had no effect on the synaptically 
localised alpha-1 (α1) subunit. These data suggest that estradiol may interfere 
with the efficacy of inhibitory transmission by disrupting synaptic stability of 
GABAAR-gephyrin synapses. Nevertheless, more studies are required to confirm 
this and to fully understand estradiol’s role in inhibitory neurotransmission. Taken 
together, these studies highlight the complexity of estradiol’s effect on the 
synaptic plasticity and that estradiol could modulate synaptic inhibition prior to, in 
concert with, or as a consequence with the changes observed at postsynaptic 
sites of excitatory neurons.   
 
This chapter reports the expression profile of a number of key excitatory and 
inhibitory synaptic proteins following a 2 hour DMSO or estradiol treatment in 
acute hippocampal slices from both male and OVX female mice. Investigating 
how estradiol influences prominent synaptic proteins found at both excitatory and 
inhibitory synapses can provide an insight into a novel way estradiol may be 
mediating neuronal transmission in the hippocampus, which may contribute to 
enhanced hippocampal synaptic plasticity.   
 
R E S U L T S   
 
Estradiol increases the expression of key excitatory post-synaptic proteins 
in both male and OVX female hippocampus 
 
Increased expression levels of post-synaptic proteins predominantly present at 
excitatory PSDs has previously been reported within 4 hour estradiol treatment 
in vivo (Liu et al., 2008). Given the importance of PSD-95 and GluA1 in 
hippocampal synaptic functioning and plasticity (Sheng and Kim, 2011), the 
current study sought to determine whether estradiol increased expression of 
these proteins, in addition to various NMDAR subunits, within an earlier time-
frame.  Acute hippocampal slices from 10-12 week old male and OVX female 
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mice were treated with DMSO or estradiol for 2 hours. Hippocampi from each 
animal were divided by hemisphere into the different treatment conditions, DMSO 
and estradiol, per slice. This set up allowed an assessment of the effect of 
estradiol compared to a control within each animal. The slices were processed 
for western blotting (as described in Chapter 2) and the expression profile of 
PSD-95, the AMPAR subunit GluA1 and the NMDA receptor subunits GluN1, 
GluN2A and GluN2B were assessed in response to estradiol treatment. A 
significant increase in PSD-95 expression levels was observed in slices treated 
with estradiol compared to DMSO treated slices in the male ([mean ± SEM] 
vehicle 1.000 ± 0.02, E2 1.371 ± 0.02; t=10.71, df=8.00, p<0.0001, n=5 per 
condition; Figure 3.1A) and OVX female ([mean ± SEM] vehicle 1.000 ± 0.03, 
E2 1.213 ± 0.03; t=5.961, df=8.00, p=0.0003, n=5 per condition; Figure 3.1C) 
hippocampus. Estradiol also increased the expression levels of GluA1 in males 
([mean ± SEM] vehicle 1.000 ± 0.03, E2 1.198 ± 0.03; t=4.714, df=10.00, 
p=0.0008, n=6 per condition; Figure 3.1B) and OVX females ([mean ± SEM] 
vehicle 1.000 ± 0.02, E2 1.311 ± 0.03; t=9.281, df=8.00, p<0.0001, n=5 per 
condition; Figure 3.1D) within the same time-frame. These results mirror the 
findings of Liu et al. (2008) and suggest that estradiol is increasing the expression 
of these proteins in a more rapid time-frame than previously reported. 
 
No significant change in GluN1 expression levels was observed between male 
hippocampal slices treated with DMSO or estradiol ([mean ± SEM] vehicle 1.000 
± 0.04, E2 1.030 ± 0.04; t=0.4757, df=8.00, p=0.6470, n=5 per condition; Figure 
3.2A). Conversely, estradiol increased GluN1 expression levels in OVX female 
slices ([mean ± SEM] vehicle 1.000 ± 0.13, E2 2.490 ± 0.45; t=3.164, df=5.842, 
p=0.0202, n=6 per condition; Figure 3.2D) within the same time-frame. The 
observed increase in GluN1 expression in OVX female hippocampus is 
contradictory to the findings of Liu et al. (2008) where estradiol induced no 
change in GluN1 expression levels in OVX female rat. Expression levels GluN2A 
were found to be increased in both male ([mean ± SEM] vehicle 1.000 ± 0.07, 
E2 1.444 ± 0.07; t=4.207, df=10.00, p=0.0018, n=6 per condition; Figure 3.2B) 
and OVX female ([mean ± SEM] vehicle 1.000 ± 0.06, E2 1.434 ± 0.06; t=5.312, 
df=8.00, p=0.0007, n=5 per condition; Figure 3.2E) estradiol treated hippocampal 
slices compared to vehicle. Comparably, estradiol also induced an increase in 
GluN2B expression levels in both male ([median] vehicle 1.028, E2 1.290; u=0, 
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p=0.0079, n=6 per condition; Figure 3.2C) and OVX female ([mean ± SEM] 
vehicle 1.000 ± 0.07, E2 1.280 ± 0.07; t=2.882, df=8.00, p=0.0204, n=5 per 
condition; Figure 3.2F) hippocampal slices. Again, the increase in GluN2B 
expression contradicted with that of Liu et al.'s (2008).   
 
Taken together, these data suggest that estradiol rapidly increases the 
expression of key proteins highly abundant at the PSDs of excitatory synapses in 
both the male and OVX female mice hippocampus. These results highlight a key 
event estradiol acutely promotes that may contribute to mediate hippocampal 
synaptic plasticity. More so, that estradiol may use different mechanisms within 
























Figure 3.1 Estradiol acutely increases PSD-95 and GluA1 expression in the male 
and ovx female hippocampus. A-D, Representative western blots and 
quantification of male (A+B) and ovx female (C+D) acute hippocampal slices 
prepared from 10-12 week old mice and treated with vehicle or estradiol (10 nM, 
2 hours). Slices were processed for western blotting and probed for PSD-95 and 
GluA1 and normalised to housekeeper, β-actin. Estradiol increased expression 
levels of PSD-95 in the male (A) and ovx female (C) hippocampus within 2 hours; 
n=5-6 per condition. Unpaired student’s t-tests, Welch’s correction; Error bars 
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Figure 3.2 NMDAR subunits are increased in the male and ovx female 
hippocampus following 2 hour estradiol treatment. A-F, Representative western 
blots and quantification of male (A-C) and ovx female (D-F) acute hippocampal 
slices prepared from 10-12 week old mice and treated with vehicle or estradiol 
(10 nM, 2 hours). Slices were processed for western blotting and probed for 
GluN1, GluN2A and GluN2B and normalised to housekeeper, β-actin. Estradiol 
had no effect on GluN1 expression levels in the male hippocampus (A) but was 
increased in the ovx female (D) hippocampus after 2 hours. Expression levels of 
both GluN2A and GluN2B were increased within the same time-frame in both 
male (B+C) and ovx female (D+E) hippocampus; n=5-6 per condition. Unpaired 
student’s t-test with Welch’s correction was used with parametric data sets; 
Mann-Whitney test was used with non-parametric data sets; Error bars represent 
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Estradiol induces a sex specific difference in the expression of post-
synaptic inhibitory proteins 
 
Effective communication between neurons involves the synchronisation of 
excitatory and inhibitory neurotransmission. Previous research has suggested 
that acute estradiol treatment disrupts the stability of inhibitory synapses 
(Mukherjee et al., 2017) and suppresses inhibitory neurotransmission in a sex-
specific manner (Huang and Woolley, 2012; Tabatadze et al., 2015). This 
suggests that estradiol may influence synaptic inhibition in concert with, or as a 
consequence of, changes it exhibits at excitatory synapses. To understand 
whether estradiol-mediated increases seen in synaptic proteins is restricted to 
excitatory synapses, the expression profile of key proteins found at inhibitory 
synapses were assessed within the same time-frame.   
 
As above, male and OVX female hippocampal slices were treated with DMSO or 
estradiol for 2 hours and processed for western blotting. The expression levels of 
scaffolding protein gephyrin and adhesion protein neuroligin-2 (Nlgn2) were 
assessed in response to estradiol. Estradiol significantly increased expression 
levels of gephyrin in the male ([mean ± SEM] vehicle 1.000 ± 0.01, E2 1.218 ± 
0.01; t=14.63, df=8.00, p<0.0001, n=5 per condition; Figure 3.3A) but not the 
OVX female ([mean ± SEM] vehicle 1.000 ± 0.06, E2 0.9673 ± 0.06; t=0.3806, 
df=8.00, p=0.7134, n=5 per condition; Figure 3.3D) hippocampal slices. Critically, 
no significant difference in Nlgn2 expression levels was found in either male 
([mean ± SEM] vehicle 1.000 ± 0.03, E2 1.088 ± 0.03; t=1.800, df=8.00, 
p=0.1096, n=5 per condition; Figure 3.3B) or OVX female ([mean ± SEM] vehicle 
1.000 ± 0.07, E2 0.8675 ± 0.07; t=1.362, df=8.00, p=0.2104, n=5 per condition; 
Figure 3.3E) hippocampus. Additionally, given that gephyrin has a critical role in 
GABAAR clustering and stabilisation (Tyagarajan and Fritschy, 2014), the 
expression of alpha-1 (α1) subunit of GABAAR was assessed in male 
hippocampal slices alone for preliminary testing. GABAAR α1 was found to be 
significantly increased in estradiol treated hippocampal slices compared to 
vehicle ([mean ± SEM] vehicle 1.000 ± 0.04, E2 1.248 ± 0.04; t=4.083, df=4.00, 







Figure 3.3 Estradiol differentially regulates key inhibitory post-synaptic proteins 
in the male and ovx female hippocampus. A-E, Representative western blots and 
quantification of male (A-C) and ovx female (D+E) acute hippocampal slices 
prepared from 10-12 week old mice and treated with vehicle or estradiol (10 nM, 
2 hours). Slices were processed for western blotting and probed for Gephyrin and 
Neurologin-2 (Nlgn2) and normalised to housekeeper, β-actin. For preliminary 
investigation, GABAAR alpha1 subunit (GABAAR α1) was assessed only in male 
slices. Estradiol increased Gephyrin expression in the male (A) but not ovx 
female (D) hippocampus within 2 hours. No expression change was observed in 
Nlgn2 levels in neither males (B) nor ovx females (E) following estradiol treatment 
within the same time-frame. Estradiol increased GABAAR α1 expression in the 
male hippocampus; n=5-6 per condition, n=3 for GABAAR α1. Unpaired student’s 
t-tests, Welch’s correction; Error bars represent mean ± SEM; * p =0.05, **** p = 
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This is the first study to report the effects of estradiol on both Nlgn2 and gephyrin 
in the mouse hippocampus. These data show that estradiol increases gephyrin 
and GABAAR α1 expression levels in the male hippocampus. A distinct effect is 
observed in the OVX hippocampus suggesting estradiol may behave differently 
at inhibitory synapses in the females. Further studies are required to understand 
the effect of estradiol on the expression level of GABAAR α1 in the OVX female 
hippocampus.  
 
Excitatory pre-synaptic proteins are differentially altered in response to 
estradiol  
 
Previous research has demonstrated that estradiol engages a presynaptic 
mechanism to potentiate excitatory neurotransmission (Smejkalova and Woolley, 
2010). Interestingly, estradiol has previously been shown to enhance 
synaptophysin in a region specific manner (Liu et al., 2008), but the effect of acute 
estradiol on other pre-synaptic proteins have not been investigated. To this end, 
the expression profile of neurotransmitter release regulator synapsin 1, SNAP 25 
and synaptic vesicle protein 2A (SV2A) were all assessed in acute hippocampal 
slices from adult male and OVX female mice following a 2 hour estradiol 
treatment. Synapsin 1 expression was not significantly different between DMSO 
treated and estradiol treated hippocampal slices from either males ([mean ± SEM] 
vehicle 1.000 ± 0.02, E2 0.9915 ± 0.02; t=0.2509, df=8.00, p=0.8082, n=5 per 
condition; Figure 3.4A) or OVX females ([median] vehicle 1.004, E2 0.8956; 
u=3, p=0.2000, n=4 per condition; Figure 3.4D). Sex specific difference in 
expression was observed in both SNAP 25 and SV2A. Estradiol had no effect on 
SV2A expression in the male hippocampus ([mean ± SEM] vehicle 1.000 ± 0.03, 
E2 0.9766 ± 0.03; t=0.6264, df=8.00, p=0.5485, n=5 per condition; Figure 3.4B) 
whereas, it decreased SV2A expression in the OVX female hippocampus ([mean 
± SEM] vehicle 1.000 ± 0.05, E2 0.8330 ± 0.05; t=0.2522, df=8.00, p=0.0.357, 
n=5 per condition; Figure 3.4E). Conversely, an increase in SNAP 25 expression 
was observed in estradiol treated hippocampal slices from males ([mean ± SEM] 
vehicle 1.000 ± 0.07, E2 1.275 ± 0.07; t=2.679, df=8.00, p=0.0280, n=5 per 
condition; Figure 3.4C), but not OVX females ([mean ± SEM] vehicle 1.000 ± 
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0.10, E2 1.022 ± 0.02; t=0.1406, df=10.00, p=0.8910, n=6 per condition; Figure 
3.4F), compared to vehicle. 
 
Figure 3.4. Estradiol increases a subset of excitatory pre-synaptic proteins in a 
sex dependent manner after 2 hours. A-F, Representative western blots and 
quantification of male (A-C) and ovx female (D-F) acute hippocampal slices 
prepared from 10-12 week old mice and treated with vehicle or estradiol (10 nM, 
2 hours). Slices were processed for western blotting and probed for synapsin1, 
SV2A and snap 25 and normalised to housekeeper, β-actin. Estradiol changed 
pre-synaptic protein expression levels in a sexually dimorphic manner. Estradiol 
did not change synapsin1 expression levels in the male (A) or ovx female (D) 
hippocampus. SV2A expression levels were decreased in ovx females (E) but not 
males (B) within the same time-frame following estradiol treatment. Estradiol 
however, increased snap 25 expression levels in the male (C) but not ovx female 
(F) hippocampus; n=4-6 per condition. Unpaired student’s t-test with Welch’s 
correction was used with parametric data sets; Mann-Whitney test was used with 
non-parametric data sets; Error bars represent mean ± SEM; * p = <0.05, ns = 
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These data further confirm a sex specific regulation of protein pools found at 
excitatory synapses by estradiol. Nonetheless, it illustrates that estradiol is able 
to differentially alter pre-synaptic proteins suggesting that changes at pre-
synaptic terminals may contribute to or be a consequence of estradiol-mediated 
synaptic plasticity in the hippocampus.  
 
Sex specific expression difference is observed in specific pre-synaptic 
inhibitory proteins     
 
In line with the changes estradiol induces in the expression of post-synaptic 
inhibitory proteins, it could be reasoned that estradiol may differentially alter 
critical proteins present pre-synaptically in inhibitory neurons. To this end, the 
expression profile of GAD-65/67 and vesicular GABA transporter (VGAT), both 
markers of inhibitory interneurons, was assessed in DMSO or estradiol treated (2 
hours) hippocampal slices from males and OVX females. Estradiol significantly 
increased GAD-65/67 expression in the male ([median] vehicle 0.9918, E2 
1.360; u=0, p=0.0286, n=4 per condition; Figure 3.5A), but not in the OVX female 
([median] vehicle 0.9998, E2 0.9218; u=4, p=0.3429, n=4 per condition; Figure 
3.5C) hippocampus. Interestingly, estradiol did not alter the expression of VGAT 
in males ([mean ± SEM] vehicle 1.000 ± 0.06, E2 1.085 ± 0.06; t=1.026, df=8.00, 
p=0.3351, n=5 per condition; Figure 3.5B) but significantly reduced its 
expression in OVX females ([mean ± SEM] vehicle 1.000 ± 0.04, E2 0.7589 ± 
0.04; t=4.0680, df=8.00, p=0.0036, n=5 per condition; Figure 3.5D). 
 
Taken together, these data demonstrate a sexually dimorphic regulation of key 
inhibitory pre-synaptic proteins by estradiol. Increased GAD-65/67 expression 
was observed solely in the male hippocampus, suggesting that estradiol may be 
increasing GABA synthesis, through an unknown mechanism, which ultimately 
may contribute to estradiol-mediated hippocampal synaptic plasticity. Further, 
decreased VGAT expression found in the OVX female hippocampus may be 
indicative of a different mechanism estradiol may employ, to regulate 
hippocampal synaptic plasticity. This could indicate a consequential event in 





Figure 3.5. Key inhibitory synaptic proteins are differentially regulated by acute 
estradiol treatment. A-D, Representative western blots and quantification of male 
(A+B) and ovx female (C+D) acute hippocampal slices prepared from 10-12 week 
old mice and treated with vehicle or estradiol (10 nM, 2 hours). Slices were 
processed for western blotting and probed for GAD-65/67 and VGAT and 
normalised to housekeeper, β-actin. GAD-65/67 expression levels were 
increased in the male (A) but not ovx female (C) hippocampus in response to 2 
hour estradiol treatment. Estradiol had no effect on VGAT expression levels in 
males (B) but decreased expression levels in ovx female (D) within the same 
time-frame; n=4-6 per condition. Unpaired student’s t-test with Welch’s correction 
was used with parametric data sets; Mann-Whitney test was used with non-
parametric data sets; Error bars represent mean ± SEM; * p = <0.05, ** p = <0.01, 
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D I S C U S S I O N  
 
Summary of results 
 
This chapter has provided data on the effect of acute estradiol treatment on the 
expression of key excitatory and inhibitory synaptic proteins in male and OVX 
female mouse hippocampus (see Table 3.1 for a summary). A subset of post-
synaptic proteins were observed to be significantly increased in both male and 
OVX female hippocampus although, estradiol had no effect on some proteins. 
Additionally, sex-specific increases and decreases in expression were found in 
pre-synaptic proteins. Collectively, acute estradiol treatment induced a sex-
specific expression change of an array of proteins prominent at both excitatory 
and inhibitory synapses. Consequently, estradiol may influence both excitatory 
and inhibitory neurotransmission to regulate hippocampal synaptic plasticity in a 
sexually dimorphic manner.   
 
Estradiol mediates synaptic plasticity predominantly through post-synaptic 
neurotransmission in the hippocampus  
 
Estradiol modulates several neuronal processes which may contribute to 
regulating synaptic plasticity, including increased spinogenesis, increased 
synaptogenesis, potentiated synaptic transmission and enhanced LTP. Some of 
these synaptic events have been reported to occur within 2 hour estradiol 
treatment. For example, Liu et al. (2008) reported that ERβ potentiated CA3-CA1 
LTP after 2 hours in female mouse hippocampal slices. The current study found 
increased expression of key synapse-associated post-synaptic proteins such as, 
PSD-95 and AMPAR and NMDAR subunits. The increase in PSD-95 and 
AMPARs are consistent with previous reports (Liu et al., 2008). This suggests 
that estradiol’s ability to enhance LTP is driven in part by an increase in the 
expression of key post-synaptic proteins. However, whether this protein increase 
is occurring at the synapses is unknown. Interestingly, Lui et al. (2008) did not 
observe increased GluN1 or GluN2B expression in either sex, although increases 
in GluN1 cluster size has been reported before in response to 24 hour estradiol 
treatment in primary hippocampal neurons (Jelks et al., 2007). In the current 
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study, estradiol induced a sex-specific increase in GluN1 in the OVX female, but 
not male, hippocampus. Differences in estradiol administration (in vivo vs. in vitro) 
and treatment time can be accounted for the dissimilarities in Lui et al.’s (2008) 
results with the current study. Nevertheless, the results from the current study 
suggest that estradiol increases key proteins typically localised to excitatory 
synapses thereby, promoting a change in the excitatory synaptic proteome. 
 
PSD-95 and GluN1 are thought to be critical for normal synaptic functioning. 
Enrichment of these proteins at dendritic spines is seen following synaptic 
potentiation (Bosch and Hayashi, 2012). In addition, a complex of PSD-95 and 
GluN1 are thought to be the first proteins to arrive at nascent spines, and are 
required for synaptogenesis to occur (Chubykin et al., 2007; Gerrow et al., 2006). 
Therefore, the increase in PSD-95 and GluN1 expression reported here are 
consistent with previous reports that estradiol increases spinogenesis and 
synaptogenesis. Work from our lab has shown an increase in the synaptic 
localisation of PSD-95 and GluN1 within 30 minutes (Sellers et al., 2015b). 
Critically, this is thought to be achieved without an increase in the expression of 
these proteins within this time-frame. Thus, a subsequent (after 2 hours) increase 
in the expression of these proteins may replenish the protein previously trafficked 
to synapses thereby, providing the neuron with the availability of proteins to either 
newly formed or potentiated synapses. 
 
Estradiol also increased the expression of other NMDAR subunits implicated in 
LTP. Multiple studies have reported that GluN2B-containing NMDARs are critical 
for estradiol-induced enhancement in LTP (Smith and McMahon, 2005, 2006; 
Smith et al., 2016; Snyder et al., 2011; Vedder et al., 2013). Although, these 
studies examine these changes following longer estradiol exposures (24-48 
hours), they report that GluN2B is a key driver of estradiol-induced synaptic 
neurotransmission. Interestingly, Potier et al. (2015) recently reported that 
estradiol transiently decreased GluN2B surface diffusion within 15 minutes whilst, 
having no effect on GluN2A. Following a longer treatment (24 hour), estradiol 
increased GluN2B and decreased GluN2A surface diffusion. An impairment of 
the surface diffusion of both NMDAR subunits inhibited estradiol-mediated 
increase in dendritic spines suggesting this reorganisation of NMDARs may 
contribute to estradiol-mediated synaptic plasticity. The current study 
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demonstrated increases in both total GluN2A and total GluN2B expression. Thus, 
GluN2A and GluN2B may be working in concert to mediate changes in synaptic 
plasticity. Potier et al. (2015) proposed a model whereby GluN2B may drive the 
strengthening of synapses via LTP whereas, the increase in GluN2A may play a 
role in maintaining these connections. This cannot be determined biochemically 
within the scope of the current study but it points to an important role for both in 
mediating estradiol-mediated synaptic plasticity.  
 
The present results also uncovered a unique influence on inhibitory synaptic 
proteins. Estradiol did not change Nlgn2 expression in either male or OVX female 
but, a sex-specific increase was seen in gephyrin and the α1 subunit of GABAAR 
in the male hippocampus. These results seemingly contradict the findings from 
our collaborators, who found estradiol destabilised inhibitory synapses 
(Mukherjee et al., 2017). The authors found decreased α1, α2 and γ2 –containing 
GABAARs and gephyrin synaptic clustering in primary cortical neurons after 2 
hour estradiol treatment. However, they had solely measured synaptic, but not 
total, protein levels whereas, the current study determined changes in total 
protein levels. Additionally, these effects were observed in mixed sex cortical 
cultures whereas, hippocampal slices from both males and OVX females were 
employed in the current study. Mukherjee et al. (2017) also found that estradiol 
(2 hours) reduced mIPSCs and sIPSCs amplitude in CA1 hippocampus in male 
slices. In support, a reduction in IPSC transmission has also been previously 
observed in CA1 hippocampus in OVX female (Tabatadze et al., 2015). However, 
the results from the current study are derived from measuring total protein levels 
from the whole hippocampus and so it does not have the same resolution to 
measure functional changes as the electrophysiology studies benefits from.  
 
Neural information is orchestrated by both excitatory and inhibitory synapses and 
thus, an appropriate balance must be maintained by each (Levinson and El-
Husseini, 2005). Studies illustrate that it is the expression of either Nlgn2 and 
Nlgn1 that give synapses their inhibitory or excitatory identity (Chubykin et al., 
2007; Levinson and El-Husseini, 2005). Notably, Nlgn2 contributes to increases 
in inhibitory synapses (Chubykin et al., 2007) but its expression was not changed 
within this study. What was not tested, but would be interesting to determine is 
whether Nlgn1 expression is also increased within this time-frame. Work from our 
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lab has previously shown that Nlgn1 expression, and co-localisation with PSD-95 
is increased in vitro (Sellers et al. 2015b). In line with increased PSD-95 and 
AMPAR/NMDAR subtypes, estradiol could increase Nlgn1 within 2 hours. This 
would suggest estradiol may increase excitatory synapses, whilst having no 
effect on inhibitory synapses. It has been proposed that estradiol may initially 
suppress inhibitory neurotransmission which, could lead to regulation of 
excitatory neurotransmission (Rudick and Woolley, 2001). Yet, an important 
characteristic of the changes at excitatory and inhibitory synapses observed 
within this study is that these changes are occurring at the same time. Previous 
reports of changes found at excitatory (Sellers et al., 2015a; Srivastava et al., 
2008) and inhibitory (Mukherjee et al., 2017) synapses suggest a shift towards 
the excitatory side of the excitatory/inhibitory (E/I) balance. The present results 
show differential changes in both excitatory and inhibitory proteins. Changes to 
either can affect the ratio between these two types of input and subsequently, 
lead to a change in the E/I balance. Critically, disruptions to the E/I balance has 
been proposed to be implicated in psychiatric disorders such as autism spectrum 
disorders (Rubenstein and Merzenich, 2003) and schizophrenia (Gao and 
Penzes, 2015).       
 
Contribution of estradiol-mediated pre-synaptic neurotransmission  
 
Within the current study, estradiol also mediated sex-specific changes in pre-
synaptic proteins present at both excitatory and inhibitory synapses. Estradiol 
increased pre-synaptic proteins in the males (GAD-65/67, SNAP 25) in concert 
with decreased pre-synaptic proteins in the OVX females (VGAT, SV2A) after 2 
hour treatment. There were several proteins that did not change such as synapsin 
1, SV2A and VGAT in males, and SNAP 25 and GAD-65/67 in OVX females. 
Nevertheless, estradiol also shifts towards the excitatory side of the E/I balance 
pre-synaptically. It is unclear whether this is contributing to, or is a consequence, 
of sex-specific estradiol-mediated changes in the hippocampus.  
 
Increases in specific pre-synaptic proteins are consistent with previous reports. 
A number of studies found increases following a 24 or 48 hour estradiol treatment 
(Brake et al., 2001; Jelks et al., 2007; Rune et al., 2002). These time-frames are 
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much longer than what is of interest in this present study and could point to a 
consequence of estradiol-induced synaptic neurotransmission. In that, estradiol 
may rapidly increase a subset of post-synaptic proteins to mediate hippocampal 
plasticity, and in turn may consequently increase pre-synaptic proteins. Thus, the 
changes seen in this study could be a transient change. Previously, increased 
SNAP 25 mRNA, within 1 hour, and protein expression, at 4 hours, was observed 
in OVX female mouse (Pechenino and Frick, 2009). However, this increased 
protein expression was not evident at 3 hours. This suggests that estradiol-
mediated increase in mRNA levels manifest into increased protein expression 2 
hours later. This could explain why changes in SNAP 25 expression was only 
observed in males, but not OVX females, within the current study. A possibility 
may be that SNAP 25 expression may not be affected at 2 hours. Other proteins 
were also changed in a sexually dimorphic manner such as GAD-65/67, VGAT, 
and SV2A. The expression profile of these proteins could be also changed within 
a different time-frame to this study. Nevertheless, the sexual dimorphism in the 
change in protein expression in response to estradiol indicates that estradiol may 
be regulating the components of the pre-synaptic architecture in a sex dependent 
manner. This would in turn suggest that males and OVX females may use distinct 
signalling mechanisms to modulate estradiol-mediated changes. 
 
A sex independent expression change found within this study was that Synapsin 
1 was not changed in either sex following 2 hour estradiol treatment. A similar 
observation was made by Liu et al. (2008) in synaptophysin expression following 
4 hour estradiol treatment. Except that following a region specific investigation, 
synaptophysin expression was found to be changed specifically in pyramidal and 
radial cell layer of hippocampal CA1. Thus, any region-specific changes in protein 
expression cannot be ruled out. A caveat of the current study was that the whole 
hippocampus was used to determine expression changes and so there is less 
sensitivity to region specific changes. This could be accountable to several 
proteins that were not found to be affected by estradiol levels. A number of 
studies found increases following a 24/48 hour estradiol treatment (Brake et al., 
2001; Jelks et al., 2007; Rune et al., 2002). These time-frames are much longer 
than what is of interest in this present study and could point to a consequence of 
estradiol-induced synaptic neurotransmission. In that, estradiol may rapidly 
increase a subset of post-synaptic proteins to mediate hippocampal plasticity, 
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and in turn may consequently increase pre-synaptic proteins. Thus, the changes 
seen in this study could be a transient change.  
 
Changes in the pre-synaptic proteome suggest that estradiol may be modulating 
the pre-synaptic architecture. Whether this influences, or is a consequence of, 
changes it mediates post-synaptically is not clear. Estradiol-mediated increase in 
glutamate probability release has previously been implicated to contribute to 
estradiol-induced EPSCs (Smejkalova and Woolley, 2010). This was observed at 
30 minutes. The short time-frame within which this occurs may indicate that 
estradiol could be modulating pre-synaptic machinery prior to mediating post-
synaptic changes. Thereby, the changes seen following 2 hour estradiol 
treatment could be a secondary effect. Estradiol could be modulating changes at 
pre-synaptic terminals upon application and subsequently the proteomic 
signature seen at 2 hours in the current study could be the resultant effect. 
Although, a higher concentration (100 nM) of estradiol was employed compared 
to the present study (10 nM), the presynaptic protein signature seen may be 
different at an earlier time-point. Additionally, GAD-65/67 protein (Murphy et al., 
1998) and mRNA (McCarthy et al., 1995) expression changes have previously 
been reported in response to estradiol. This suggests that estradiol may be 
mediating changes at inhibitory neurons, in addition to inhibitory synapses within 
this time-frame. Although, this is not the scope of this study, it was of interest to 
see whether estradiol effects proteins present in inhibitory neurons within this 
time-frame.   
          
Estradiol induces expression changes in synaptic proteins in a sexually 
dimorphic manner 
 
One of the biggest caveats in estradiol research is that majority of the studies 
investigate and report findings on a single sex. Sex differences between males 
and females are found in hippocampal morphology, physiology and function 
(Choleris et al., 2018). There is also evidence that estradiol can be produced in 
both the male and female hippocampus de novo (Hojo et al., 2004; Prange-Kiel 
et al., 2003). Nonetheless, recently studies into the effect of estradiol in the 
hippocampus have been taking sex into consideration and have reported the 
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effect of latent differences, within which the outcome may be the same but the 
underlying molecular mechanism can be different (Oberlander and Woolley, 
2016). The sexually dimorphic regulation of the proteins present in both excitatory 
and inhibitory synapses observed in this study highlight that estradiol may be 
regulating hippocampal synaptic plasticity independently of sex. For example, 
different ERs have recently been found to mediate estradiol-induced excitatory 
synaptic neurotransmission in the male and OVX female hippocampus 
(Oberlander and Woolley, 2016). In another case, systemic inhibition of 
aromatase in male, female and OVX female mouse hippocampus impaired LTP 
to different degrees in both sexes after 1 day (Vierk et al., 2012); these 
observations were coupled with spine loss in female and OVX female but not in 
males. Thereby, considering the data posits sex-specific changes in estradiol-
induced protein composition at both types of synapses it highlights the need to 
incorporate both sexes in future research investigating estradiol-mediated 
hippocampal synaptic plasticity. This would also give us insights on sex-specific 




This chapter demonstrated that estradiol induced a sex-specific change at 
synapses by regulating the expression of key proteins. Estradiol had different 
effects on the proteome of both excitatory and inhibitory synapses in each sex.  
Importantly, it highlights that estradiol increases key excitatory post-synaptic 
proteins in the hippocampus of both sexes. This is also accompanied by 
increases in inhibitory proteins GABAAR α1 and gephyrin in males but not in OVX 
females. Thus, estradiol manipulates a shift towards the excitatory side of the 
excitatory/inhibitory (E/I) balance. This was also observed pre-synaptically. 
Therefore, both excitatory and inhibitory proteins are affecting the E/I balance.  
These data raises multiple questions: 1. whether the consistent increase seen in 
excitatory post-synaptic proteins in the present study are being mediated through 
the same ER; 2. whether it is indeed the same receptor but different signalling 
pathways; and 3. whether estradiol is causing a similar cellular distribution of 
these proteins. As a first of its kind study, it is informative on the effect estradiol 
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is exerting on key proteins found at both excitatory and inhibitory synapses, if at 
all, and whether the output, protein expression, is the same in males and females.  
 
Given the relatively short time-frame within which estradiol increases specific 
protein expression suggests a non-genomic mechanism of action. Thus, estradiol 
may be engaging with locally available translational machinery and locally 
translating specific proteins to mediate these effects on synaptic 
neurotransmission in the hippocampus. To address whether estradiol is indeed 
engaging translational machinery, Chapter 4 will focus on determining whether 



























Table 3.1: Summary of synaptic protein expression change in male and OVX 
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S U M M A R Y  
 
This chapter has focused on determining whether the estradiol-mediated 
increase in synaptic protein expression levels could be attributable to local protein 
synthesis. Previous reports have suggested that estradiol can regulate local 
protein synthesis, but this has not been specifically tested. Employing acute 
hippocampal slice preparations from both male and OVX female mice, and rat 
primary hippocampal neurons, this chapter aimed to investigate whether estradiol 
increased protein synthesis following a 2 hour estradiol treatment. Two 
independent protein synthesis visualisation assays, SUnSET and FUNCAT, were 
employed to investigate this. The results revealed an increase in protein 
synthesis, independently of gene transcription in both sexes. The data further 
demonstrated that estradiol employed different signalling pathways in male and 
OVX female rodents to mediate this. Interestingly, newly synthesised proteins 
could be detected along dendrites and specifically in larger dendritic spines.      
 
This is the first study to illustrate that estradiol rapidly enhances protein synthesis 
specifically at dendritic and synaptic regions. This demonstrates a novel 
mechanism by which estradiol may modulate hippocampal synaptic plasticity. 
Critically, it reiterates the need to consider sex as a variable during estradiol 
research as the signalling pathways estradiol may employ to mediate different 
aspects of synaptic plasticity may not be synonymous in both sexes. 
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I N T R O D U C T I O N  
 
Local protein synthesis is deemed a critical component of long-lasing changes in 
synaptic plasticity, neuronal circuitry and cognition (Costa-Mattioli et al., 2009; 
Liu-Yesucevitz et al., 2011). It has been demonstrated to occur in dendrites 
(Steward and Schuman, 2001), axons (Lin and Holt, 2007) and astrocytes (e.g. 
Sakers et al. 2017). Dendritic synthesis of proteins can rapidly provide synapses 
with essential proteins circumventing the communication required between the 
nucleus and synapse to coordinate transcription and subsequent transport of 
proteins. In neurons, translational machinery such as ribosomes and translation 
factors are found along dendrites and in dendritic spines in addition, to their 
presence in the soma (Steward and Schuman, 2001). An abundance of mRNA 
for synaptic proteins are also present along dendrites (Cajigas et al., 2012). 
Indeed, local protein synthesis can occur within minutes if the target mRNA is 
present at the site of translation (Steward and Schuman, 2001). Collectively, this 
alludes to the notion that both the translational machinery and substrates required 
for protein synthesis is present at dendrites. This local control of protein synthesis 
indicates that new proteins can be synthesised within the vicinity of synapses 
(Holt and Schuman, 2013), bypassing gene transcription and thus, mediate a 
local control of the synaptic proteome (Rangaraju et al., 2017). Thereby, the local 
synthesis of proteins provides a mechanism to control synaptic changes 
independently and may contribute to underlying long-lasting forms of synaptic 
plasticity (Aakalu et al., 2001).  
 
Indeed, local protein synthesis has been implicated as a critical component of 
various forms of long-lasting hippocampal synaptic plasticity (Klann et al., 2004). 
Evidence posits that new protein synthesis is required for the maintenance of L-
LTP (Cracco et al., 2005; Kang and Schuman, 1996; Nguyen et al., 1994; Ostroff 
et al., 2018) and mGluR-dependent LTD (Graber et al., 2013; Huber et al., 2000) 
in the hippocampus. A number of neuronal events that are independent of new 
protein synthesis are triggered following the initial stimulation of both phenomena, 
such as modifications to spine density and morphology and exo/endocytosis of 
ionotropic glutamate receptors (iGluRs), such as AMPARs and NMDARs. Newly 
synthesised proteins maintain and stabilise these phenomena by regulating the 
trafficking of iGluRs (Pfeiffer and Huber, 2006). Some parallels in the 
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reorganisation of the neuronal architecture can be observed in response to 
estradiol. Estradiol rapidly, within 30 minutes, promotes protein trafficking and 
spine modifications in vitro, which are independent of new protein synthesis 
(Sellers et al. 2015b; Srivastava et al. 2008). Whether the stabilisation of these 
neuronal events require protein synthesis is yet to be determined (Sellers et al. 
2015a). Nevertheless, following this time-frame, estradiol increases protein 
expression in a relatively short time-scale suggesting a non-genomic mechanism 
of action, such as local protein synthesis. In support, estradiol has previously 
been demonstrated to increase dendritic mRNA translation of CAMKIIα over 1 
hour in primary hippocampal neurons (Sarkar et al., 2010). However, the 
mechanisms linking estrogenic signalling with local protein synthesis are 
currently unknown.       
 
A signalling pathway proposed to have a pivotal role in estradiol-induced local 
protein synthesis is the mTOR kinase signalling pathway. In support, countless 
studies have illustrated that estradiol rapidly phosphorylates mTOR in the 
hippocampus within 5 minutes in vivo (Fortress et al., 2013) and 15 minutes in 
the hippocampus and cortex in vitro (Briz & Baudry 2014; Sellers et al. 2015b). 
mTOR is activated by many kinases, one of which is ERK (Winter et al., 2011). 
Evidence also presents that estradiol rapidly phosphorylates ERK in the 
hippocampus in vivo (Fan et al., 2010; Fernandez et al., 2008; Fortress et al., 
2013) and in the hippocampus and cortex in vitro (Briz & Baudry 2014; Sellers et 
al. 2015b); this was specifically seen in the p42 isoform of ERK (Fan et al., 2010). 
The mTOR pathway has been shown to have a key role in mediating local protein 
synthesis by phosphorylating two prominent proteins of the translation initiation 
machinery, S6K and 4EBP1 (Costa-Mattioli et al., 2009; Hoeffer and Klann, 2010; 
Lipton and Sahin, 2014). The ERK pathway has also been implicated in regulating 
translation initiation machinery via mTOR (Roux et al., 2007; Tsokas et al., 2007; 
Winter et al., 2011) and independently of mTOR by activating eukaryotic 
translation initiation factor 4E (eIF4E) (Banko et al., 2004; Waskiewicz et al., 
1999). However, less is known regarding the molecular basis of ERK-mediated 
protein synthesis. Studies demonstrate that estradiol rapidly modulates the 
activation of several proteins directly involved in regulating protein translation 
machinery. Estradiol rapidly phosphorylates: 4EBP1 in vitro (Akama and 
McEwen, 2003; Sarkar et al., 2010) and in vivo within 5 minutes (Fortress et al., 
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2013); S6K in vivo within 5 minutes (Fortress et al., 2013); and RPS6, a direct 
downstream target of S6K, in vitro within 10 minutes (Sarkar et al., 2010). The 
activation of ERK and mTOR are required for estradiol to activate these proteins 
(Fortress et al., 2013) demonstrating a possible cross-talk between these two 
kinases. These kinases have also been linked to triggering an increase in 
synaptic plasticity (Hoeffer and Klann, 2010). Thus, a mechanism is in place to 
underlie estradiol-induced translation of dendrite-localized mRNA transcripts. 
 
In the previous chapter, estradiol drove an increase in specific synaptic protein 
expression levels within a short time-frame, indicating the potential involvement 
of a protein synthesis- but not gene transcription-dependent mechanism. 
Critically, while estradiol engages translational machinery and activates signalling 
pathways involved in local protein synthesis, there is no direct evidence that 
estradiol regulates protein synthesis. This chapter investigated whether estradiol 
regulates protein synthesis within the same time-frame as it increases synaptic 
proteins using two established assays of direct visualisation of protein synthesis, 
SUnSET and FUNCAT. Consequently, given the strong evidence suggesting 
mTOR and ERK could converge onto protein synthesis machinery, whether 
either, or both, would be required to mediate estradiol-dependent local protein 
synthesis remains unclear. Therefore, the role of mTOR in estradiol-mediated 
effects on protein synthesis was assessed in both male and OVX female 
hippocampus to determine whether the underlying molecular mechanisms 
involved in regulating estradiol-mediated protein synthesis were synonymous. 
Additionally, using primary hippocampal neurons, the sub-cellular location of 
newly synthesised proteins following estradiol treatment was examined. 
 
R E S U L T S  
 
Estradiol increases the rate of protein synthesis in hippocampal slices  
 
To determine whether estradiol regulates protein synthesis directly within the 
same time-frame as estradiol-induced increases in synaptic protein expression, 
the rate of protein synthesis in response to estradiol was assessed in the male 
and OVX female hippocampus. Acute hippocampal slices were prepared from 
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10-12 week old male and OVX female mice followed by a 2 hour DMSO or 
estradiol treatment. The SUnSET assay was employed to monitor the effect of 
estradiol on protein synthesis whereby, 5µg/mL puromycin was added to each 
condition during the last 30 minutes of treatment. Figure 4.1A illustrates the 
pharmacological timeline of the experiment. The experimental set up was similar 
to that of the previous chapter whereby, the hippocampi were divided by 
hemispheres into two of the different conditions, DMSO and estradiol, per slice 
(Figure 4.1B). This set up was chosen to favour an internal representation of the 
effect of estradiol on protein synthesis compared to a vehicle control. The slices 
were subsequently lysed and puromycin incorporation was measured through 
western blotting and normalised to house-keeper, β-actin. A significant increase 
in protein synthesis was observed in slices treated with estradiol compared to 
DMSO treated slices in both male ([mean ± SEM] vehicle 1.000 ± 0.04, E2 1.378 
± 0.04; t=5.993, df=10.00, p=0.0001, n=6; Figures 4.1C+E) and OVX female 
([mean ± SEM] vehicle 1.000 ± 0.04, E2 1.244 ± 0.04; t=4.828, df=8.00, 
p=0.0013, n=6; Figures 4.1D+F) hippocampus. The SUnSET assay was 
validated through western blotting and ICC in both DIV 24 primary cortical 
neurons and male hippocampal slices (Appendix 1A-C). No puromycin 
incorporation was detected in the absence of puromycin incubation during the 
pharmacological treatment; the signal is reduced in the presence of anisomycin 
(Appendix 1A+B). Equally, no signal is detected through ICC in the absence of 
puromycin incubation (Appendix 1C) inferring the specificity of the antibodies 
used in the current study.  
 
These data are the first of its kind to show that estradiol acutely increases protein 













Figure 4.1 Estradiol increases protein synthesis in the male and OVX female 
hippocampus. A, Time-line of pharmacological treatments. B, Diagram of the 
experimental set up: acute hippocampal slices were prepared from 10-12 week 
old mice and treated with vehicle or estradiol within the same animal. C+D, 
Representative western blots of male (C) and OVX female (D) hippocampal slices 
treated with estradiol (10 nM, 2 hours) and puromycin (SUnSET assay, 5 µg/mL, 
last 30 minutes), processed for western blotting, probed for puromycin and 
normalised to housekeeper, β-actin. E+F, Quantification of C+D. Estradiol acutely 
increased the rate of translation in male (E) and OVX female (F) hippocampus; 
n=5-6 per condition. Unpaired student’s t-tests, Welch’s correction; Error bars 
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Estradiol-induced increase in protein synthesis is dependent on a translation 
mechanism 
 
Although the results corroborated an effect of estradiol on protein synthesis, the 
data does not differentiate how much of this increase in protein synthesis is a 
consequence of local protein synthesis. Thus, it was critical to next identify 
whether this increase is still augmented or absent in the presence of protein 
synthesis inhibitors; and importantly whether the mechanisms are identical in 
both sexes. To test this, hippocampal slices were pre-treated with either protein 
synthesis inhibitor, anisomycin (40µm), or gene transcription inhibitor, 
actinomycin D (20µm) for 30 minutes. Slices were then treated with DMSO or 
estradiol for 2 hours followed by the addition of puromycin (Figures 4.2A-B, 4.3A-
B). The experimental set up was as previously whereby, all 4 conditions were 
applied to hippocampal slices from one animal. The slices were divided by 
hemispheres and sequentially treated with DMSO, estradiol, inhibitor + DMSO, 
inhibitor + estradiol distributing 3 hippocampal slices per condition. The set up 
allowed the verification of successful estradiol treatment ensuring that the effects 
seen in response to respective inhibitors was attributable to the inhibition of that 
specific mechanism. The slices were subsequently lysed and processed for 
western blotting and measured for the readout of protein synthesis. 
 
Estradiol-mediated increase in protein synthesis was blocked in the presence of 
anisomycin in both male (F(3,20)=23.70, p=<0.0001; Figures 4.2C+E) and OVX 
female (F(3,20)=25.12, p=<0.0001; Figures 4.2D+F) hippocampal slices. A 
multiple comparisons test with Bonferroni’s correction confirmed an increase in 
protein synthesis in estradiol treated slices compared to vehicle in males ([mean 
± SEM] vehicle 1.000 ± 0.09, E2 1.294 ± 0.09; p=0.0152, n=6) and OVX females 
([mean ± SEM] vehicle 1.000 ± 0.10, E2 1.309 ± 0.10; p=0.0249, n=6). However, 
no difference was observed in slices treated with anisomycin + DMSO compared 
to anisomycin + estradiol in either male ([mean ± SEM] anisomycin + vehicle 
0.700 ± 0.09, anisomycin + E2 0.667 ± 0.09; p>0.9999, n=6) nor OVX female 
([mean ± SEM] anisomycin + vehicle 0.608 ± 0.10, anisomycin + E2 0.614 ± 
0.10; p>0.9999, n=6). Additionally, anisomycin + estradiol treated slices exhibited 
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significantly decreased levels of protein synthesis compared to estradiol treated 
slices in both sexes (p<0.0001 for both). 
 
Conversely, estradiol continued to augment the increase in protein synthesis in 
the presence of actinomycin D in both male (F(3,16)=15.19, p=<0.0001; Figures 
4.3C+E) and OVX female (F(3,20)=31.87, p=<0.0001; Figures 4.3D+F) 
hippocampal slices. A post hoc Bonferroni’s multiple comparisons test 
recapitulated a significant difference between DMSO and estradiol treated slices 
in males ([mean ± SEM] vehicle 1.000 ± 0.12, E2 1.372 ± 0.12; p=0.0399, n=6) 
and OVX females ([mean ± SEM] vehicle 1.000 ± 0.15, E2 1.459 ± 0.15; 
p=0.0324, n=6). This increase was conserved when gene transcription was 
blocked in both male ([mean ± SEM] actinomycin D + vehicle 1.313 ± 0.12, 
actinomycin D + E2 1.800 ± 0.12; p=0.0053, n=6) and OVX female ([mean ± 
SEM] actinomycin D + vehicle 1.904 ± 0.15, actinomycin D + E2 2.366 ± 0.15; 
p=0.0306, n=6) hippocampus. Surprisingly, actinomycin D + DMSO treated slices 
exhibited an increase in protein synthesis compared to slices treated solely with 
DMSO in OVX females (p=<0.0001) but not males (p=0.1114).       
 
Taken together, these data suggest that a mechanism that is independent of gene 
transcription underlies estradiol-mediated increases in protein synthesis, which is 

















Figure 4.2 Estradiol-mediated increase in protein synthesis is inhibited in the 
presence of anisomycin. A, Time-line of pharmacological treatments. B, Diagram 
of the experimental set up: acute hippocampal slices were prepared from 10-12 
week old mice and treated with vehicle, with or without anisomycin, or estradiol, 
with or without anisomycin, within the same animal. C+D, Representative western 
blots of male (C) and OVX female (D) hippocampal slices pre-treated with 
anisomycin (40 µM, 30 mins) followed by 2 hour estradiol (10 nM) treatment and 
puromycin (SUnSET assay, 5 µg/mL, last 30 minutes). Slices were processed for 
western blotting, probed for puromycin and normalised to housekeeper, β-actin. 
E+F, Quantification of C+D. Anisomycin inhibited estradiol-mediated increases of 
the rate of protein synthesis; n=5-6 per condition. One-way ANOVA, Bonferroni 
corrected; Error bars represent mean ± SEM; * p = <0.05, ** p = <0.01, **** p = 
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Figure 4.3 Estradiol increases protein synthesis independent of gene 
transcription. A, Time-line of pharmacological treatments. B, Diagram of the 
experimental set up: acute hippocampal slices were prepared from 10-12 week 
old mice and treated with vehicle, with or without actinomycin D, or estradiol, with 
or without actinomycin D, within the same animal. C+D, Representative western 
blots of male (C) and OVX female (D) hippocampal slices pre-treated with 
actinomycin D (20 µM, 30 mins) followed by 2 hour estradiol (10 nM) treatment 
and puromycin (SUnSET assay, 5 µg/mL, last 30 minutes). Slices were 
processed for western blotting, probed for puromycin and normalised to 
housekeeper, β-actin. E+F, Quantification of C+D. Estradiol-mediated increases 
in the rate of protein synthesis were not reduced in the presence of a gene 
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corrected; Error bars represent mean ± SEM; * p = <0.05, ** p = <0.01, **** p = 
<0.0001.        
 
mTOR is required for estradiol-dependent increase in protein synthesis in 
the male, but not OVX female, hippocampus 
 
mTOR kinase signalling has been implicated in mediating local protein synthesis 
(Hoeffer and Klann, 2010) and countless studies have exhibited estradiol’s ability 
to rapidly phosphorylate mTOR (Briz and Baudry, 2014; Fortress et al., 2013) in 
the hippocampus. Specifically, mTOR is still phosphorylated after 1 hour estradiol 
treatment in acute hippocampal slices (Briz and Baudry, 2014). What is more, 
mTOR is upstream of a number of protein translation initiation elements. It can 
be reasoned that this rapid activation of mTOR prior to the induction of protein 
synthesis observed after 2 hour estradiol exposure may point to a critical role for 
mTOR in mediating estradiol-dependent increases in protein synthesis. 
Therefore, hippocampal slices were pre-treated with the mTOR inhibitor, 
rapamycin (1µM), 30 minutes prior to DMSO or estradiol treatment; puromycin 
was subsequently added to the slices (Figures 4.4A+B). The slices were lysed 
and processed for western blotting and measured for puromycin levels and the 
activation of mTOR. Interestingly, rapamycin inhibited estradiol-mediated 
increase in protein synthesis in the male (F(3, 20) = 9.616, p=0.0004; Figures 
4.4C+E) but not the OVX female (F(3,20)=6.010, p=0.0043; Figures 4.4D+F) 
hippocampus. A multiple comparisons test with Bonferroni’s correction 
corroborated increased protein synthesis in estradiol treated slices compared to 
vehicle in males ([mean ± SEM] vehicle 1.000 ± 0.09, E2 1.330 ± 0.09; p=0.0062, 
n=6) and OVX females ([mean ± SEM] vehicle 1.000 ± 0.06, E2 1.188 ± 0.06; 
p=0.0398, n=6).  Increases in protein synthesis were inhibited in slices treated 
with rapamycin + estradiol compared to rapamycin + DMSO treated slices only in 
males ([mean ± SEM] rapamycin + vehicle 1.025 ± 0.09, rapamycin + E2 0.889 
± 0.09; p=0.7840, n=6) but not OVX females ([mean ± SEM] rapamycin + 
vehicle 0.9960 ± 0.06, rapamycin + E2 1.181 ± 0.06; p=0.0451, n=6). 
Specifically, protein synthesis was decreased in slices treated with rapamycin + 
estradiol in comparison to slices treated with estradiol in males (p=0.0003) 
however, no difference was observed in OVX females (p>0.9999). Additionally, 
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protein synthesis levels were found to be significantly higher in estradiol treated 
slices compared to slices treated with rapamycin + DMSO (male: p=0.0123; OVX 
female: p=0.0343). 
 
Figure 4.4 mTOR is required for estradiol-mediated protein synthesis in the male 
hippocampus. A, Time-line of pharmacological treatments. B, Diagram of the 
experimental set up: acute hippocampal slices were prepared from 10-12 week 
old mice and treated with vehicle, with or without rapamycin, or estradiol, with or 
without rapamycin, within the same animal. C+D Representative western blots of 
male (C) and OVX female (D) hippocampal slices pre-treated with rapamycin (1 
µM, 30 mins) followed by 2 hour estradiol (10 nM) treatment and puromycin 
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blotting, probed for puromycin and normalised to housekeeper, β-actin. E+F, 
Quantification of C+D. Estradiol-mediated increases in the rate of protein 
synthesis were inhibited in the male, but not the OVX female, hippocampus; n=5-
6 per condition. One-way ANOVA, Bonferroni corrected; Error bars represent 
mean ± SEM; * p = <0.05, ** p = <0.01, *** p = <0.001, ns = not significant.        
_______________________________________________________________ 
 
The observation of a sexual dimorphism in the activation of mTOR being required 
to induce estradiol-mediated increase in protein synthesis suggests that estradiol 
may differentially activate mTOR. A similar time-course of mTOR phosphorylation 
was observed in DIV 25 primary rat cortical neurons (Appendix 2A+B) to that of 
Briz & Baudry (2014) in male rat hippocampal slices. Primary cortical neurons 
were prepared from E18 rat embryos and cultured until DIV 25 upon which, the 
neurons were temporally treated with DMSO or estradiol over 2 hours. Estradiol 
increased mTOR phosphorylation in a time-dependent manner (F(4,25)=5.875, 
p=0.0018). A multiple comparison test with Bonferroni’s correction demonstrated 
a significant increase of mTOR phosphorylation within 30 minutes (p=0.0012), 
which remained increased at 1 hour (p=0.0128). At 2 hours, mTOR 
phosphorylation decreased but remained above baseline (p=0.156), although not 
statistically different from baseline ([mean ± SEM] vehicle 1.00 ± 0.06, 15’ E2 
1.055 ± 0.06, 30’ E2 1.263 ± 0.06, 60’ E2 1.204 ± 0.06, 120’ E2 1.147 ± 0.06; 
n=6 for all). Comparably, this effect was emulated in hippocampal slices from 
both male (F(3,16)=29.09, p<0.0001; Figures 4.5 A+C) and OVX female after 2 
hours of estradiol treatment (F(3,12)=14.64, p=0.0003; Figures 4.5 B+D) 
hippocampal slices. A post hoc Bonferroni’s multiple comparisons test illustrated 
no significant difference in mTOR phosphorylation between vehicle and estradiol 
in either sex ([mean ± SEM] male, vehicle 1.000 ± 0.08, E2 0.8478 ± 0.08, 
p=0.3793; female: vehicle 1.000 ± 0.07, E2 0.9135 ± 0.07, p>0.9999; n=5, 4 
respectively). Concomitantly, estradiol did not increase mTOR phosphorylation in 
the presence of rapamycin in males nor OVX females ([mean ± SEM] male, 
rapamycin + vehicle 0.4322 ± 0.08, rapamycin + E2 0.4318 ± 0.08; OVX female 
rapamycin + vehicle 0.6168 ± 0.07, rapamycin + E2 0.6496 ± 0.07; p>0.9999 
for both; n=5, 4 respectively). As expected, mTOR phosphorylation was 
significantly decreased in rapamycin + DMSO (male, p<0.0001; OVX female, 
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p=0.0181) and rapamycin + estradiol (male, p<0.0001; OVX female, p=0.0243) 
treated slices compared to vehicle. This was also true when rapamycin + DMSO 
(male, p=0.0003; OVX female p=0.0072) and rapamycin + estradiol (male, 
p=0.0003; OVX female, p=0.0167) treated slices were compared to estradiol 















Figure 4.5 Activation of mTOR kinase signalling pathway following 2 hour 
estradiol treatment. A+B, Representative western blots of male (A) and OVX 
female (B) hippocampal slices pre-treated with rapamycin (1 µM, 30 mins) 
followed by 2 hour estradiol (10 nM) treatment. Slices were processed for western 
blotting, probed for phospho-mTOR and normalised to total mTOR. C+D, 
Quantification of A+B. No change in the activation of mTOR was observed 
compared to total mTOR levels following 2 hour estradiol treatment in the male 
(C) and OVX female (D) hippocampus. Rapamycin blocked activation of mTOR; 
n=4-5 per condition. One-way ANOVA, Bonferroni corrected; Error bars represent 
mean ± SEM; * p = <0.05, ** p = <0.01; *** p = <0.001, **** p = <0.0001, ns = not 
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Current results and previous reports indicate that estradiol temporally activates 
mTOR prior to the increase in protein synthesis observed after 2 hours estradiol 
treatment suggesting that mTOR may be contributing to this increase. However, 
these data show that mTOR signalling is critical for estradiol to increase protein 
synthesis in the male rodent hippocampus, but not OVX females. This suggests 
that although estradiol may be mediating protein synthesis in both sexes, the 
underlying mechanism specifically, the signalling pathway it utilises, is distinct in 
each sex.   
 
Estradiol acutely increases protein translation in crude synaptosomal 
fractions 
 
Previous results in this chapter have exhibited rapid increases in protein 
synthesis following estradiol treatment in both male and OVX female 
hippocampus. This increase is dependent on a mechanism independent of gene 
transcription in both sexes though, the biochemical data presented does not 
allude to the cellular location of this increase. Therefore, it was determined 
whether estradiol specifically increases protein synthesis at or near synapses.  
 
Primary hippocampal neurons were prepared from E18 rat embryos and cultured 
until DIV 25-27 upon which, the neurons were treated with DMSO or estradiol for 
2 hours; 10µg/mL puromycin was added to each condition 10 minutes prior to 
lysing. Subsequently, the lysates were fractionated, as detailed in Chapter 2, and 
puromycin incorporation was measured in the extra-nuclear and crude 
synaptosomal fractions through western blotting. A significant increase in the rate 
of protein translation was found in the extra-nuclear fraction ([mean ± SEM] 
vehicle 1.000 ± 0.10, E2 1.531 ± 0.10; t=3.633, df=4.00, p=0.0221, n=3; Figures 
4.6A+C) following estradiol treatment compared to vehicle. Equivalently, 
estradiol also increased the rate of protein translation specifically in the crude 
synaptosomal fraction ([mean ± SEM] vehicle 1.000 ± 0.03, E2 1.361 ± 0.03; 




The results from the primary neurons mirror the estradiol-dependent increase in 
protein synthesis observed in hippocampal slices and specifically, infer a spatial 
location for where this increase is occurring.  
 
 
Figure 4.6 Estradiol acutely increases protein synthesis in crude synaptosomal 
fractions from primary hippocampal neurons.  A+B, Representative western blots 
of DIV 27 primary hippocampal neurons treated with estradiol (10 nM, 2 hours) 
or vehicle and puromycin (SUnSET assay, 10 µg/mL, last 10 minutes) 
fractionated upon lysing to separate out the extra-nuclear and crude 
synaptosomal fractions. Fractions were processed for western blotting, and 
probed for puromycin and normalised to housekeeper, β-actin. C+D, 
Quantification of A+B. Rate of translation was increased in estradiol treated 
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neurons Estradiol increased the rate of translation in the extra-nuclear (C) and 
crude synaptosomal (D) fractions; n=3 per condition. Unpaired student’s t-tests, 
Welch’s correction; Error bars represent mean ± SEM; * p = <0.05, *** p = <0.001.       
 
Newly synthesised proteins are found in dendritic spines and along 
dendrites following 2 hour estradiol treatment 
 
Protein synthesis at dendrites can rapidly target nascent proteins to specific parts 
of the synaptic architecture in response to neuronal activity (Holt and Schuman, 
2013; Steward and Schuman, 2001). This allows a synapse specific control and 
replenishment of the synaptic proteome. The SUnSET assay demonstrated that 
estradiol rapidly increases the rate of translation specifically in crude 
synaptosomal fractions. The assay is an established approach, employed in 
multiple cell and tissue types (Goodman and Hornberger, 2013), which provides 
a readout of protein synthesis determined by puromycin incorporation into 
elongating polypeptide chains. This process however, leads to an early 
termination of the translation of corresponding mRNAs resulting in truncated 
peptides tagged with puromycin to be released from the ribosomes. Therefore, 
SUnSET illustrates how much translation is occurring in response to a treatment 
but does not inform about the distribution of newly synthesised proteins. A more 
suitable approach to measure newly synthesised proteins is FUNCAT (detailed 
in Chapter 2), which drives the incorporation of a ‘methionine surrogate’ into 
nascent proteins being formed (tom Dieck et al., 2012). Therefore, FUNCAT was 
employed to determine the spatial localisation of newly synthesised proteins 
following estradiol treatment.      
 
The FUNCAT reaction was optimised in primary cortical and hippocampal 
neurons (Appendix 3A-C). The incubation time and concentration for AHA was 
chosen following the temporal optimisation outlined by Dieterich et al. (2010). DIV 
24 primary cortical neurons were incubated with 4mM AHA for 30 and 120 
minutes to determine sensitivity for the detection of newly synthesised proteins 
along neuronal secondary and tertiary dendrites; 120 minutes incubation was 
favoured by higher AHA intensity compared to 30 minutes (Appendix 3A). In the 
absence of AHA incubation during pharmacological treatment, tagging with an 
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alkyne bearing fluorophore Alexa-555 (Alkyne-555) did not bind and fluoresce 
any signal. Additionally, AHA intensity is decreased in the presence of anisomycin 
(Appendix 3B). Resonating the findings from Dieterich et al. (2010), newly 
synthesised proteins could be seen in spine like protrusions in hippocampal 
neurons (Appendix 3C). 
 
Primary hippocampal neurons were transfected with eGFP at DIV 12 and cultured 
until DIV 20-21. Neurons were simultaneously treated with AHA (4mM) and either 
DMSO or estradiol for 2 hours. Following the treatment, neurons were fixed and 
Alkyne-555 was bound to the AHA via click chemistry. The eGFP was thereafter 
amplified using a GFP specific antibody and subsequently imaged on a confocal 
microscope. AHA intensity was crudely measured across approximately 100µm 
sections of secondary and tertiary dendrites (as detailed in the Chapter 2, Figure 
6); the crude section comprised of the dendritic and dendritic spine regions. AHA 
intensity was significantly increased in the crude dendritic and spine regions 
([median] vehicle 1.063, E2 1.357; u=45, p=0.0439, n=13 for both; Figures 
4.7A+B) following a 2 hour estradiol treatment, suggesting that there was an 
increase in newly synthesised proteins specifically in dendritic and spine regions. 
When assessed separately, estradiol increased new proteins specifically in 
dendrites ([mean ± SEM] vehicle 1.000 ± 0.19, E2 2.324 ± 0.51; t=2.432, 
df=24.00, p=0.0229, n=13 for both; Figures 4.7C) and spines ([median] vehicle 
1.021, E2 1.946; u=41, p=0.0225, n=13 for both; Figures 4.7D). These data 
provide supporting evidence that estradiol-mediated increased protein synthesis 
results in newly synthesised protein localised along dendrites and within dendritic 





Figure 4.7 AHA-tagged newly synthesised proteins are increased along 
dendrites and within dendritic spines. A, Representative confocal images (60x) 
of GFP transfected DIV20 primary hippocampal neurons treated with estradiol 
(10 nM, 2 hours) and AHA (4 mM, 2 hours), tagged with 2 mM Alyne-555 and 
immunostained for GFP. B, Quantification of A. Estradiol increased synthesis of 
new proteins in dendritic and spine regions measured crudely. C+D, 
Quantification of A. Estradiol specifically increased newly synthesised proteins 
along dendrites (C) and within dendritic spines (D); n=13 per condition. Mann-
Whitney test; Error bars represent mean ± SEM; * p = <0.05. Arrowheads denote 
nascent proteins localised at dendrites (yellow) and dendritic spines (white). 




















































































C ru d e  d e n d r it ic  &
s p in e  r e g io n s
























V e h ic le
E 2
A c tD  +  V e h ic le












 New proteins are synthesised independently of gene transcription through 
the mTOR signalling pathway in dendritic regions in response to estradiol 
  
To compliment the biochemical data presented previously, it was determined 
whether estradiol increased new proteins within dendrites and dendritic spines 
independently of gene transcription. Additionally, whether mTOR was required 
for this process was also considered. As above, transfected (eGFP) DIV 20-21 
primary hippocampal neurons were pre-treated with either 40µM anisomycin, 
20µM actinomycin D or 10nM rapamycin 30 minutes prior to the addition of DMSO 
+ AHA or estradiol + AHA for 2 hours. Neurons were fixed subsequently followed 
by binding of Alkyne-555 via click chemistry and imaged on a confocal 
microscope. Estradiol-mediated increase in newly synthesised proteins was 
blocked in the presence of anisomycin (H(3)=19.96, p=0.0002; Figures 4.8A+B) 
but not actinomycin D (H(3)=21.11, p<0.0001; Figures 4.9A+B). A post hoc 
Dunn’s multiple comparisons test identified a significant difference in AHA 
intensity between neurons treated with DMSO or estradiol ([mean rank] vehicle 
28.38, E2 44.00; p=0.0474, n=16, 17 respectively), whilst there was no difference 
between neurons treated with anisomycin + DMSO and anisomycin + estradiol 
([mean rank] anisomycin + vehicle 19.73, anisomycin + E2 20.86; p>0.9999, 
n=11, 14 respectively). Consequently, AHA intensity was significantly higher in 
estradiol treated neurons compared to anisomycin + DMSO (p=0.0012) and 
anisomycin + estradiol (p=0.0009). Comparably, neurons treated with 
actinomycin D + estradiol exhibited higher AHA intensity than neurons treated 
with actinomycin D + DMSO ([mean rank] actinomycin D + vehicle 15.79, 
actinomycin D + E2 33.57; p=0.0482, n=14 for both) mirrored by neurons treated 
with solely estradiol compared to DMSO ([mean rank] vehicle 27.63, E2 44.59; 
p=0.0365, n=16, 17 respectively). No difference in AHA intensity was observed 
between neurons treated with estradiol and actinomycin D + estradiol treated 
neurons (p=0.5132). Thus, estradiol continued to increase the synthesis of new 
proteins in the presence of a gene transcription inhibitor.  
 
Rapamycin inhibited estradiol from increasing newly synthesised proteins within 
the dendritic and dendritic spine area (H(3)=15.75, p=0.0013; Figures 4.10A+B). 
A multiple comparisons test with Dunn’s correction confirmed increased AHA 
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intensity in estradiol treated neurons compared to DMSO ([mean rank] vehicle 
25.69, E2 42.53; p=0.0292, n=16, 17 respectively). Whilst no difference in AHA 
intensity was detected in the neurons treated with rapamycin + estradiol 
compared to rapamycin + DMSO neurons ([mean rank] rapamycin + vehicle 
29.86, rapamycin + E2 18.17; p=0.5016, n=14, 12 respectively). Consequently, 
a decrease in AHA intensity was observed in neurons treated with rapamycin + 
estradiol compared to those treated solely with estradiol (p=0.0010) suggesting 
a critical role for mTOR in mediating estradiol-mediated increase in new proteins 
in dendritic and spine regions.   
 
Taken together, these data show that estradiol uses a translation-dependent 
mechanism employing the mTOR signalling pathway to increase the synthesis of 
new proteins specifically in dendritic and spine regions. These data recapitulated 
























Figure 4.8 Anisomycin inhibits the increase of nascent proteins along dendrites 
and within dendritic spines in estradiol treated neurons. A, Representative 
confocal images (60x) of GFP transfected DIV20 primary hippocampal neurons 
pre-treated with anisomycin (40 µM, 30 mins) followed by estradiol (10 nM, 2 
hours) and AHA (4 mM, 2 hours) treatments. Neurons were thereafter, tagged 
with 2 mM Alyne-555 and immunostained for GFP. B, Quantification of A. 
Estradiol increased newly synthesised proteins in dendritic and spine regions, 
which was blocked by anisomycin; n=12-17 per condition. Kruskal-Wallis test, 
Dunn’s corrected; Error bars represent mean ± SEM; * p = <0.05, ** p = <0.01, 
*** p = <0.001, ns = not significant. Arrowheads denote nascent proteins localised 
at dendrites (yellow) and dendritic spines (white) and lack thereof (red). Scale bar 




















































Figure 4.9 Estradiol treated neurons exhibit increased nascent proteins in 
dendritic and spine regions in the presence of actinomycin D. A, Representative 
confocal images (60x) of GFP transfected DIV20 primary hippocampal neurons 
pre-treated with actinomycin D (20 µM, 30 mins) followed by estradiol (10 nM, 2 
hours) and AHA (4 mM, 2 hours) treatments. Neurons are thereafter, tagged with 
2 mM Alyne-555 and immunostained for GFP. B, Quantification of A. Estradiol 
increased newly synthesised proteins in dendritic and spine regions and 
continued to do so in the presence of actinomycin D; n=14-17 per condition. 
Kruskal-Wallis test, Dunn’s corrected; Error bars represent mean ± SEM; * p = 
<0.05, **** p = <0.0001, ns = not significant. Arrowheads denote nascent proteins 
localised at dendrites (yellow) and dendritic spines (white). Scale bar = 10 µm. 





















































Figure 4.10 mTOR is required for estradiol to increase new proteins along 
dendrites and spines. A, Representative confocal images (60x) of GFP 
transfected DIV20 primary hippocampal neurons pre-treated with rapamycin (1 
µM, 30 mins) followed by estradiol (10 nM, 2 hours) and AHA (4 mM, 2 hours) 
treatments. Neurons are thereafter, tagged with 2 mM Alyne-555 and 
immunostained for GFP. B, Quantification of A. mTOR blocked estradiol-
mediated increases of newly synthesised proteins at dendritic and spine regions; 
n=12-17 per condition. Kruskal-Wallis test, Dunn’s corrected; Error bars 
represent mean ± SEM; * p = <0.05, ** = p <0.01, ns = not significant. Arrowheads 
denote nascent proteins localised at dendrites (yellow) and dendritic spines 
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Estradiol induces spinogenesis within the same time-frame 
 
Dendritic spines can be arbitrarily classified by their morphology (Hering and 
Sheng, 2001) as: ‘filopodia-like’; thin, ‘lollipop like’; stubby; or ‘mushroom-like’ 
(Berry and Nedivi, 2017; Hering and Sheng, 2001; Srivastava et al., 2011). As 
stated in the previous chapter, many studies have reported spinogenesis 
following 30 minute estradiol treatment (Inagaki et al., 2012; MacLusky et al., 
2005; Phan et al., 2012; Tuscher et al., 2016b). Estradiol-mediated increases in 
spine density have also been observed in male (Jacome et al., 2016; Mukai et 
al., 2007) and OVX female mouse hippocampus (Inagaki et al. 2012; Phan et al. 
2015; Tuscher et al. 2016b) following 2 hour estradiol treatment. Particularly, 
Mukai et al. (2007) saw an increase in thin and filopodia-like spines with a 
decrease in average spine diameter in hippocampal slices. As spine morphology 
is thought to be associated with synaptic function, the ability of estradiol to 
modulate spine density and morphology was assessed within the current study. 
Principally, the class of dendritic spines that contain nascent proteins was 
assessed following estradiol treatment. 
 
Transfected (eGFP) DIV 20-21 primary hippocampal neurons treated with either 
DMSO + AHA or estradiol + AHA for 2 hours were fixed followed by Alkyne-555 
binding; the neurons were thereafter, immunostained and imaged on a confocal 
microscope. Consistent with previous findings, estradiol significantly increased 
spine density after 2 hours (spine density per 10 µm: [mean ± SEM] vehicle 2.376 
± 0.30, E2 3.357 ± 0.37; t=2.071, df=24.00, p=0.0493, n=13 for both; Figures 
4.11A+B). Analysis of dendritic spine morphology revealed that treatment with 
estradiol resulted in a larger spine area (spine area (µm²): [mean ± SEM] vehicle 
0.4120 ± 0.01, E2 0.4732 ± 0.02; t=2.402, df=19.54, p=0.0264, n=13 for both; 
Figures 4.11A+C). A closer analysis of the morphological changes induced by 
estradiol illustrated an increase in spines with an area larger than 0.6 µm² where 
at control levels there were more smaller spines, between 0.2-0.4 µm² (Figures 









Figure 4.11 Estradiol increases spine number and area within 2 hours. A, 
Representative confocal images (60x) of GFP transfected DIV20 primary 
hippocampal neurons treated with estradiol (10 nM, 2 hours) and immunostained 
for GFP. B-D, Quantification of A. Estradiol acutely increased dendritic spine 
density (B) and spine area (C) after 2 hours. Histogram of spine area showed 
that estradiol increased spines with a larger area (D); n=13 per condition. 
Unpaired student’s t-tests, Welch’s correction; Error bars represent mean ± SEM; 
* p = <0.05. Yellow dashed box denotes section of dendrite displayed in inset. 
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Consequently, the number and morphological profile of spines that contained 
AHA-tagged newly synthesised proteins were evaluated. No significant difference 
in AHA intensity was observed in AHA positive spines in estradiol treated neurons 
(spine density per 10 µm: [mean ± SEM] vehicle 0.9399* ± 0.16, E2 1.290 ± 0.25; 
t=1.166, df=20.23, p=0.2572, n=12, 13 respectively; Figures 4.12A+B; *one cell 
data removed following Grubb’s test for outliers). However, analysis of spine 
morphology illustrated an increase of larger spines containing AHA in response 
to estradiol treatment (spine area (µm²): [mean ± SEM] vehicle 0.4035 ± 0.02, 
E2 0.4869 ± 0.03; t=2.214, df=17.99, p=0.0400, n=13 for both; Figures 
4.12A+C). Categorising spines that were positive for AHA by morphology 
displayed a shift in the spine area that contained AHA. Estradiol increased AHA 
intensity in larger spines, with an area larger than 0.8µm², where more AHA could 
be observed in smaller spines, areas smaller than 0.8µm², at control levels 
(Figures 4.12A+D) confirming that there is an increased level of new proteins in 
bigger spines in estradiol treated neurons compared to vehicle.   
 
These data show that estradiol increases spine number and size after 2 hours. 
Interestingly, it is the larger spines that contain increased levels of AHA-tagged 
newly synthesised proteins in estradiol treated neurons in response to estradiol 
suggesting that newly synthesised proteins are predominantly localised in larger 










































Figure 4.12 New proteins are localised to larger dendritic spines in estradiol 
treated neurons. A, Representative confocal images (60x) of GFP transfected 
DIV20 primary hippocampal neurons treated with estradiol (10 nM, 2 hours) and 
AHA (4 mM, 2 hours) treatments. Neurons are thereafter, tagged with 2 mM 
Alyne-555 and immunostained for GFP. B-D, Quantification of A. Estradiol 
treated neurons did not show increased AHA-positive spines (B) however, 
increased AHA-tagged newly synthesised proteins were localised to larger spines 
compared to vehicle (C). Histogram of spine area of AHA positive spines showed 
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student’s t-tests, Welch’s correction; Error bars represent mean ± SEM; * p = 
<0.05, ns = not significant. Yellow dashed box denotes section of dendrite 
displayed in inset. Arrowheads denote nascent proteins localised at dendrites 
(yellow) and dendritic spines (white). Scale bar = 50 µm; 1 µm (inset). 
 
D I S C U S S I O N  
 
Summary of results 
 
This chapter has demonstrated a novel mechanism by which estradiol may be 
employing to mediate synaptic plasticity in the hippocampus, specifically through 
modulating local protein synthesis. Estradiol increased global protein synthesis 
in both male and OVX female mouse hippocampus within 2 hours, independent 
of gene transcription. Newly synthesised proteins could specifically be observed 
along dendrites and in dendritic spines. Critically, the underlying signalling 
pathways estradiol engaged were different between males and OVX females. 
The mTOR signalling pathway was found critical for estradiol to mediate an 
increase in protein synthesis in the male, but not OVX female hippocampus. 
Together, these data detail how rapid modulation of local protein synthesis by 
estradiol may result in an increase in synaptic function in males and OVX females 
underlying the facilitation of cognition offered by estrogens. Importantly, this 
occurs via distinct signalling mechanisms between sexes. 
 
Estradiol increases protein synthesis, independent of gene transcription, in 
hippocampal neurons 
 
The results from the current chapter are consistent with the previous notions of a 
concomitant relationship between estradiol and local protein synthesis. 
Biochemically, studies have shown rapid activation of protein synthesis initiation 
machinery, that tightly regulate protein synthesis, in the hippocampus following 
estradiol treatment; within a time-frame that is consistent with the current study 
(Akama and McEwen, 2003; Briz and Baudry, 2014; Fortress et al., 2013; Sarkar 
et al., 2010). Through live-imaging, estradiol has been illustrated to increase 
dendritic mRNA translation of CAMKIIα, a key protein implicated in LTP and 
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various forms of memory (Giese and Mizuno, 2013; Miller et al., 2002), in vitro 
within a similar time-frame (Sarkar et al., 2010). Indeed, this chapter provides 
confirmation that estradiol rapidly regulates protein synthesis without engaging 
gene transcription in the hippocampus providing a rationale for the rapid 
increases of synaptic proteins observed in Chapter 3 and by others (eg. Liu et 
al. 2008). 
 
By employing two independent assays, estradiol was demonstrated to rapidly 
increase protein synthesis in vitro both in primary hippocampal neurons and in a 
more intact system - acute hippocampal slice preparations. A drawback of using 
SUnSET is that puromycin is incorporated into elongating polypeptide chains. 
Thus, biochemically employing SUnSET provides invaluable detail on how 
estradiol influences the rate of protein translation, but not where the newly 
synthesised proteins localise. By coupling FUNCAT and ICC, the subcellular 
distribution of newly synthesised proteins was inferred in estradiol-treated 
neurons. Visualising increases of nascent proteins specifically within subcellular 
compartments that expresses the machinery and substrates needed for protein 
synthesis (Cajigas et al., 2012; Holt and Schuman, 2013; Steward and Schuman, 
2001) suggests that estradiol may be driving the synthesis of these new proteins 
along dendrites and in spines within 2 hours to drive changes in hippocampal 
synaptic plasticity. A recurrent observation from Figures 4.7-4.9 suggests that 
there may be two populations of neurons within the estradiol treatment condition 
that encompass AHA-tagged newly synthesised proteins. A reasoning for this 
could be that only a subset of neurons is responsive to the estradiol treatment. In 
support, albeit using an in vivo approach, Oberlander and Woolley (2016) 
reported that only a subset of neurons (~20%) were responsive to estradiol when 
measuring mEPSCs. Although the authors were applying estradiol at a single 
neuron level, estradiol is applied to the whole coverslip of neurons within the 
current experimental set up. Additionally, only a subset of neurons is successfully 
transfected with eGFP within a coverslip and therefore, the ratio of the number of 
neurons that have both responded to estradiol and are eGFP positive may vary 
from biological replicates. Therefore, the results may reflect neurons that have 




Using hippocampal slices permitted the exploration of how estradiol, if at all, 
mediates local protein synthesis in both males and females. Moreover, an 
advantage of using this system to investigate this phenomena is that the integrity 
of majority of the synaptic connections within the hippocampus is retained (Lein 
et al., 2011). This was specifically useful for the nature of this current study. 
Nevertheless, by approaching this hypothesis biochemically using hippocampal 
slices denoted that the output of the effect of estradiol on local protein synthesis 
did not solely represent dendritic protein synthesis. Indeed axons (Milner et al., 
2001) and astrocytes (Azcoitia et al., 1999; Santagati et al., 1994) also express 
ERs in addition to post-synaptic compartments in the hippocampus, suggesting 
that the exogenously applied estradiol could be binding to ERs in neuronal and 
non-neuronal compartments. Nevertheless, the non-genomic estradiol-mediated 
increase in protein synthesis observed in slices was recapitulated in primary 
hippocampal neurons through ICC. Corroborating the findings of rapid dendritic 
mRNA translation by estradiol (Sarkar et al., 2010), the current results 
demonstrated increased protein translation in crude synaptosomal fractions and 
increased nascent proteins along dendrites and within dendritic spines in 
estradiol treated hippocampal neurons. However, an avenue worth exploring is 
investigating whether estradiol affects protein synthesis in astrocytes or axons. It 
is of note, however, that estradiol did not affect the expression of select pre-
synaptic proteins examined in Chapter 3, whereas increases were seen in select 
inhibitory and excitatory post-synaptic proteins, possibly suggesting that 
estradiol-mediated local protein synthesis is predominately focused on post-
synaptic targets in this time-frame. 
 
Distinct signalling mechanisms mediate local protein synthesis between 
sexes 
 
As observed in the previous chapter, both male and OVX female hippocampus 
can respond to estradiol in different ways. The results of the current study 
highlight the significance of considering both sexes during estradiol research and 
the potential effect of latent differences (Oberlander and Woolley, 2016). 
Although, estradiol non-genomically increases local protein synthesis in both 
sexes, the mTOR pathway was found to be required to mediate global protein 
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synthesis in the male, but not OVX female, hippocampus. mTOR activates local 
protein synthesis machinery such as 4EBP1, S6K and RPS6 (Costa-Mattioli et 
al., 2009; Hoeffer and Klann, 2010; Lipton and Sahin, 2014) and has been shown 
to be required for the establishment of L-LTP (Tang et al., 2002). Inhibition of 
mTOR prevents estradiol mediated increases in phosphorylation of 4EBP1 and 
S6K, impairs OR memory (Fortress et al., 2013) and prevents estradiol-induced 
increases in spine density in CA1 (Tuscher et al. 2016b). This suggests a critical 
role for mTOR in mediating hippocampal memory and spine density in OVX 
female rodents, possibly through local protein synthesis. Estradiol-mediated 
enhancement in memory and dendritic spines have also been observed in male 
rodents but the underlying cell signalling pathways involved are unknown. 
Nevertheless, this is the first study to suggest a critical role for mTOR signalling 
in the male hippocampus.   
 
The current data suggests that estradiol utilises another signalling pathway to 
mediate protein synthesis in the OVX female hippocampus. The ERK signalling 
pathway has been reported to be necessary for enhancing CA1 spine density 
(Tuscher et al. 2016b), OR (Fan et al., 2010; Fortress et al., 2013) and OP 
(Fortress et al., 2013) memory tasks in response to estradiol in OVX female 
rodents. Inhibition of ERK prevents estradiol from activating mTOR signalling 
proteins 4EBP1 and S6K (Fernandez et al., 2008; Fortress et al., 2013; Sarkar et 
al., 2010) insinuating that ERK also regulates estradiol’s ability to regulate 
proteins implicated in initiating protein synthesis. Critically, estradiol has been 
shown to rapidly phosphorylate both mTOR and ERK signalling pathways in male 
and OVX female hippocampus (Akama & McEwen 2003; Briz & Baudry 2014; 
Fan et al. 2010; Fernandez et al. 2008; Fortress et al. 2013; Tuscher et al. 2016b) 
and thus, both pathways are active prior to the increased protein synthesis 
observed at 2 hours. Nevertheless, the downstream targets they engage are 
unknown. Critically, despite the dogma that mTOR regulates protein synthesis, it 
also regulates a number of other cellular processes (Saxton and Sabatini, 2017) 
thus, mTOR could be mediating estradiol’s effect on another cellular process in 
the OVX female hippocampus. Alternatively, owing to the system used to 
investigate this, the effect of mTOR may be too specific to be seen as an overall 
effect on global protein translation and its action may be more specific. In support, 
mTOR was critical for estradiol to increase nascent proteins locally in synaptic 
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regions. Consequently, mTOR may be key in modulating estradiol-mediated 
protein synthesis in the male hippocampus but may have more specific effects 
within the female hippocampus. Alternatively, estradiol could be utilising another 
pathway, such as ERK, to regulate protein synthesis in OVX females.  
 
Newly synthesised proteins are found in larger dendritic spines 
 
Increased AHA tagged-newly synthesised proteins were found along dendrites 
and within dendritic spines of estradiol treated neurons. Recapitulating the 
biochemical data, estradiol increased newly synthesised proteins independently 
of gene transcription and through an mTOR dependent manner within the 
dendritic and spine regions. The biochemical data confirmed that estradiol 
increases the rate of translation in the rodent hippocampus but did not indicate 
where newly synthesised proteins are localised. Thereby, suggesting that 
estradiol could be engaging local machinery available along dendrites to promote 
the synthesis of new proteins within the vicinity of spines.    
 
In line with previous findings, estradiol increased dendritic spines density over 2 
hours (Jacome et al. 2016; Mukai et al. 2007; Tuscher et al. 2016b). Specifically, 
larger spines were found to be increased. Conversely, Mukai et al. (2007) found 
that estradiol increases the density of thinner spines after 2 hours. The 
differences in observation could be due to the use of different systems; Mukai et 
al. (2007) assessed spine morphology in hippocampal slice preparations from 
male rats whereas, the current study used primary hippocampal neurons. 
Moreover, they also used a lower concentration of estradiol (1 nM). Nevertheless, 
the current data suggests that estradiol may promote stronger synapses, which 
is consistent with previous reports of estradiol facilitating glutamatergic synaptic 
transmission (Oberlander and Woolley, 2016). Although, it is not clear whether 
pre-existing or estradiol-induced nascent spines are enlarged. Nevertheless, 
spine enlargement depends on protein synthesis (Tanaka et al., 2008) and the 
current study shows that it is specifically the larger spines that contain AHA-
tagged newly synthesised proteins suggesting that new proteins are travelling to 
these larger dendritic spines. In support, Sambandan et al. (2017) demonstrated 
that following activity-dependent stimulation, there is increased protein synthesis 
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at the dendritic shaft of or within the potentiated dendritic spine. Consistent with 
this notion, there is some level of specificity in the estradiol-mediated synthesis 
of proteins being targeted to larger dendritic spines. The identity of these new 
proteins is unknown however, they could contribute to the stability of the dendritic 




This chapter illustrated that estradiol increases protein synthesis, independently 
of gene transcription, in both male and OVX female hippocampus. This is 
dependent on the mTOR signalling pathway in males but estradiol seems to be 
engaging a different signalling pathway in OVX females. As different signalling 
pathways seem to be critical in mediating estradiol’s effects on protein synthesis 
in both sexes, it would be interesting to see which ER is important in enhancing 
protein synthesis and whether the receptors responsible for enhancing protein 
synthesis in each sex is synonymous. Furthermore, estradiol specifically 
increases the density of larger dendritic spines and augmented levels of newly 
synthesised proteins can be observed in larger dendritic spines suggesting that 
new proteins may be contributing to the stability to these new dendritic spines. 
This chapter offers a novel mechanism by which estradiol may be regulating 
synaptic plasticity in the rodent hippocampus.  
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S Y N T H E S I S  D E P E N D E N T  




S U M M A R Y  
 
The previous chapters have demonstrated that estradiol rapidly increases the 
expression of key synaptic proteins in both male and OVX female hippocampus, 
concurrent to increasing protein synthesis independently of gene transcription. 
This is observed within the same time-frame in both male and OVX female rodent 
hippocampus. Using primary hippocampal neurons, this chapter aimed to 
determine whether the estradiol-mediated increase in PSD-95 and GluN2B 
expression levels observed in Chapter 3, were increased via a local protein 
synthesis-dependent mechanism. Importantly, it was examined whether males 
and OVX females both use the same signalling mechanism to regulate candidate 
protein expression. Furthermore, with the knowledge that there is a high presence 
of translational machinery and substrates along dendrites and below dendritic 
spines (Steward and Schuman, 2001), and employing super-resolution imaging, 
the spatial distribution of translation, through SUnSET-ICC, and ribosomal 
proteins was determined following 2 hour estradiol treatment. 
 
PSD-95 and GluN2B were both found to be increased independently of gene 
transcription by estradiol, through distinct signalling pathways in the male and 
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OVX female hippocampus. Estradiol also increased the presence and size of a 
candidate ribosomal protein and translation within synaptic regions and along 
dendrites within the same time-frame. 
  
I N T R O D U C T I O N   
  
Subcellular localisation of specific proteins enables local and specialised control 
of cellular compartments. For example, dendritic mRNAs can be locally translated 
to provide this localised response to extracellular stimuli. The presence of a rich 
pool of dendritic mRNAs involved in translation initiation and elongation, and 
synaptic plasticity (Cajigas et al., 2012; Eberwine et al., 2002; Poon et al., 2006; 
Zhong et al., 2006), to name a few, have been identified employing various 
methods. GluN2B mRNA has been observed along dendrites of primary rat 
hippocampal neurons (Miyashiro et al., 1994) and hippocampal slices (Cajigas et 
al., 2012) in addition to dendritic mRNA for PSD-95 in hippocampal slices 
(Cajigas et al., 2012). Therefore, the mRNAs for these candidate proteins are 
ideally situated to be locally translated through estradiol specifically in the 
hippocampus.  
 
Both PSD-95 and GluN2B are localised at excitatory synapses implicated to have 
critical roles at synapses and several studies have shown that estradiol can 
rapidly interact with these proteins. PSD-95 has been shown to be enriched at 
PSDs (Sugiyama et al., 2005) with a key role in synapse formation (Washbourne 
et al., 2002) and activity dependent spine stabilisation through its ability to 
scaffold and localise a number of synaptic proteins (Chubykin et al., 2007). Our 
lab has shown estradiol-mediated increases of PSD-95 containing spines and 
neuroligin-1/PSD-95 complexes within 30 minutes in vitro (Sellers et al. 2015b); 
neuroligin-1/PSD-95 complexes are thought to be needed for functional synaptic 
connections (Gerrow et al., 2006). Others have found that estradiol increases 
PSD-95 expression within 4 hours (Liu et al., 2008). In support of this, it has 
previously been reported that PSD-95 can be synthesised, independently of gene 
transcription, in a differentiated neuroblastoma cell line (d-NG108-15) following 6 
hour estradiol treatment, identified by [35S]-methionine/cysteine pulse labelling 
(Akama and McEwen, 2003). Furthermore, GluN2B-containing synaptic 
NMDARs have been exhibited to be important for LTP (Barria and Malinow, 2005; 
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Berberich et al., 2007; Tang et al., 1999) but, also shown to be involved in LTD 
(Bartlett et al., 2007). Activation of GluN2B-containing synaptic NMDARs have 
been implicated in mediating estradiol-induced increase in LTP magnitude (Smith 
and McMahon, 2006; Smith et al., 2016; Vedder et al., 2013). Thus, both proteins 
have been demonstrated to be important in estradiol-mediated regulation of 
synaptic plasticity in both the hippocampus and cortex.  
 
The machinery that estradiol may require to orchestrate the local translation of 
PSD-95 and GluN2B can be found along dendrites. In addition to the localisation 
of their respective mRNAs along dendrites (Cajigas et al., 2012), polyribosomes 
can also be typically found along dendrites specifically in or below dendritic 
spines (Steward and Levy, 1982; Steward and Schuman, 2001). Spines can also 
encompass multiple polyribosomes suggesting multiple pre-existing mRNA 
transcripts may be being translated within or near a single spine (Ostroff et al., 
2018). Polyribosomes have been found to accumulate along dendrites in 
response increased levels of estrogen during the rat estrous cycle (McCarthy and 
Milner, 2003). Additionally, both ERα and ERβ have also been localised at 
dendrites (Sellers et al. 2015b) and estradiol activates signalling kinases along 
dendrites that can mediate a number of cellular changes (Srivastava, personal 
communication). Thus, estradiol may be able to influence the machinery that is 
locally present near spines to engineer the translation of pre-existing mRNA 
transcripts. This is in line with the data from Chapter 4, whereby an increase in 
new proteins can be visualised along dendrites and specifically, within larger 
spines. However, it is unknown where this translation could be occurring. 
Nevertheless, data from Chapter 4 alludes to increases of the rate of translation 
in crude synaptosomal fractions.  
 
This chapter firstly tries to decipher whether estradiol-mediated increases in 
excitatory postsynaptic proteins, PSD-95 and GluN2B, could be dependent on 
local protein synthesis in both male and OVX female hippocampal slices. 
Moreover, mTOR has been demonstrated to have a pivotal role in mediating 
estradiol-dependent protein synthesis in the male hippocampus and so its role in 
mediating estradiol-dependent increases in both PSD-95 and GluN2B is 
assessed in both sexes. Finally, the spatial distribution of ribosomal protein S10 
(RPS10), member of the smaller 40S ribosomal subunit, was assessed within 2 
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hours to determine the acute effects of estradiol on ribosomes at synapses. 
Coupled with SUnSET-ICC and super resolution imaging, the spatial distribution 
of where estradiol could be facilitating translation was investigated.          
 
R E S U L T S  
 
Estradiol increases expression of PSD-95 and GluN2B in a translation 
dependent manner 
 
Chapter 3 reported an increase in PSD-95 and GluN2B expression levels in both 
male and female hippocampus following 2 hour estradiol treatment. As alluded 
previously, the short time-frame within which estradiol drives changes in protein 
expression suggests estradiol may be engaging a non-genomic mechanism of 
action, such as local protein synthesis. Therefore, the effect of estradiol on PSD-
95 and GluN2B expression was assessed in the presence of protein synthesis 
inhibitor, anisomycin and gene transcription inhibitor, actinomycin D to determine 
whether estradiol-mediated increase of both proteins was gene transcription 
dependent or independent.  
 
As in previous chapters, acute hippocampal slices prepared from male and OVX 
females were pre-treated with either anisomycin (40µm) or actinomycin D (20µm) 
30 minutes prior to the 2 hour estradiol or DMSO exposure. The experimental set 
up was similar to that of the previous chapters. The slices were lysed and 
processed for western blotting and expression profile of PSD-95 and GluN2B was 
determined. Estradiol-mediated increase in PSD-95 expression was blocked in 
the presence of anisomycin in both male (F(3,16)=7.591, p=0.0022, Figure 5.1A) 
and OVX female (F(3,16)=9.657, p=0.0007, Figure 5.1C)  hippocampus. A 
multiple comparisons test with Bonferroni’s correction confirmed an increase in 
PSD-95 expression in estradiol treated slices compared to those treated with 
DMSO in males ([mean ± SEM] vehicle 1.000 ± 0.08, E2 1.308 ± 0.08; p=0.0087, 
n=5) and OVX females ([mean ± SEM] vehicle 1.000 ± 0.12, E2 1.495 ± 0.12; 
p=0.0049, n=5). However, no expression difference was observed in slices 
treated with anisomycin + DMSO compared to anisomycin + estradiol in either 
male ([mean ± SEM] anisomycin + vehicle 1.024 ± 0.09, anisomycin + E2 
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0.9705 ± 0.09; p>0.9999, n=5) nor OVX female ([mean ± SEM] anisomycin + 
vehicle 0.9486 ± 0.12, anisomycin + E2 0.9550 ± 0.12; p>0.9999, n=5). 
Additionally, PSD-95 expression was significantly decreased in slices treated with 
anisomycin + DMSO (male, p=0.0166; OVX female, p=0.0020) and those treated 
with anisomycin + estradiol (male, p=0.0040; OVX female, p=0.0022) compared 
to solely estradiol treated slices in both sex.   
 
GluN2B expression was assessed in a similar manner. Estradiol significantly 
increased GLuN2B, which was blocked in the presence of anisomycin in both 
male (F(3,16)=11.10, p=0.0003, Figure 5.1B) and OVX female (F(3,16)=8.167, 
p=0.0016, Figure 5.1D) hippocampus. A post hoc Bonferroni’s multiple 
comparisons test recapitulated a significant increase in GluN2B expression 
between DMSO and estradiol treated slices in males ([mean ± SEM] vehicle 
1.000 ± 0.05, E2 1.236 ± 0.05; p=0.0020, n=5) and OVX females ([mean ± SEM] 
vehicle 1.000 ± 0.12, E2 1.357 ± 0.12; p=0.0324, n=5). Notably, GluN2B 
expression was not different between anisomycin + DMSO treated and 
anisomycin + estradiol treated slices in either males ([mean ± SEM] anisomycin 
+ vehicle 0.9868 ± 0.05, anisomycin + E2 0.9864 ± 0.05; p>0.9999, n=5) or 
OVX females ([mean ± SEM] anisomycin + vehicle 1.001 ± 0.12, anisomycin 
+ E2 0.7855 ± 0.12; p=0.5038, n=5). Estradiol treated slices exhibited higher 
GluN2B expression levels than those treated with anisomycin + DMSO (male, 
p=0.0012; OVX female p=0.0474) or anisomycin + estradiol (male, p=0.0012; 
OVX female p=0.0010).  
 
As anisomycin blocked the estradiol-mediated increase of expression of synaptic 
proteins, the next logical step was to investigate whether these increases were 
maintained or blocked in the presence of actinomycin D. Increases in PSD-95 
expression were corroborated in estradiol treated slices compared to DMSO 
treated slices, even in the presence of actinomycin D in both sexes (male, 
F(3,16)=20.05, p<0.0001, Figure 5.2A; OVX female, (F(3,16)=7.906, p=0.0019, 
Figure 5.2C). A multiple comparisons test with Bonferroni’s correction confirmed 
a significant increase in PSD-95 expression slices treated with estradiol when 
compared to DMSO treated slices in the male ([mean ± SEM] vehicle 1.000 ± 
0.06, E2 1.277 ± 0.06; p=0.0026, n=5) and OVX female ([mean ± SEM] vehicle 
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1.000 ± 0.08, E2 1.302 ± 0.08; p=0.0020, n=5) hippocampus. The increase in 
PSD-95 expression levels were maintained between actinomycin D + DMSO 
treated and actinomycin D + estradiol treated slices in males ([mean ± SEM] 
actinomycin D + vehicle 0.8427 ± 0.06, actinomycin D + E2 1.208 ± 0.06; 
p=0.0002, n=5) and OVX females ([mean ± SEM] actinomycin D + vehicle 
0.9219 ± 0.08, actinomycin D + E2 1.193 ± 0.08; p=0.0416, n=5). Slices treated 
with estradiol or actinomycin D + estradiol did not reveal any difference in PSD-
95 expression in either sex (p>0.9999). PSD-95 expression was found to be 
higher in estradiol treated slices compared to anisomycin + DMSO treated slices 
in both sexes (male, p<0.0001; OVX female, p=0.0031). 
 
Similar expression profile of GluN2B was found in response to estradiol in the 
presence of actinomycin D. Estradiol enhanced GluN2B expression levels, and 
this was emulated in the presence of actinomycin D in both sexes (male, 
F(3,16)=10.40, p=0.0005, Figure 5.2B; OVX female, F(3,16)=9.076, p=0.0010, 
Figure 5.2D). Upon a multiple comparisons test with Bonferroni’s correction, 
estradiol substantiated the increase in GluN2B in both male ([mean ± SEM] 
vehicle 1.000 ± 0.10, E2 1.334 ± 0.10; p=0.0306, n=5) and OVX female ([mean 
± SEM] vehicle 1.000 ± 0.11, E2 1.437 ± 0.11; p=0.0081, n=5), compared to 
vehicle. GluN2B expression continued to be increase in actinomycin + estradiol 
treated slices compared to those treated with actinomycin + DMSO in the male 
([mean ± SEM] actinomycin D + vehicle 0.7647 ± 0.10, actinomycin D + E2 
1.083 ± 0.10; p=0.0422, n=5) and OVX female ([mean ± SEM] actinomycin D + 
vehicle 1.181 ± 0.11, actinomycin D + E2 1.526 ± 0.11; p=0.0450, n=5) 
hippocampus. No difference in expression was observed in slices treated solely 
with estradiol or actinomycin + estradiol in either (male, p=0.1611; OVX female, 
p=0.0031). Additionally, GluN2B expression was found to be significantly higher 
in slices treated with estradiol compared to actinomycin D + DMSO in males 





Figure 5.1 Estradiol-mediated increase in PSD-95 and GluN2B expression is 
inhibited in the presence of anisomycin in both male and OVX female 
hippocampus. A-D, Representative western blots and quantification of acute 
hippocampal slices of male (A+B) and OVX female (C+D) hippocampal prepared 
from 10-12 week old mice. Slices were pre-treated with anisomycin (40 µM, 30 
mins) followed by 2 hour estradiol (10 nM) or DMSO treatment and processed for 
western blotting. Blots were probed for either PSD-95 or GluN2B and normalised 
to housekeeper, β-actin. Anisomycin inhibited estradiol-mediated increases of 
PSD-95 in the male (A) and OVX female (C) hippocampus. Increased GluN2B 
expression was also inhibited in the presence of anisomycin in males (C) and 
OVX females (D); n=5 per condition. One-way ANOVA, Bonferroni corrected; 
Error bars represent mean ± SEM; * p = <0.05, ** p = <0.01, *** p = <0.001, ns = 
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Figure 5.2 Actinomycin D does not affect estradiol-mediated increase of PSD-95 
and GluN2B expression in the male and OVX female hippocampus. A-D, 
Representative western blots and quantification of acute hippocampal slices of 
male (A+B) and OVX female (C+D) hippocampal prepared from 10-12 week old 
mice. Slices were pre-treated with actinomycin D (20 µM, 30 mins) followed by 2 
hour estradiol (10 nM) or DMSO treatment and processed for western blotting. 
Blots were probed for either PSD-95 or GluN2B and normalised to housekeeper, 
β-actin. Estradiol mediated an increase in PSD-95 expression in the presence of 
actinomycin D in the male (A) and OVX female (C) hippocampus. Estradiol also 
continued to increase GluN2B expression in the presence of actinomycin D in 
both males (C) and OVX females (D); n=5 per condition. One-way ANOVA, 
Bonferroni corrected; Error bars represent mean ± SEM; * p = <0.05, ** p = <0.01, 
**** p = <0.0001, ns = not significant.   
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These data demonstrate that the estradiol-mediated increases in PSD-95 and 
GluN2B protein expression levels is dependent on a non-genomic mechanism of 
action. Where anisomycin blocks these increases, they continue to be facilitated 
by estradiol in the presence of actinomycin D. This result draws parallels from the 
biochemical data of SUnSET-WB (Figures 4.2 & 4.3), whereby estradiol-
mediated increase in the rate of translation continued to be facilitated in the 
presence of actinomycin D.    
 
Estradiol increases PSD-95 and GluN2B expression in crude synaptosomal 
fractions while having no effect on mRNA levels in primary hippocampal 
neurons   
 
The lysates from male and OVX female hippocampus from the previous section 
encompass the whole hippocampus thus, the subcellular site which estradiol is 
mediating the increase in protein synthesis cannot be determined. Therefore, 
there was a need to investigate where in the cell estradiol increases protein 
synthesis. Additionally, whether estradiol also induced changes in PSD-95, 
GluN2B and GluA1 mRNA levels within the same time-frame were examined. 
Crude synaptosomal fractions were prepared from mature (DIV 27) primary rat 
hippocampal neurons to identify whether the estradiol-mediated increases in 
PSD-95 and GluN2B expression was occurring specifically at synapses. PSD-95 
expression levels were found to be significantly increased ([mean ± SEM] vehicle 
1.000 ± 0.22, E2 1.983 ± 0.22; t=3.052, df=4.00, p=0.0380, n=3; Figure 5.3A) in 
crude synaptosomal fractions from estradiol treated cells compared to vehicle. 
Indeed, estradiol also increased GluN2B expression levels ([mean ± SEM] 
vehicle 1.000 ± 0.44, E2 1.446 ± 0.44; t=7.044, df=4.00, p=0.0021, n=3; Figure 
5.3B) within the same time-frame.         
 
These data show enhanced protein levels of both PSD-95 and GluN2B in 
response to estradiol and so whether estradiol influences these proteins at the 
mRNA level was also determined. Expression of DLG4 (for PSD-95) and GRIN2B 
(for GluN2B) expression was assessed using a RT-qPCR for changes in 
response to 2 hour estradiol treatment. Estradiol induced no significant change 
in either DLG4 ([mean ± SEM] vehicle 2.562 ± 0.52, E2 2.353 ± 0.394 t=0.3230, 
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df=5.585, p=0.7584, n=4; Figure 5.3C) or GRIN2B ([mean ± SEM] vehicle 
0.7017 ± 0.15, E2 0.6896 ± 0.11; t=0.06613, df=5.548, p=0.9496, n=4; Figure 
5.3D) expression when normalised to housekeepers ACTB, GUSB and B2M, 
compared to DMSO. This is in line with previous research where estradiol 
treatment induced no change in PSD-95 mRNA levels after 6 hours in the d-
NG108-15 cell line (Akama and McEwen, 2003). Additionally, no expression 
change was detected in GRIA1 (for GluA1) ([mean ± SEM] vehicle 1.315 ± 0.18, 
E2 1.280 ± 0.15; t=0.1473, df=5.875, p=0.8878, n=4; Figure 5.3E) in estradiol 
treated neurons compared to vehicle within the same time-frame.   
 
These results demonstrate that estradiol increases PSD-95 and GluN2B protein 
expression specifically at crude synaptosomes whilst having no effect on their 
mRNA levels. This provides further evidence that estradiol is influencing the local 
synthesis of PSD-95 and GluN2B. As GRIA1 expression is not sensitive to 
estradiol treatment, it would be a good candidate protein to investigate whether 
the estradiol-mediated increase in GluA1 expression in Chapter 3 could be 






Figure 5.3 Estradiol increases PSD-95 and GluN2B expression in crude 
synaptosomal fractions but doesn’t affect the respective mRNA expression in 
primary hippocampal neurons. A-E, DIV 27 primary hippocampal neurons were 
treated with estradiol (10 nM, 2 hours) or a vehicle control. A-B, Representative 
western blots and quantification. Neurons were fractionated upon lysing to 
separate out the extra-nuclear and crude synaptosomal fractions and processed 
for western blotting. Blots were probed for either PSD-95 or GluN2B and 
normalised to housekeeper, β-actin. PSD-95 and GluN2B protein expression was 
increased in the crude synaptosome fractions in estradiol treated neurons; n=3 
per condition. C-E, Quantification of RT-qPCR. RNA was extracted from the 
neurons and measured for difference in DLG4, GRIN2B and GRIA1 expression. 
No differences were found in the relative abundance of DLG4, GRIN2B and 
GRIA1 transcripts between estradiol or vehicle treated neurons within the same 
time-frame. Expression level was normalised to the geometric mean of three 
reference genes (ACTB, GUSB and B2M); n=4 per condition. Unpaired student’s 
t-tests, Welch’s correction; Error bars represent mean ± SEM; * p = <0.05, **p = 
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PSD-95 and GluN2B are increased specifically within dendritic spines and 
along dendrites following estradiol treatment 
  
Biochemical detection of increased PSD-95 and GluN2B expression within crude 
synaptosome fractions suggests that estradiol is increasing the presence of these 
proteins specifically at synaptic terminals. Consequently, Sarkar et al.'s (2010) 
work showing increased mRNA translation along dendrites in response to 
estradiol over 1 hour, suggests that estradiol has the potential to rapidly initiate 
translation of dendritic mRNA. Taken together with the evidence of the presence 
of a large number of mRNAs and several translation initiation proteins at 
dendrites (Steward and Schuman, 2001), the estradiol-mediated increase of both 
PSD-95 and GluN2B could be targeted to dendrites. To investigate the 
subcellular location of protein increases, primary hippocampal neurons were 
transfected as previously at DIV 12 with eGFP and cultured until DIV 20-21. 
Neurons were treated with DMSO or estradiol for 2 hours and subsequently fixed 
and immunostained for PSD-95 and GluN2B. Neurons were then imaged on a 
confocal microscope and protein intensity was measured within spines and along 
dendrites across approximately 100 µm sections of secondary and tertiary 
primary dendrites, as detailed in Chapter 2. PSD-95 expression was increased 
within spines ([mean intensity ± SEM] vehicle 0.9399* ± 0.05, E2 1.207 ± 0.11; 
t=2.264, df=17.28, p=0.0367, n=13 per condition; Figures 5.4A+B; *one cell data 
removed following Grubb’s test for outliers) and dendrites ([mean intensity ± 
SEM] vehicle 1.000 ± 0.08, E2 1.554 ± 0.17; t=2.898, df=15.48, p=0.0108, n=14, 
12 respectively; Figures 5.4A+C)  following estradiol treatment. Figure 5.4A 
demonstrates increases in PSD-95 intensity specifically at spines (white arrows) 
and along dendrites (yellow arrows). Specifically, PSD-95 can be visualised 
within spine heads of estradiol treated neurons represented by colocalization (in 
white) of PSD-95 (magenta) in GFP positive spine (green) (Figure 5.5D). 
Estradiol also increased GluN2B expression at spines ([mean intensity ± SEM] 
vehicle 0.9742 ± 0.04, E2 1.509 ± 0.23; t=2.331, df=10.75, p=0.0403; n=13, 11 
respectively; Figures 5.5A+B). However, no GluN2B expression changes were 
detected along the dendrites in estradiol treated neurons (p=0.5438; vehicle 
1.000 ± 0.13, E2 1.133 ± 0.17; t=0.6171, df=21.00, p=0.5438; n=14, 12 
respectively, Figures 5.5A+C) compared to vehicle. Figures 5.4A+D 
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demonstrate increased PSD-95 intensity within spines (white arrows) and 
dendrites (yellow arrows). Figure 5.5A+D demonstrate increased GluN2B 
intensity within spines (white arrows) whereas, there is no pronounced increase 
at dendrites (yellow arrows).     
 
Figure 5.4 PSD-95 is increased along dendrite and within dendritic spines in 
primary hippocampal neurons. A+D, Representative confocal images (60x) of 
GFP transfected DIV20 primary hippocampal neurons treated with estradiol (10 
nM, 2 hours) or DMSO and immunostained for GFP (green) and PSD-95 
(magenta). B-C, Quantification of A. Estradiol increased PSD-95 intensity within 
dendritic spines (B) and along dendrites (C). D, Orthogonal projections confirmed 
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Unpaired student’s t-tests, Welch’s correction; Error bars represent mean ± SEM; 
* p = <0.05. Arrowheads denote PSD-95 localised at dendrites (yellow) and 
dendritic spines (white). Co-localisation of PSD-95 within GFP positive regions is 
shown in white.  Scale bars = 10 µm (A), 5 µm (D).        
 
 
Figure 5.5 GluN2B is increased within dendritic spines but not extrasynaptically 
in primary hippocampal neurons. A+D, Representative confocal images (60x) of 
GFP transfected DIV20 primary hippocampal neurons treated with estradiol (10 
nM, 2 hours) and immunostained for GFP (green) and GluN2B (magenta). B-C, 
Quantification of A. Estradiol increased GluN2B intensity within dendritic spines 
(B) but not along dendrites (C). D, Orthogonal projections confirmed localisation 















































































student’s t-tests, Welch’s correction; Error bars represent mean ± SEM; * p = 
<0.05. Arrowheads denote PSD-95 localised at dendrites (yellow) and dendritic 
spines (white). Co-localisation of GluN2B within GFP positive regions is shown in 
white. Scale bars = 10 µm (A), 5 µm (D).               
_______________________________________________________________ 
 
These data confirm that estradiol is increasing PSD-95 and GluN2B expression 
in close proximity to dendritic spines within 2 hours. As estradiol has no significant 
effect on their respective mRNA levels, these results suggest that estradiol may 
be engaging dendritic mRNA to translate these proteins locally.   
 
mTOR is required for estradiol-dependent increase of PSD-95 in both male 
and OVX females 
 
Chapter 4 demonstrated that mTOR was needed for estradiol-dependent protein 
synthesis in the male but not OVX female hippocampus. However, SUnSET does 
not give out individual protein readout and so although mTOR may be important 
for global protein synthesis in males, whether this signalling pathway is needed 
for increasing PSD-95 expression levels was specifically determined. Pre-treated 
acute hippocampal slices with rapamycin (1µm, 30 minutes) followed by 2 hour 
estradiol or DMSO exposure from males and OVX females were lysed and 
processed for western blotting and expression profile of PSD-95. Interestingly, 
rapamycin blocked the estradiol-mediated increase of PSD-95 expression in both 
male (F(3,20)=9.955, p=0.0003, Figure 5.6A) and OVX female (F(3,20)=8.206, 
p=0.0009, Figures 5.6B) hippocampus. A post hoc Bonferroni’s multiple 
comparison test confirmed the increase of PSD-95 expression in estradiol treated 
slices compared to vehicle in both males ([mean ± SEM] vehicle 1.000 ± 0.07, 
E2 1.356 ± 0.07; p=0.0002, n=6) and OVX females ([mean ± SEM] vehicle 1.000 
± 0.07, E2 1.356 ± 0.07; p=0.0006, n=6). This increase was attenuated in the 
presence of rapamycin in estradiol treated slices in both males ([mean ± SEM] 
rapamycin + vehicle 1.218 ± 0.67, rapamycin + E2 1.147 ± 0.67; p>0.9999, 
n=6) and OVX females ([mean ± SEM] vehicle 1.153 ± 0.07, E2 1.115 ± 0.07; 
p>0.9999, n=6). PSD-95 expression was significantly higher in slices treated with 
estradiol compared to rapamycin + estradiol treated hippocampal slices in both 
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sexes (males p=0.0267; OVX female, p=0.0218). Slices treated with rapamycin 
+ DMSO also increased PSD-95 expression compared to DMSO alone in males 
(p=0.0231), which was not observed between OVX female slices (p=0.2993).  
 
Thus, the current data illustrates that mTOR is specifically important in increasing 
PSD-95 expression in males but also OVX females. This suggests that although 
mTOR is not required to increase global protein synthesis in the OVX female 





Figure 5.6 mTOR is required for estradiol-mediated increase in PSD-95 
expression in the male and OVX female hippocampus but mTOR is required for 
estradiol-mediated increase in GluN2B only in the male but not OVX female 
hippocampus. A-D, Representative western blots and quantification of acute 
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hippocampal slices of male (A+C) and OVX female (B+D) hippocampal prepared 
from 10-12 week old mice. Slices were pre-treated with rapamycin (1 µM, 30 
mins) followed by 2 hour estradiol (10 nM) or DMSO treatment and processed for 
western blotting. Blots were probed for either PSD-95 or GluN2B and normalised 
to housekeeper, β-actin. Rapamycin inhibited estradiol-mediated increases of 
PSD-95 in the male (A) and OVX female (B) hippocampus. Increased GluN2B 
expression was also inhibited in the presence of rapamycin in males (C) but not 
OVX females (D); n=5 per condition. One-way ANOVA, Bonferroni corrected; 
Error bars represent mean ± SEM; * p = <0.05, ** p = <0.01, *** p = <0.001, **** 
p = < 0.0001, ns = not significant.         
 
Estradiol increases GluN2B expression independent of mTOR in OVX 
females but not males   
 
It was next identified whether mTOR was critical for increasing expression levels 
of GluN2B in both of the male and OVX female hippocampus. The same 
hippocampal slices treated with DMSO and estradiol in the presence or absence 
of rapamycin were processed for western blotting to assess the expression profile 
of GluN2B. Interestingly, mTOR blocked the increase in GluN2B expression in 
the male (F(3,16)=6.932, p=0.0033, Figure 5.6C) but not the OVX female 
(F(3,16)=9.305, p=0.0009, Figure 5.6D) hippocampus. A multiple corrections test 
with Bonferroni’s correction multiple comparisons test recapitulated increased 
GluN2B expression in estradiol treated slices compared to vehicle in both males 
([mean ± SEM] vehicle 1.000 ± 0.24, E2 2.049 ± 0.24; p=0.0025, n=5) and OVX 
females ([mean ± SEM] vehicle 1.000 ± 0.13, E2 1.554 ± 0.13; p=0.0030, n=5). 
This increase in GluN2B expression was attenuated in rapamycin + estradiol 
treated slices compared to rapamycin + DMSO in the male ([mean ± SEM] 
rapamycin + vehicle 1.405 ± 0.24, rapamycin + E2 1.322 ± 0.24; p>0.9999, 
n=5) but not OVX female ([mean ± SEM] rapamycin + vehicle 1.004 ± 0.13, 
rapamycin + E2 1.392 ± 0.13; p=0.0390, n=5) hippocampus. This suggested that 
mTOR was not required for estradiol to increase GluN2B expression in the OVX 
females. In fact, GluN2B expression was found to be increased in slices treated 
with rapamycin + estradiol compared to vehicle (p=0.0370). When compared to 
rapamycin + estradiol treated slices, GluN2B expression was significantly higher 
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in slices treated solely treated with E2 in males (p=0.0433) but no significant 
change was found in OVX females (p=0.6040). Additionally, GluN2B expression 
was found to be profoundly increased in slices treated with estradiol compared to 
those treated with rapamycin + DMSO in the OVX female (p= 0.0031) 
hippocampus.  
 
These data show that estradiol increased GluN2B expression in a sexually 
dimorphic manner. mTOR signalling was not required for estradiol to increase 
GluN2B expression in the OVX female hippocampus, unlike PSD-95. Critically, 
mTOR is required to increase GluN2B expression in the male hippocampus. 
These results mirror the findings from Chapter 4, whereby the increase in 
estradiol-mediated global protein synthesis is mTOR dependent in males but not 
OVX females. Interestingly, mTOR is important in regulating increases in PSD-
95 in both sexes suggesting that the mTOR signalling pathway is critical in 
mediating estradiol-dependent increases in select proteins in OVX females 
proposing the contribution of a second pathway in the OVX female hippocampus. 
 
RPS6 is phosphorylated in males but not OVX females  
 
A consequence of the activation of mTOR is the subsequent phosphorylation of 
RPS6 (p-RPS6) through S6K1/2 (Meyuhas, 2015). Estradiol increases p-RPS6 
within 10 minutes in primary hippocampal neurons, which remains 
phosphorylated after 1 hour (Sarkar et al., 2010). p-RPS6 has been associated 
with LTP in the CA1 (Cammalleri et al., 2003; Panja et al., 2009; Tsokas et al., 
2005) in addition to having a regulatory role in translation initiation and protein 
synthesis (Thomas et al., 1982). Phosphorylation at serine sites 235 and 236 
(Ser235/236) have been demonstrated to be shown to be MAPK/ERK dependent 
near active synapses whereas, phosphorylation at serine sites 240 and 244 
(Ser240/244) are predominantly mTOR dependent in dendrites (Pirbhoy et al., 
2017). This suggests a convergence at RPS6 for both signalling pathways. To 
determine the contribution of p-RPS6 within the current study, the activation of 





Employing the hippocampal slice lysates treated with DMSO or estradiol with or 
without pre-treatment of rapamycin from the previous 2 results sections, p-RPS6 
was measured through western blotting. Estradiol increased phosphorylation of 
RPS6 Ser235/236, which subsequently blocked by rapamycin (F(3,16)=40.99, 
p<0.0001, Figure 5.7A) and ser240/244  (F(3,16)=90.76, p<0.0001, Figure 5.7B) in 
the male hippocampus. However, no change in RPS6 phosphorylation was 
observed at either phosphorylation sites in the OVX female hippocampus 
(Ser235/236: F(3,20)=12.5, p<0.0001, Figure 5.7C,  Ser
240/244: F(3,20)=109.1, 
p<0.0001, Figure 5.7D); rapamycin categorically attenuated the phosphorylation. 
A Bonferroni corrected multiple comparisons test illustrated a significant increase 
in p-RPS6 at Ser235/236 ([mean ± SEM] vehicle 1.000 ± 0.10, E2 1.360 ± 0.10; 
p=0.0203, n=5) and Ser240/244 ([mean ± SEM] vehicle 1.000 ± 0.08, E2 1.308 ± 
0.08; p=0.0051, n=5) in estradiol treated slices compared to vehicle in males. 
Whereas, no change in RPS6 activation was detected in either Ser235/236 ([mean 
± SEM] vehicle 1.000 ± 0.13, E2 0.8405 ± 0.13; p>0.9999, n=5) or Ser240/244 
([mean ± SEM] vehicle 1.000 ± 0.06, E2 0.8977 ± 0.06; p=0.5859, n=5) in OVX 
female slices treated with estradiol. Expectedly, p-RPS6 was significantly 
decreased in rapamycin + DMSO and rapamycin + estradiol treated slices 
compared to vehicle at Ser235/236 ([mean ± SEM] rapamycin + vehicle 0.3291 ± 
0.10, p<0.0001, n=5; rapamycin + E2 0.4826 ± 0.10, p=0.0009, n=5) and 
Ser240/244 ([mean ± SEM] rapamycin + vehicle 0.2983 ± 0.08, p<0.0001, n=5; 
rapamycin + E2 0.3085 ± 0.08, p<0.0001, n=5). This was parallel in the OVX 
female hippocampus, RPS6 activation was found to be attenuated in rapamycin 
+ DMSO and rapamycin + estradiol treated slices compared to vehicle at both 
Ser235/236 ([mean ± SEM] rapamycin + vehicle 0.3200 ± 0.13, p=0.0003, n=5; 
rapamycin + E2 0.4036 ± 0.13, p=0.0013, n=5) and Ser240/244 ([mean ± SEM] 
rapamycin + vehicle 0.2026 ± 0.06, p<0.0001, n=5; rapamycin + E2 0.1964 ± 
0.06, p<0.0001, n=5). Indeed, p-RPS6 at Ser235/236 was also significantly lower 
in rapamycin + DMSO (male, p<0.0001; OVX female, p=0048) and rapamycin + 
estradiol treated (male, p<0.0001; OVX female, p=0209) slices when compared 
to slices treated with estradiol. This was also the case for p-RPS6 at Ser240/244 
compared to estradiol treated slices (male, rapamycin + DMSO & rapamycin + 
E2, p<0.0001 for both; OVX female, rapamycin + DMSO & rapamycin + E2, 


























Figure 5.7 Estradiol increases phosphorylation of ribosomal protein S6 (RPS6) 
in the male, but not OVX female hippocampus. A-D, Representative western blots 
and quantification of acute hippocampal slices of male (A+B) and OVX female 
(C+D) hippocampal prepared from 10-12 week old mice. Slices were pre-treated 
with rapamycin (1 µM, 30 mins) followed by 2 hour estradiol (10 nM) or DMSO 
treatment and processed for western blotting. Blots were probed for either RPS6 
phosphorylation at serine sites 235 (Ser235/236) and 236 or serine sites 240 and 
244 (Ser240/244) and normalised to total RPS6 expression. Estradiol increased 
phosphorylation of both Ser235/236 and Ser240/244 in the male, but not the OVX 
female, hippocampus. Rapamycin blocked the phosphorylation of all the serine 
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Bonferroni corrected; Error bars represent mean ± SEM; * p = <0.05, ** p = <0.01, 
*** p = <0.001, **** p = < 0.0001, ns = not significant.         
_______________________________________________________________ 
 
Collectively, these data show that estradiol phosphorylated RPS6 at Ser235/236 
and Ser240/244 in males within 2 hours, which complement the findings that mTOR 
is required for estradiol-mediated increases in global protein synthesis in the male 
hippocampus. Critically, estradiol does not activate either Ser235/236 or Ser240/244 
in the OVX female hippocampus within the same time-frame. Amalgamating this 
finding with the findings from Chapter 4, estrogen engages a different pathway 
to increase GluN2B levels in the OVX but requires mTOR to increase PSD-95. 
Thus, estradiol may need increased phosphorylation of RPS6 to mediate the 
increase of specific proteins in the OVX hippocampus. Yet, this sensitivity may 
not be picked up through western blotting.      
 
Estradiol rapidly increases the rate of translation along dendrites and 
juxtaposing synaptic regions  
 
Data from Chapter 4 showing that increased AHA-tagged newly synthesised 
proteins localised to spines suggests that nascent proteins may be synthesised 
nearby. In concert, estradiol increased PSD-95 and GluN2B expression near and 
within spines. Thereby, a subset of these proteins could be newly synthesised. 
To investigate this, SUNSET-ICC was employed to determine the subcellular 
location of active translation sites in estradiol treated neurons. As puromycin 
incorporates onto elongating polypeptide chains, the mechanism can provide a 
notion of where in the neuron puromycin terminates the elongation. Thereby, 
demonstrating where increased translation occurs in neurons following estradiol 
treatment. Primary hippocampal neurons (DIV20-21) were treated for 2 hours 
with either DMSO or estradiol over 2 hours as previously, subsequently 
immunostained with the neuronal marker MAP2 and puromycin. Neurons were 
imaged using structured illumination microscopy (SIM) to provide a better 
resolution than traditional confocal microscopy. Puromycin puncta number and 
area was analysed along dendrites approximately 50 µm in length. Puromycin 
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puncta number and area was also measured in the spine area, which was defined 
by measuring 2 µm either side of the dendrite, as detailed in Chapter 2.  
 
Puromycin puncta number was increased in estradiol treated neurons in crude 
synaptic regions (per 10 µm [mean ± SEM] vehicle 27.73 ± 2.45, E2 43.96 ± 
2.30; t=4.830, df=26.00, p<0.0001, n=15, 13 respectively; Figures 5.8A+B) 
demonstrating increased rate of translation compared to a vehicle control. Upon 
closer analysis, there is increased puromycin puncta specifically along dendrites 
(per 10 µm [mean ± SEM] vehicle 8.031 ± 0.97, E2 12.51 ± 0.83; t=3.505, 
df=25.80, p=0.0017, n=15, 13 respectively; Figures 5.8A+C) and in spine 
regions (per 10 µm [mean ± SEM] vehicle 19.70 ± 1.67, E2 31.46 ± 2.02; t=4.481, 
df=24.30, p=0.0002, n=15, 13 respectively; Figures 5.8A+D). Estradiol also 
increased puncta area in the synaptic area ([mean ± SEM] vehicle 0.04146 ± 
0.001, E2 0.4719 ± 0.001; t=3.024, df=25.98, p=0.0056, n=15, 13 respectively; 
Figures 5.8A+E). This is specifically pronounced along dendrites ([mean ± SEM] 
vehicle 0.04027 ± 0.002, E2 0.4628 ± 0.002; t=2.579, df=26.00, p=0.0159, n=15, 
13 respectively; Figures 5.8A+F) and synaptic regions ([mean ± SEM] vehicle 
0.04183 ± 0.002, E2 0.4629* ± 0.001; t=2.304, df=24.55, p=0.0299, n=15, 12 
respectively; Figures 5.8A+G; *one cell data removed following Grubb’s test for 
outliers). Figure 5.8A demonstrates increased puromycin puncta number and 
area within spine regions (white arrows) and dendrites (yellow arrows).  
 
Collectively, these data firstly provide further evidence that puromycin 
incorporation is promoted in estradiol treated neurons. Thus, there is an increase 
in the rate of translation specifically along dendrites and within spine areas, 
confirming data from SUnSET-WB in crude synaptosomes in Chapter 4 (Figure 
4.6). Increased puncta size could suggest that multiple proteins undergoing 
elongation could be in close proximity, that may not be detected through SIM in 
neurons treated with estradiol.  
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Figure 5.8 Estradiol increases puromycin-tagged elongating proteins, 
representing active translation sites, along dendrites and within dendritic spines 
in primary hippocampal neurons. A, Representative SIM images (100x) of DIV20 
primary hippocampal neurons treated with estradiol (10 nM, 2 hours) or DMSO, 
incubated with puromycin (10 µg/mL, last 10 minutes). Neurons were 
immunostained for neuronal marker MAP2 (magenta) and puromycin (green; 
SUnSET-ICC). B-G, Quantification of A. Estradiol increases puromycin puncta 
number (B-D) and puncta size (E-G) within synaptic areas (B-E). Specifically, 
increased puromycin puncta number and size was found in dendrites (C+F) and 
within spine regions (D+G); n= 13-15. Unpaired student’s t-tests, Welch’s 
correction; Error bars represent mean ± SEM; * p = <0.05, ** p = <0.01, *** p = 
<0.001, **** p = < 0.0001, ns = not significant. Arrowheads denote puromycin 
localised at dendrites (yellow) and within spine regions (white). Co-localisation of 
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RPS10 is increased along dendrites and within spine regions 
 
As estradiol increases the rate of translation along dendrites and the juxtaposing 
spine regions, it was reasoned that estradiol may affect translational machinery. 
Polyribosomes have previously been shown to fluctuate during the female rat 
estrous cycle (McCarthy and Milner, 2003). Expressions of both ribosomal S3 
protein, member of the smaller 40S ribosomal subunit, and ribosomal p-proteins, 
part of the larger 60S ribosomal subunit, were increased during estrus, when 
estrogen levels are higher, compared to diestrus and proestrus in the 
hippocampal CA1 stratum radiatum. Since, no further interaction between 
estradiol and ribosomal proteins have been documented. Thus, given the nature 
of this study, ribosomal protein S10, a component of the 40S ribosomal subunit, 
was assessed in response to 2 hour estradiol treatment. 
 
Employing the same experimental set up as SUnSET-ICC, treated primary 
hippocampal neurons were additionally co-immunostained with RPS10. All 
images were acquired with SIM as above, coupled with the SUnSET-ICC 
experiment. RPS10 puncta number and size were determined using the same 
regions of interest (ROI) as puromycin. This also allowed the investigation of any 
co-localisation between puromycin and RPS10, which will be detailed in the next 
results section. Estradiol treatment significantly increased RPS10 puncta number 
in the crude synaptic region (per 10 µm [mean ± SEM] vehicle 19.57 ± 1.75, E2 
28.26 ± 3.02; t=2.487, df=19.54, p=0.0221, n=15, 13 respectively; Figures 
5.9A+B) compared to DMSO. When assessed separately, increased RPS10 
puncta could be visualised along dendrites (per 10 µm [mean ± SEM] vehicle 
4.766 ± 0.38, E2 6.886 ± 0.78; t=2.653, df=18.63, p=0.0159, n=15, 13 
respectively; Figures 5.9A+C)  spine regions (per 10 µm [mean ± SEM] vehicle 
14.41 ± 1.33, E2 21.38 ± 2.50; t=2.463, df=18.50, p=0.0238, n=15, 13 
respectively; Figures 5.9A+D) compared to vehicle suggesting estradiol was 
increasing RPS10 expression locally at dendrites. Whether this is solely the 
RPS10 positive 40S ribosomal subunits or whether it represents increases of 
functional ribosomes cannot be determined.    
 
The increase in RPS10 puncta number was in concert with increases in puncta 
size. Estradiol treated neurons expressed larger RPS10 puncta area compared 
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to vehicle ([mean ± SEM] vehicle 0.04205 ± 0.002, E2 0.05165 ± 0.003; t=2.594, 
df=20.89, p=0.0170, n=15, 13 respectively; Figures 5.9A+E). This signature was 
observed specifically along dendrites ([mean ± SEM] vehicle 0.04031 ± 0.002, 
E2 0.05059 ± 0.004; t=2.544, df=16.77, p=0.0211, n=15, 13 respectively; Figures 
5.9A+F) and within spine regions ([mean ± SEM] vehicle 0.04258 ± 0.002, E2 
0.05162 ± 0.003; t=2.391, df=21.99, p=0.0258, n=15, 13 respectively; Figures 
5.9A+G). Therefore, estradiol not only increased the distribution of 40S ribosomal 
subunits, but this was coupled with an increase in RPS10 puncta area. Figure 
5.9A demonstrates increased RPS10 puncta number and area within spine 
regions (white arrows) and dendrites (yellow arrows).  
 
Taken together, these data suggest that RPS10 distribution is increased along 
dendrites and spine regions in estradiol treated neurons. It is unknown whether 
these are active ribosomes nevertheless, it illustrates that estradiol is interacting 
with ribosomal machinery with this time-frame. RPS10 puncta area was also 
found increased in the same time-frame in estradiol treated neurons. It can be 
reasoned that this could represent clustering of RPS10 positive ribosomal 
subunits that may be actively translating mRNA. Nevertheless, this echoes the 
findings of increased dendritic polyribosomal accumulation during estrus 


















Figure 5.9 Ribosomal protein S10 (RPS10) is increased along dendrites and 
within spine regions following 2 hour estradiol treatment in primary hippocampal 
neurons. A, Representative SIM images (100x) of DIV20 primary hippocampal 
neurons treated with estradiol (10 nM, 2 hours) or DMSO and immunostained for 
neuronal marker MAP2 (magenta) and RPS10 (green). B-G, Quantification of A. 
Estradiol increased RPS10 puncta number (B-D) and puncta size (E-G) within 
synaptic areas (B-E). Specifically, increased RPS10 puncta number and size was 
found in dendrites (C+F) and within spine regions (D+G); n= 13-15. Unpaired 
student’s t-tests, Welch’s correction; Error bars represent mean ± SEM; * p = 
<0.05. Arrowheads denote RPS10 localised at dendrites (yellow) and within spine 
regions (white). Co-localisation of RPS10 within MAP2 positive regions is shown 
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Co-localisation of puromycin-tagged nascent proteins and RPS10 is 
increased   
 
Increased puromycin and RPS10 puncta were observed in the same chosen 
ROIs along estradiol treated neurons. Thus, it was determined whether 
puromycin and RPS10 would colocalise with each other. It can be reasoned that 
co-localisation between puromycin and RPS10 may be indicative of an actively 
translating ribosome where puromycin has terminated the elongation of 
polypeptide chain in RPS10 positive ribosomes. To investigate this, RPS10 
puncta were assessed for co-localisation with puromycin by projecting identified 
RPS10 puncta ROIs into the respective puromycin channel from the same 
neuron. This would allow to measure how much RPS10 would localise with 
puromycin. Estradiol drove an increase in RPS10 co-localisation with puromycin 
in synaptic regions (per 10 µm [mean ± SEM] vehicle 17.56 ± 1.67, E2 25.60 ± 
3.13; t=2.265, df=18.50, p=0.0358, n=15, 13 respectively; Figures 5.10A+B) 
compared to vehicle. This was observed both along dendrites (per 10 µm [mean 
± SEM] vehicle 4.649 ± 0.38, E2 6.747 ± 0.73; t=2.537, df=18.26, p=0.0205, 
n=15, 13 respectively; Figures 5.10A+C) and spine regions (per 10 µm [mean ± 
SEM] vehicle 12.54 ± 1.28, E2 18.85 ± 2.54; t=2.265, df=18.50, p=0.0393, n=15, 
13 respectively; Figures 5.10A+D) in estradiol treated neurons. Figure 5.10A 
depicts high levels of co-localisation of RPS10 and puromycin in estradiol treated 
neurons compared to DMSO treated neurons, specifically at synaptic regions 
(white arrows) and along dendrites (yellow arrows). 
 
These data illustrate that estradiol treated neurons encompass increased co-
localisation of RPS10 with puromycin along dendrites and around spine regions. 
Given that puromycin tags elongating polypeptide chains, co-localisation with 
RPS10 could suggest an active translation site. Increased co-localisation could 
be visualised in both dendrites and spine regions. This corroborates previous 
data showing AHA-tagged newly synthesise proteins localised in the same 
subcellular compartments as RPS10/puromycin co-localisation. Thus, a scenario 
could be that estradiol may be influencing protein translation, by directly or 




    
 
Figure 5.10 Estradiol increases co-localisation of RPS10 with puromycin along 
dendrites and within spine regions following 2 hour estradiol treatment in primary 
hippocampal neurons. A, Representative SIM images (100x) of DIV20 primary 
hippocampal neurons treated with estradiol (10 nM, 2 hours) or DMSO and 
immunostained for neuronal marker RPS10 (green) and puromycin (magenta). 
B-D, Quantification of A. Estradiol increased the co-localisation between RPS10 
and puromycin puncta within synaptic areas (B). This was specifically 
pronounced along dendrites (C) and within spine regions (D); n= 13-15. Unpaired 
student’s t-tests, Welch’s correction; Error bars represent mean ± SEM; * p = 










































































regions (white). Co-localisation of RPS10 puncta with puromycin puncta is shown 
in white. Scale bar = 5 µm. 
 
D I S C U S S I O N  
 
Summary of results  
 
This chapter tested whether estradiol-induced increase expression of PSD-95 
and GluN2B was occurring via a local protein synthesis mechanism. Both 
proteins were found to be increased independently of gene transcription. This is 
consistent with the data in Chapter 4 that shows estradiol modulates a local 
protein synthesis mechanism. Thus, the increase in PSD-95 and GluN2B, and 
other proteins that have not been assessed, are the likely result of this. Estradiol 
dependent increase in PSD-95 was dependent on mTOR in both sexes however, 
mTOR was critical in increasing GluN2B only in males but not OVX females. 
These data further complement the notion that estradiol utilises distinct signalling 
mechanisms in both males and OVX females within this time-frame. Additionally, 
PSD-95 and GluN2B expression was found to specifically be increased dendritic 
spines and along dendrites. Within the same time-frame, estradiol increases the 
localisation of RPS10 and the active sites of translation along dendrites. This 
suggests that estradiol may be engaging protein translation machinery available 
locally to increase PSD-95 and GluN2B expression. 
 
Estradiol increases expression of PSD-95 and GluN2B in a local protein 
synthesis dependent manner at dendritic spines 
 
Estradiol increased the protein expression of both PSD-95 and GluN2B within 
dendritic spines and PSD-95 along dendrites. However, the fraction of these 
proteins detected that represent newly synthesised proteins cannot be confirmed 
with the existing experimental setup. Nevertheless, multiple lines of evidence 
from the current and previous chapter support the scenario that estradiol may be 
mediating the synthesis of PSD-95 and GluN2B at or near synapses. Imaging 
data illustrated that newly synthesised proteins are present along dendrites and 
within dendritic spines in estradiol treated neurons (Figures 4.7 & 4.12). 
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Biochemically, both PSD-95 and GluN2B were found to be enriched in the crude 
synaptosomal fraction following estradiol treatment, and it had no effect on their 
mRNA levels. As PSD-95 and GluN2B mRNAs are dendritically localised (Cajigas 
et al., 2012; Miyashiro et al., 1994), it is plausible that estradiol could employ 
these pools of existing PSD-95 and GluN2B mRNA transcripts to synthesize 
these proteins at, or near, spines. In support, estradiol has previously been shown 
to induce dendritic translation, as assessed by examining GFP expression based 
on a  CAMKIIα 3’-UTR reporter, within a similar time-frame (Sarkar et al., 2010). 
SUnSET-ICC confirmed that estradiol increases active translation sites, and that 
the site translation is occurring is near spines and within dendrites. Therefore, 
estradiol has the capacity to stimulate the initiation of dendritic mRNA translation 
if the mRNA is already present. Critically, increases in both PSD-95 and GluN2B 
expression was blocked by a translation inhibitor yet, continued to be facilitated 
by estradiol in the presence of a gene transcription inhibitor. In line with this, 
SUnSET-ICC, SUnSET-WB (Figures 4.1 & 4.6) and FUNCAT (Figure 4.7) all 
confirm the temporal profile within which estradiol mediates these events. Thus, 
collectively these data indicate that estradiol increased expression of PSD-95 and 
GluN2B along dendrites and at or near spines, which resulted in an increase of 
both at synapses. PSD-95 has an important role in synapse formation 
(Washbourne et al., 2002), spine stabilisation (Chubykin et al., 2007) and AMPAR 
recruitment to synapses (Ehrlich and Malinow, 2004; Schnell et al., 2002) and 
GluN2B-containing synaptic NMDARs are implicated in LTP (Barria and Malinow, 
2005; Berberich et al., 2007; Tang et al., 1999). Consequently, estradiol’s ability 
to increase two proteins implicated in synaptic plasticity provides a or several 
mechanisms by which estradiol may be regulating hippocampal synaptic 
plasticity. 
 
Given the importance of PSD-95 in synaptic plasticity, the effect of estradiol in 
mediating the increase of new PSD-95 has been investigated before. As 
mentioned previously, new PSD-95 protein levels were detected following 6 hour 
estradiol treatment (10 nM) in a neuroblastoma cell line (Akama and McEwen, 
2003). This was shown to be independent of gene transcription as actinomycin D 
blocked the increase in new PSD-95 complimented by no changes in mRNA 
levels. These data support the current results as they directly measured new 
PSD-95 protein expression levels. Although, this was carried out in a 
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neuroblastoma cell line through immunoprecipitation, the study lacked the 
specificity of investigating this within the hippocampus, where the majority of 
estradiol research has shown regulation of structural plasticity. Moreover, 
because of the methods used, the study did not specify where the newly 
synthesised PSD-95 was targeted. However, the time-frame of that observation 
supports the current study.  
 
The observation of estradiol increasing active translation sites along dendrites 
may indicate that estradiol could be engaging machinery readily available at 
dendrites through secondary pathways. Previously, fluctuations of estrogen 
levels during the rat estrous cycle has been shown to trigger polyribosome 
accumulation at dendrites (McCarthy and Milner, 2003). However, estradiol’s 
interaction with ribosome expression at dendrites has not since been 
investigated. Within the current study, increased RPS10 distribution is observed 
along dendrites and near spines supporting the findings from McCarthy & Milner 
(2003). Additionally, estradiol also increases the size of RPS10 puncta. A 
possible scenario is that estradiol could be promoting the trafficking of multiple 
RPS10 positive ribosomes to the dendrite to initiate the translation of target 
mRNA transcripts. Alternatively, another scenario is that estradiol may be 
activating stalled ribosomes. In neurons, RNA granules, comprised of non-
translating ribosomes containing translationally repressed synaptic mRNA, can 
be transported to synapses and dwell there until an external stimuli activates 
these ribosomes to complete the initiation of translation (Batish et al., 2012; 
Costa-Mattioli et al., 2009; Krichevsky and Kosik, 2001). Recently, Graber et al. 
(2017) elegantly showed that some of these mRNAs are in fact translationally 
stalled at elongation or termination stage of translation. Therefore, this scenario 
provides a more rapid time-scale at which target proteins could be made. This 
would be ideal in a situation where there is increased depletion of a target protein. 
This would allow estradiol to bypass the translation initiation of pre-existing 
mRNA transcripts by activating a ribosome stalled at either elongation or 
termination of a target protein. Although RPS10 distribution is increased along 
dendrites, whether the RPS10 is part of ribosomal complex cannot be 
determined. Therefore, it is not known whether these contain mRNA or not as 
PSD-95 or GluN2B mRNA localisation was not observed. Alternatively, the 
location of estradiol-mediated translation was assessed through SUnSET-ICC. 
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This shows that it is occurring both at dendrites and near spines. Consistent with 
this, RPS10 is increased within the same subcellular compartments, and there is 
increased co-localisation of puromycin with RPS10. Some puromycin puncta 
were also observed to not co-localise with RPS10, a possible explanation for this 
could be that the puromycin-labelled proteins may have undergone premature 
termination and thus, deviated away from any ribosomal protein complexes. 
Although, how fast this can occur is unknown. Alternatively, puromycin-labelled 
proteins may be part of a ribosomal complex which, does not include RPS10. 
Taken together, more studies are warranted to fully elucidate the interaction 
between estradiol and ribosomal distribution for example, using approaches such 
as Translating Ribosome Affinity Purification (TRAP) to label polyribosomes 
containing translating mRNAs (Heiman et al., 2014).        
 
mTOR is required for estradiol to increase the expression of specific 
proteins  
 
A reoccurring theme amidst the data presented in this thesis is that estradiol 
behaves in a sexually dimorphic manner in the rodent hippocampus. mTOR was 
shown to be required to induce estradiol-dependent global protein synthesis in 
the male but not female hippocampus (Figure 4.4). Furthermore, mTOR was also 
required for estradiol-induced increase in PSD-95 and GluN2B expression levels 
in the male hippocampus and interestingly, only PSD-95 in OVX female 
hippocampus. As SUnSET is a measure of global protein synthesis, it is likely 
that multiple signalling pathways are involved in mediating estradiol-mediated 
protein synthesis. Therefore, it is possible that mTOR is required for mediating a 
proportion of estradiol-mediated protein synthesis, but this cannot be detected 
using SUnSET-WB. Thus, looking at specific proteins provides a greater 
specificity to decipher whether mTOR is needed for estradiol to mediate the 
translation of that specific protein. Nevertheless, the data also showed that mTOR 
was not required for estradiol to increase GluN2B in the OVX female 
hippocampus. This further confirms that another signalling pathway could be 
involved in mediating estradiol-mediated global protein synthesis, and the 




Estradiol phosphorylated RPS6, a downstream target of mTOR, at both Ser235/236 
and Ser240/244 in the male hippocampus, but not the OVX female hippocampus. 
This suggests that the phosphorylation of RPS6 may contribute to the mTOR-
dependent increase in PSD-95 and GluN2B in the male hippocampus. This 
supports the data showing mTOR was required for increasing estradiol-mediated 
global protein synthesis in males. A potential route estradiol could employ is 
activating RPS6 through mTOR. In support, RPS6 activation at Ser235/236 has 
recently been shown to be induced along dendrites and particularly near active 
synapses in the hippocampus, suggesting that it may have a critical role in the 
translation of mRNA present near synapses (Pirbhoy et al., 2016). Furthermore, 
RPS6 has been reported to be trafficked into dendritic spines following LTP 
induction in the dentate gyrus (Nihonmatsu et al., 2015), further proposing a 
potential role for RPS6 in dendritic protein synthesis. Interestingly, ser235/236 
phosphorylation has been shown to be MAPK/ERK dependent near active 
synapses whereas, phosphorylation at Ser240/244 is predominantly mTOR 
dependent in dendrites (Pirbhoy et al., 2017). However, estradiol did not increase 
phosphorylation of either Ser235/236 or Ser240/244 in the OVX female hippocampus. 
Therefore, although mTOR is needed to increase PSD-95 in the OVX females, it 
would not utilise the phosphorylation of RPS6 within the time-frame. mTOR also 
phosphorylates 4EBP1, which prevents eIF4E from initiating translation by 
suppressing its association with the mRNA ‘cap’ (Hoeffer and Klann, 2010). 
Phosphorylation through mTOR releases eIF4E to resume this binding and 
initiation of translation. Thus, estradiol could possibly be increasing PSD-95 
through mTOR via 4EBP1. ERK is also able to phosphorylate eIF4E (Banko et 
al., 2004; Waskiewicz et al., 1999), which is another signalling pathway estradiol 
may utilise to increase GluN2B, and global protein synthesis, in the OVX female 
hippocampus. A future experiment to consider would be assessing expression 
changes of PSD-95, and GluN2B, in the presence of U0126 (MAPK/ERK cascade 
inhibitor) to see whether ERK is critical in mediating expression changes in OVX 
females, and males. However, there are other signalling kinases estradiol could 







This chapter highlights that estradiol-mediated increases in PSD-95 and GluN2B 
expression is via a local protein synthesis mechanism. As a result, there is an 
increase of PSD-95 and GluN2B at spines and PSD-95 along dendrites. 
Increased PSD-95 is dependent on mTOR in both sexes whereas, GluN2B is not. 
This contrasts with the fact that assessment of global protein synthesis indicated 
that mTOR was not required in the OVX female hippocampus, which could be 
attributed to the insensitivity to the methods employed in the current study. The 
data strongly supports that estradiol is able to increase translation along dendrites 
and within spines and moreover, modulate the distribution of ribosomes.  
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C H A P T E R  6  
 




S U M M A R Y  O F  F I N D I N G S   
 
Multiple lines of evidence have demonstrated that sex steroid hormones such as 
estrogens, particularly estradiol, can rapidly regulate cellular and behavioural function. 
Estradiol can enhance memory acquisition and consolidation within the hippocampus 
in both male and female rodents in a ‘non-genomic’ manner. The mechanisms 
underlying estrogenic-facilitation of memory are driven partly through the activation of 
signalling cascades, resulting in the modulation of synaptic structure and function. 
These signalling cascades have been implicated in modulating local protein synthesis. 
Corroborated with evidence that estradiol can rapidly regulate local protein synthesis 
machinery, it provides a potential role for estradiol to utilise a local protein synthesis 
mechanism. However, the molecular and cellular mechanisms that underlie estradiol’s 
ability to regulate local protein synthesis, and whether this is synonymous in both 
males and females are unknown.  
 
Firstly, the expression profile of key excitatory and inhibitory synaptic proteins was 
assessed in response to acute estradiol treatment. Estradiol was found to induce a 
sex-specific change at synapses by regulating the expression of both excitatory and 
inhibitory proteins within the male and OVX female hippocampus (Chapter 3). This 
resulted in an increase of several excitatory proteins. This is consistent with previous 
studies suggesting a shift of the E/I balance towards the excitatory side (Huang and 
Woolley, 2012; Mukherjee et al., 2017; Oberlander and Woolley, 2016). Additionally, 
estradiol induced a synonymous change in the excitatory and inhibitory synaptic 
proteome between the sexes. This suggests that estradiol may regulate synaptic 
plasticity through different mechanisms within the male and OVX female 
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hippocampus. A striking observation was that estradiol increased key excitatory 
proteins such as PSD-95 and GluN2B in both sexes within a time-frame that indicated 
a non-genomic mechanism was possibly being engaged. Consistent with this, an 
increase in the rate of protein synthesis was observed in concert with an increase in 
nascent proteins being produced or targeted to synapses (Chapter 4). Upon 
investigation, both biochemically and through ICC, estradiol was found to increase 
both PSD-95 and GluN2B near synapses suggesting estradiol was rapidly enhancing 
plasticity by orchestrating the increase of these key synaptic proteins (Chapter 5). 
Critically, data from Chapters 4 and 5 indicate that newly synthesised PSD-95 and 
GluN2B is being targeted to synapses. 
   
Within this context, one of the main objectives of this thesis was to establish whether 
estradiol could rapidly regulate protein synthesis in a local protein synthesis manner 
in the male and female hippocampus. Employing the SUnSET assay in an intact 
system to address this question, estradiol was demonstrated to increase protein 
synthesis in male and OVX female hippocampal slices within 2 hours (Chapter 4). 
This increase was attenuated in the presence of protein synthesis inhibitor suggesting 
estradiol was using a translation mechanism to induce an increase. This was 
confirmed when a gene transcription inhibitor had no effect on this increase, 
suggesting that estradiol may be employing local protein synthesis machinery to 
mediate this increase. This is consistent with previous studies that have shown 
estradiol is able to regulate proteins involved in the initiation of translation within 5 
minutes (Akama and McEwen, 2003; Fortress et al., 2013; Sarkar et al., 2010). In 
support, Chapter 5 illustrated increased puromycin incorporation near spines and 
within dendrites of estradiol treated primary hippocampal neurons. As puromycin 
incorporation terminates the elongation of amino acid polypeptides, it can be reasoned 
that there is an increase in active translation within spines and dendrites. Consistent 
with this, estradiol increased the distribution of ribosomal protein S10 near spines and 
within dendrites, the same subcellular locations as the site of translation (Chapter 5). 
This supported the notion that estradiol may be engaging ribosomal machinery to co-
ordinate translation. Amalgamating these findings with the FUNCAT assay to detect 
newly synthesised proteins, it was observed that nascent proteins were targeted to 
synapses in estradiol treated neurons, and this was found to be significantly increased 
in estradiol treated neurons compared to a vehicle control (Chapter 4). Within the 
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same time-frame, estradiol increased spine density. Notably, dendritic spines with a 
larger spine area were found to be significantly increased in response to estradiol. 
Additionally, more nascent proteins were found in larger spines in estradiol treated 
neurons compared to a vehicle control. Thus, this supports the scenario that the 
increase in both PSD-95 and GluN2B observed in spines could be dependent on a 
local protein synthesis mechanism. Therefore, based on these data, it is possible to 
propose a novel mechanism by which estradiol may be mediating the reorganisation 
synaptic architecture that may contribute to the memory enhancing effects of estradiol 
in the male and OVX female hippocampus.  
 
A recurrent theme within the thesis was that estradiol mediated plasticity in a sexually 
dimorphic manner upon a 2 hour treatment. Chapter 4 demonstrated that mTOR was 
required for estradiol to increase global protein synthesis within the male hippocampus 
but not within the OVX female hippocampus. Critically, it was seen that mTOR was 
required for estradiol to increase in PSD-95 in both male and OVX female 
hippocampus and GluN2B only in the males. This highlighted a caveat of using 
SUnSET to measure global protein synthesis as mTOR may be important in mediating 
the synthesis of a subset of proteins in the OVX females, such as PSD-95. Additionally, 
estradiol rapidly phosphorylated ribosomal protein S6 in the males but not OVX 
females. Therefore, the activation of this ribosomal protein may be important in 
increasing protein synthesis in the males, but that estradiol could be utilising different 
signalling molecules within a different pathway in the OVX female hippocampus. 
Overall, these findings demonstrate that estradiol increased protein synthesis through 
a local protein synthesis mechanism at synapses through distinct mechanisms in the 
male and female hippocampus. It was however, beyond the scope of this study to 
identify which proteins were being synthesised via a local protein synthesis manner 
following estradiol treatment. However, several lines of evidence from this study would 
indicate that the synthesis of synaptic proteins would be strong candidates. In the 
future, studies identifying which proteins are synthesised and moreover, whether they 
are targeted to and functionally integrated into synapses, will need to be carried out to 





I M P L I C A T I O N S  
 
A novel mechanism to regulate synaptic plasticity  
 
The regulation of the synaptic proteome underlies synaptic strength, and thus, also 
drives synaptic plasticity (Hafner et al., 2018). Indeed, local protein synthesis has been 
demonstrated to be necessary for synaptic plasticity such as L-LTP (Bradshaw et al., 
2003; Vickers et al., 2005), BNDF-induced stimulation (Kang and Schuman, 1995) and 
mGluR-LTD (Costa-Mattioli et al., 2009). Synaptic turnover is regulated by both local 
protein synthesis and protein degradation that work in concert (Alvarez-Castelao and 
Schuman, 2015). Proteins are synthesised and degraded continuously at synapses to 
modulate cellular function and allow change in response to an internal stimulus such 
as an action potential or external stimuli such as hormones or induced stimulation 
(Alvarez-Castelao and Schuman, 2015). These stimuli can locally increase synaptic 
protein expression either by protein trafficking or local protein synthesis. This provides 
synapses a rapid local control of their own pool of synaptic proteins to change and 
modulate its strength in response to these stimuli.  
 
The sexually dimorphic manner by which estradiol reorganises the synaptic proteome 
of both excitatory and inhibitory synapses suggest that estradiol is having differential 
effects in both sexes. These differences are important in understanding how estradiol 
affects synaptic plasticity as this may not be synonymous in each sex. Reiterating the 
notions of latent effects discussed by Oberlander and Woolley (2016), whereby 
different molecular mechanisms may underlie the same outcome in both sex, it is 
essential to consider both sexes in estradiol-related research. Indeed, this was evident 
within the current study when one signalling pathway did not mediate the increase in 
global protein synthesis in both sexes. This is particularly important when estradiol 
may be considered as a therapeutic target, since estradiol does not utilise the same 
signalling pathway it may mean that estradiol is also activating different ERs as 
observed by Oberlander and Woolley (2016) in vivo. A caveat to the current literature 
in estradiol research is that what we currently know about the signalling pathways and 
ERs mediating synaptic changes and behaviour is derived from OVX females 
highlighting the need for more research employing male rodent models. Significantly, 
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many laboratories have started considering using both animal models to investigate 
estradiol’s effects in the brain. Sexual dimorphism can be observed in a number of 
diseases therefore, it emphasises the need to consider sex as a variable to tailor sex 
specific treatments.  
 
A question that arises is that why would estradiol need to engage such a mechanism 
of local protein synthesis? Estradiol increases dendritic spines within 30 minutes in 
vitro, which has been shown to be independent of protein synthesis (Srivastava et al., 
2008). These novel spines however, are transient unless stimulated. Thus, this led to 
Srivastava et al. (2008) to propose the ‘two-step wiring plasticity’ model that purports 
estradiol increases the number of novel spines whilst causing the removal of GluA1-
containing AMPARs concomitantly with insertion of GluN1-containing NMDARs into 
new spines. However, stimulation could lead to the preservation of these nascent 
spines. Coupled with the trafficking of GluA1-containing AMPAR trafficking into the 
nascent spines this could result in enhanced synaptic connectivity over a longer 
period. The data from the current study shows that estradiol not only increased spine 
area, but also nascent protein within larger spines after 2 hours. Consistent with the 
‘two-step wiring plasticity’ model, one possible explanation could be that estradiol-
mediated increases in protein synthesis is required to stabilise the nascently formed 
spines through the synthesis of synaptic proteins specifically at synapses. This could 
suggest that the initial estradiol-dependent spine formation is independent of protein 
synthesis, but that nascent spine stabilisation is dependent on local protein synthesis. 
This would however need to be tested in future studies. But this stabilisation could 
contribute to the consolidation of memories (Sellers et al., 2015a). Significantly, there 
has only been one account looking directly at necessity of protein synthesis in the 
memory enhancing effects of estradiol. Recently, Sheppard et al. (2018) found that a 
sub-effective dose of anisomycin, but not actinomycin D, inhibited the enhancing 
effects of estradiol on a rapid paradigm (40 minutes) of social recognition in OVX 
females. This is the first study to directly consider whether protein synthesis is required 
for estradiol to increase memory acquisition, but further studies are warranted. 
Notably, there is an argument that protein synthesis inhibitors such as anisomycin, 
have been demonstrated to induce gene transcription in vivo, termed ‘gene 
superinduction’ (Radulovic and Tronson, 2008). The authors explained that decreased 
protein synthesis may occur within 1-2 hours following injection, but that gene 
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superinduction extends for several hours following injection. Thereby, it is not clear 
whether the inhibition could inhibit protein translation. These contradictory notions 
warrant further research in fully understanding the mechanism by which estradiol-
induced protein synthesis may contribute to memory.  
 
The very rapid effects of estradiol such as increase in spine density occur acutely in a 
protein synthesis independent manner. This is followed by a phase when there is 
protein synthesis, which may potentially be stabilising estradiol’s earlier effects. 
Interestingly, we have shown for the first time that estradiol can phosphorylate histone 
H3 in neurons through the cyto-nuclear shuttling of afadin and subsequent nuclear 
activation of ERK, which occurs within 30 minutes (Sellers and Watson et al., 2018). 
Indeed, the phosphorylation of histone H3 is associated with the initiation of gene 
transcription (Berger, 2007). Thereby, this event likely controls long-lasting changes 
in gene transcription that may eventually contribute to synaptic function although 
further testing is warranted before any conclusions can be made. However, it 
demonstrates that estradiol may be mediating gene transcription in a non-canonical 
manner. This is in line what is seen with the current study, where estradiol co-ordinates 
protein synthesis independently of gene transcription with 2 hours. Corroborating all 
these data, it seems that estradiol may rapidly be inducing changes to synaptic 
plasticity and neuronal circuitry. This mode of action is important compared to the 
classical way that estrogens are thought to occur as it gives a rapid control of 
modulating synapse structure and function thereby, contributing to long-lasting 
changes in neuronal circuitry.  
 
Relevance to neurological diseases  
 
Abnormal regulation of local protein synthesis has been demonstrated to be a critical 
factor in the pathophysiology of specific neurodevelopmental and psychiatric disorders 
(Liu-Yesucevitz et al., 2011; Swanger and Bassell, 2013). This emphasises the 
importance of gaining a further understanding of the molecular mechanisms controlling 
the process of protein translation to advocate potential therapeutic targets in the future. 
One such example is Fragile X Syndrome (FXS), which is characterised by the loss of 
the fragile X mental retardation protein (FMRP) caused by an expansion of CGG 
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repeats at the 5’ UTR in the fragile X mental retardation 1 (FMR1) gene (Richter et al., 
2015). FMRP is an RNA binding protein (RBP) that reversibly supresses the 
translation of specific proteins (Liu-Yesucevitz et al., 2011) such as the group I mGluR 
mGluR5 receptor and signalling molecules downstream of ERK and PI3/mTOR 
pathway (Darnell and Klann, 2013). Mouse models of FXS have exhibited elevated 
levels of protein synthesis in the absence of FMRP. Huber et al. (2002) found 
exaggerated mGluR-LTD in FMR1 KO mice and Bear et al. (2004) suggested that 
some symptoms may be due to excessive protein synthesis  downstream of group I 
mGluR activation. Decreased mGluR5 activity has been implicated in alleviating some 
symptoms in mouse models of FXS and Osterweil et al. (2010) have recently shown 
that inhibition of mGluR5 reduces protein synthesis. Interestingly, they found that 
inhibiting ERK also reduced protein synthesis, suggesting that it is the hyperactivity of 
both mGluR5 and ERK that may contribute to some symptoms of FXS. Following this, 
Osterweil et al. (2013) found lovastatin, an FDA-approved drug and a Ras-ERK 
inhibitor, normalised excess protein synthesis in FMR1 KO mice by inhibiting Ras and 
lowering ERK activity. The treatment with lovastatin is currently being tested in clinical 
trials. Due of the known safety profile of lovastatin, an open-label study found positive 
effects of lovastatin after 4 and 12 weeks of treatment in 16 individuals with FXS (Çaku 
et al., 2014). Recently, lovastatin has been shown to normalise ERK activity in FXS 
platelets (Pellerin et al., 2016). Thus, lovastatin normalises protein synthesis 
abnormality, which in turn normalises the synaptic protein or function deficits. 
Therefore, targeting a protein synthesis pathway or mechanism may be effective in 
other disorders.   
 
Alternatively other disorders show synapse loss such as Alzheimer’s disease (Koffie 
et al., 2011), schizophrenia (Osimo et al., 2018) and major depressive disorders (Kang 
et al., 2012). In a randomised trial, ketamine was found to produce rapid-acting 
antidepressant effects (Zarate et al., 2006). Recently, this has been thought to be 
driven by a local protein synthesis mechanism (Li et al., 2010). Current work within our 
lab has shown that ketamine increases protein synthesis resulting in the production of 
synaptic proteins (Creeney et al., under preparation). Ketamine therefore, targets a 
local protein synthesis mechanism similar to that of estradiol. This could be seen 
beneficial in disorders like Alzheimer’s disease and schizophrenia where synapse loss 
is profound. Estrogens seem to be neuroprotective but also neurorestorative and thus, 
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estradiol’s ability to regulate protein synthesis may result in an increase in synaptic 
proteins thereby reversing synaptopathies, similar to that of ketamine or lovastatin. 
Indeed, recent work from our lab have shown that estradiol rapidly rescues spine 
levels in a cellular model that recapitulates the loss of synapses by manipulating 
Disrupted in schizophrenia 1 (DISC1) (Erli et al., submitted). However, more research 
is warranted to test the beneficial effects of estradiol in the context of a local protein 
synthesis mechanism being therapeutic.   
 
L I M I T A T I O N S  A N D  F U T U R E  D I R E C T I O N S   
 
OVX female rodent models  
 
One of the challenges using intact female rodents to study the influence of estradiol is 
the naturally fluctuating hormone levels over the estrous cycle that could confound 
particular behavioural tests (Tuscher et al., 2015). Majority of what is known about the 
acute effects of estradiol at both cellular and behavioural levels in females in vivo has 
been reported by estrogen replacement in OVX models for this reason. This is 
particularly true in research investigating the effect of estrogens on memory (Choleris 
et al., 2012; Frick and Kim, 2018). As with a number of studies within the estradiol 
research field, the current study utilised OVX females. This approach eliminates 
circulating estrogens thus, the effect of exogenously applied estrogens can be 
measured. A caveat to keep in mind is that some androgens are synthesised in the 
adrenal cortex that may be aromatised into estrogens thereby, contributing to the 
effects being measured (Srivastava et al., 2013). Additionally, the time between 
ovariectomy and behavioural or molecular testing could account for variabilities with 
results within the experiment or across laboratories as hormone deprivation can have 
confounding effects. In support, studies have illustrated that ovariectomy decreased 
dendritic spines in the CA1, but not CA3 (Wallace et al., 2006), which has also been 
previously observed following ovariectomy (Gould et al., 1990). Subjects in Gould et 
al.’s (1990) study had been assessed for spine loss following 1 week of post 
ovariectomy and showed less spine loss than those within Wallace et al.’s (2006) 
study, who were assessed 7 weeks post-ovariectomy. Thus, hormone deprivation 
begins to alter the synaptic architecture over time (Wallace et al., 2006). This highlights 
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the importance of keeping the time post ovariectomy the same between animals to 
ensure consistency over the data. This was maintained within the study where the 
vendors transported the OVX females 1 week post-ovariectomy and the animals were 
sacrificed within a 3 days period following 3 days of habituation. A future direction to 
consider however, would be to assess the changes in global protein synthesis in 
naturally circulating female mice. This would provide a greater insight into the effect of 
estrogens in regulating protein synthesis generally.     
 
Alternative methods to investigate local protein synthesis  
 
A limitation to this experimental set up was that estradiol was applied to the whole 
neuron. Thus, in addition to activating receptors specific for estrogens along dendrites, 
estradiol would also activate nuclear estrogen receptors. Thereby, the read out of 
protein translation at dendrites might have some influence from the soma. A number 
of studies have used severed neuronal dendrites from their cell bodies to specifically 
investigate local protein synthesis in neurons, without contribution from gene-
transcription-dependent translation (Huber et al., 2000; Kang and Schuman, 1996; 
Tsokas et al., 2005). Critically, dissociating dendrites from their soma compromises 
the integrity of the neuronal circuitry the neurons have created within a dish (Taylor et 
al. 2010). Recently Taylor et al. (2010) have developed microfluidic perfusion 
chambers where single cell neurons are seeded in one part of the chamber and as 
they develop, the dendrites and axons extend out through microgrooves to another 
compartment. Through fluidic concentration gradients, the dendrites and axons are 
maintained in microenvironments allowing local perfusion of dendrites. Recently, 
FUNCAT has been shown to be coupled with microfluidic chambers to show new 
protein synthesis at dendrites, without engaging any somatic mechanisms (tom Dieck 
et al., 2012). A future direction to consider is measuring estradiol-mediated increases 
in newly synthesised proteins using microfluidic chambers by perfusing estradiol 
directly at dendrites to eliminate any contribution of somatic activity. Other methods to 
consider complementing the current data is using approaches that detect mRNAs 
bound to ribosomes such as the Translating Ribosome Affinity Purification (TRAP) 
method. This approach labels polyribosomes containing translating mRNAs using a 
neuronal cell type specific promoter  (Heiman et al., 2014; Vlatkovic and Schuman, 
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2016). This approach allows an in situ profiling of a cells mRNA translational profile 
within a specific type of cell (Heiman et al., 2014). Additionally, it would provide spatial 
information about where actively translating mRNAs can be visualised in estradiol 
treated neurons. However, the current study was targeted in looking at synaptic 
proteins. This is a caveat as estradiol has a number of effects within the brain and so 
a large number of proteins are likely to be synthesised in response. Thus, to appreciate 
the full extent of the implications of estrogenic-regulation of protein synthesis we need 
to identify other proteins that are also being regulated within the current time-frame of 
2 hours via an unbiased approach using mass spectrometry.  
 
Multiple lines of evidence within the current study provide support for the notion that 
PSD-95 and GluN2B could be locally synthesised near synapses upon estradiol 
treatment. An ideal experiment to complement this hypothesis would be to track PSD-
95 or GluN2B mRNA translation along dendrites. PSD-95 translation events have 
previously been tracked at a single molecule level in vitro utilising a venus fluorescent 
protein tagged to 3’ UTR of PSD-95 through live imaging (Ifrim et al., 2015). Another 
method to consider is to monitor new synthesis of specific proteins is to use time-
specific tagging for the age measurement of proteins (TimeSTAMP) (Butko et al., 
2012; Lin et al., 2008). The method uses the fusion of the hepatitis C virus protease 
to an epitope or fluorescent tag within a protein, which can remove itself under basal 
conditions. In the presence of specific inhibitor however, this removal can be blocked 
thereby, tagging newly synthesised candidate protein paired with a pharmacological 
treatment to assess newly synthesised proteins in response to the pharmacological 
application. Alternatively, Erin Schuman’s laboratory developed a novel approach 
coupling SUnSET and the proximation ligation assay (PLA; puro-PLA) to visualise 
specific newly synthesised proteins in situ. PLA detects the spatial coincidence of two 
antibodies: one that tags newly synthesised proteins (puromycin) and the one that tags 
a protein target of interest (e.g. PSD-95/GluN2B) (tom Dieck et al., 2015). Newly 
synthesised proteins are incorporated with puromycin and a puromycin antibody is 
used to identify them and a second protein specific antibody is used such as PSD-95. 
Following this, secondary antibodies coupled to different oligonucleotides, PLAplus and 
PLAminus are added. When they are in close proximity, a fluorescent signal is obtained 
via linker oligonucleotides and a ligase creating a ‘rolling circle amplification’ and 
binding the fluorescently coupled detection probes; this protocol was detailed from tom 
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Dieck et al. (2015). This is an advantageous approach to consider in future 
experiments to identify estradiol mediated newly synthesised PSD-95 and GluN2B 
specifically at dendrites. Indeed, SUnSET is a fast and easy labelling approach and it 
would indeed give us in depth information of the site of translation of specific proteins. 
However, as discussed in Chapter 2, puromycin would lead to premature termination 
of the labelled polypeptide chain and enhanced degradation of truncated proteins, and 
this should be considered when attempting puro-PLA. As a substitute tom Dieck et al. 
(2015) also proposed that the PLA assay could be paired with FUNCAT (FUNCAT-
PLA), which would be a better alternative. The incorporation of AHA would be as 
detailed in Chapter 2 and due to its mechanism of action, full length proteins would 
be labelled thereby, avoiding any truncated proteins. Although, the incorporation and 
labelling is slower compared to SUnSET as it involves an extra step of click chemistry, 
it is a better alternative when tracking the synthesis of proteins over a few hours, or 
days (tom Dieck et al., 2015). Overall, these techniques all are excellent 
considerations to investigate and visualise estradiol mediated translation of PSD-95, 
GluN2B and any other candidates in the future.       
 
With the knowledge that estradiol may be rapidly mediating the translation of PSD-95 
and GluN2B near synapses, other proteins important for synaptic plasticity may also 
be translated. Alternatively, estradiol may induce the translation of a subset of proteins 
implicated in diseases. The proteins selected in Chapter 3 were chosen because of 
their important roles at excitatory and inhibitory synapses. Many other prominent 
proteins were not looked at that also have a key role at synapses. Therefore, unbiased 
approaches are warranted to identify target proteins estradiol is translating within 2 
hours in both male and OVX female hippocampus. 
 
Other signalling cascades implicated in estradiol-mediated protein synthesis  
 
A pathway that has been investigated and implicated in estradiol research that may 
contribute to the estradiol-mediated global protein synthesis in OVX females is the 
PI3K/Akt pathway. Estradiol phosphorylates Akt within 5-15 minutes in vitro and in vivo 
(Akama & McEwen 2003; Briz & Baudry 2014; Fan et al. 2010; Sellers et al. 2015b) 
and activates ERK through Akt in the dorsal hippocampus (Fan et al., 2010). This 
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demonstrates a complex cross-talk between these kinases. The Akt pathway also 
leads to activation of mTOR (Li et al., 2004) but can increase phosphorylation of 
4EBP1 directly as well (Gingras et al., 1998). Fan et al. (2013) proposed a signalling 
model which suggested that estadiol activates PI3K, which activates ERK directly or 
indirectly via Akt suggesting a close relationship between these two signalling 
pathways. Akt has been reported to be necessary, alongside ERK and mTOR, for 
enhancing OR and OP memory tasks in response to estradiol in OVX female rodents 
(Fortress et al., 2013). But it is not clear whether these kinases depend on each other, 
cross-talk with each other, or even regulate the same processes in response to 
estradiol. Nevertheless, it is possible that Akt and ERK may be converging in 
increasing protein synthesis in OVX females in response to estradiol. An important 
experiment to conduct would be to inhibit both ERK and Akt pathways to see if either 
or both are required to increase estradiol-mediated global protein synthesis.  
 
Role of ERs 
 
A subsequent step to fully understand estradiol’s mediation of local protein synthesis 
would be to assess which receptor is driving this increase. Particularly, it would be 
interesting to see whether the same receptor mediates these effects of estradiol in 
both sexes. Nevertheless, the scope of this study was to consider whether estradiol 
induces protein synthesis in a local protein synthesis dependent manner. Future 
studies are warranted to investigate which ERs are important for this effect. 
Additionally, a caveat to the current study is that a bath application of estradiol was 
used and so multiple ERs and other receptors could also be activated. Possibly, one 
ER is specifically driving the effects on protein synthesis which can be determined in 
vivo as there is a tight regulation of estradiol signalling thus, protein synthesis could 
be occurring only at select synapses in select circuits. However, having the type of 







Estrogenic signalling within the cerebral cortex 
 
There is mounting evidence on the role of estrogens within the hippocampus and has 
been the focus of many studies. However, work from our lab has exhibited an 
important role of estradiol signalling within the cerebral cortex (reviewed in Sellers et 
al. 2015a). ERs are also present in the cortex (Almey et al., 2015; Milner et al., 2001, 
2005) and have been localised to dendrites in vitro (Sellers et al. 2015b) in addition to 
the presence of aromatase (MacLusky et al., 1994; Yague et al., 2006) at synapses 
(Srivastava et al., 2010). Indeed, there are some similarities in the cellular effects of 
estradiol within the hippocampus to that of the cortex for example, rapid increase in 
dendritic spines (Sellers et al., 2015b; Srivastava et al., 2008, 2010). However, the 
underlying molecular mechanisms mediating estrogen’s actions within the cortex may 
be distinct to that of hippocampus. Preliminary in vitro results from the current study 
investigated estradiol’s effect on global protein synthesis following 2 hour treatment 
biochemically in primary cortical neurons and prefrontal cortex slices from male and 
OVX female mice. The results were synonymous to the results reported in this study. 
However, more experiments to this depth are needed to decipher the signalling 
pathways needed to increase protein synthesis and whether it is dependent on a local 
protein synthesis mechanism.       
 
C O N C L U D I N G  R E M A R K S   
 
This study highlighted the importance of considering both sexes when investigating 
molecular mechanisms underlying a cellular process. Sex differences have been 
found in many prominent diseases including AD and schizophrenia. Therefore, 
considering sex as a variable is of importance to tailor treatments to each sex. This 
study is first of its kind to directly demonstrate that estradiol mediates an increase in 
protein synthesis, in a local protein translation manner, in both male and OVX female 
hippocampus. It proposes a novel mode of estrogen signaling that could result in long-
lasting changes in neural circuitry and cognitive function. Albeit more studies are 
warranted to identify what proteins are being rapidly synthesised, which could aid in 
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A P P E N D I C E S  
 
Appendix 1 Puromycin antibody validation for Surface Sensing of Translation 
(SUnSET) assay. A-C, In the absence of puromycin treatment, the puromycin 
antibody did not bind to any signal in DIV 24 primary cortical neurons (A+B) and 
male acute hippocampal slices (B). This signal was reduced in the presence of 
protein synthesis inhibitor, anisomycin (A). This was validated both through 
western blotting for SUnSET-WB (A-B) and immunocytochemistry for SUnSET-









































































Appendix 2 Time course for mTOR activation over 2 hour estradiol treatment. 
A+B, Representative western blot and quantification of DIV 25 primary cortical 
neurons temporally treated with 10 nM estradiol. Estradiol rapidly activated 
mTOR with 30 minutes, and this persisted until 60 minutes; n=6 per condition. 
One-way ANOVA, Bonferroni corrected; Error bars represent mean ± SEM; ** p 
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Appendix 3 Validation of Fluorescent noncanonical amino acid tagging 
(FUNCAT) assay. A+B, Representative 20x (A) and 40x (B) confocal images of 
primary cortical (A) and hippocampal (B) neurons. A Pseudocolor lookup table 
indicated higher AHA-tagged newly synthesised proteins along dendrites after 2 
hour 4 mM AHA treatment compared to 30 minutes. B In the absence of AHA, 
the Alexa Fluor 555-Alkyne tag does not fluoresce any signal. The signal is 
decreased in the presence of protein synthesis inhibitor, anisomycin. Scale bar =  
100 µm (A) and 50 µm (B). 
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